|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/4/2 ¤W¤È 09:36:27
|
¯E¹©°O¡G 1¡n¯E¹©2015¦~3¤ë¥¿¦¡±q¿³ÂdÂà¤WÂd,«o±q400¤¸¶^¨ì250¤¸ 2¡nÀHµÛ¸Ñª¼®É¶¡±µªñ,¥«³õ¤W°ª«×ªºÃöª`»P°l±·,¿v©³Ãk¤É¨ì750¤¸ªº¤Ñ»ù 3¡n2016/2/21¸Ñª¼«á, ¥Ñ©ó¸Ñª¼¥¼¹F¹w¥ý³]©wªº¥Ø¼Ð, ¦A¥[¤W¦W¼L¥ß©e´CÅé½Ñ¦h¥H³_¶Ç³_,¥H°¾·§¥þ, ¥B¥¼¸gÃҹꪺ«ü±± ÁöµM¤½¥q»¡¯à°÷²£¥Í§ÜÅ骺±Ú¸s´N¯à°÷²£¥ÍÁ{§É¤WªºÀø®Ä,©ó¬O¦³©Ò¿×ªº"¤@ӸѪ¼,¨âºØ¸ÑŪ,¦U¦Ûªíz" ¤@¸ô¤U¶^¨ì350¤¸¥ª¥k 4¡n¦ý¦b2016/3/31²×©óªï¨ÓÀò±oASCO Oral presentationªº®¶¾Ä®ø®§,4¤ë1¤é·M¤H¸`·í¤Ñ,ªï¨Ó¤F¤[¹Hªº¤@¸ôº¦°±ªO 5¡n6¤ëªìªºASCO, ÁÞ¤k§Y±N´¦¶}¦oªº¯«¯µ±¯½ ¨Ì¾Ú²Î¤@§ëÅU±i¥ß¸s¤ÀªR®v¬ã¨s¡G https://www.google.com.tw/url?sa=t&rct=j&q=&esrc=s&source=web&cd=2&cad=rja&uact=8&ved=0ahUKEwins9egnPzLAhVikIMKHcc1DN8QFgggMAE&url=http%3A%2F%2Fpcmc.uni-psg.com%2Fvip%2F20160226-01.pdf&usg=AFQjCNHCCWDKl493HzcquFVIcJoolRPgnQ »PµL±¡¤jªº¤ÀªR¡G http://tsjh301.blogspot.tw/2014/08/obipharma.html ¥»µÛªø´Á§ë¸ê, °l®Ú¨s©³ªººë¯«¨Ó±´¯Á¯E¹©ªº§ë¸ê»ùÈ, ¤£¦]µu´ÁªÑ»ùªi°Ê°_¥ñ¦Ó¼vÅT¹ï "¥þ²y²Ä¤@ÁûFirst in class, Best in classªº§ÜÀùÁÞ¤À¤l¥þ·sÃĪ«"§ë¸êªº¼ö±¡ ¨ÃÅé²{¤½¥qÄ@´º: "³Ð³y¥xÆW¥Í§Þ«~µP,¦¨¬°Àù¯gÀøªkªº¥þ²y»â¯èªÌ" "2025¦~¦¨¬°¥xÆW¥Í§Þ²Ä¤@«~µP, 2035¦~¦¨¬°¥þ²yÀù¯gªvÀø»â¾É¤½¥q" Åwªï¤À¨É¥ô¦ó¹ï¯E¹©Ä@´º»P»ùȵû¦ôªº¬Ýªk»P°ª¨£~~ |
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/13 ¤U¤È 08:30:52²Ä 3900 ½g¦^À³
|
±N¥xÁÞ¤j´£¨Ñªº¼Æ¦r°µ¤@¨Ç¥[´î¼°£¡A±o¨ì¥H¤UÆ[¹î¡G 1. ±N·í¦~¨ÅÀù¦º¤`¤H¼Æ°£¥H·s¼W¯f¨Ò¡A¤w¶}µo°ê®a§¡È¬ù0.251¡A¦Ó«D¬w»PªF«n¨È¬w«h±µªñ0.5¡C¤j³°¥u¦³0.257¡A±µªñ¤w¶}µo°ê®a¤ñ¨Ò¡A³oªí¥Ü¨äÂåÀø¤ô·Ç¸û±µªñ¤w¶}µo°ê®a¡AÁÙ¬O·s¼W¯f¨Ò³t«×¦¨ªø§Ö¡AÁÙ¬OHER2+±wªÌ¤ñ¨Ò¸û§C¡H 2. ±N·í¦~·s¼W¯f¨Ò¼Æ°£¥H¤¦~¦s¬¡¤H¼Æ¡A¤w¶}µo°ê®a¬ù¬°0.246¡A¤¤°ê¤j³°¬°0.268¡C³oӼƦr¥i¯àªí¥Ü¤¤°êªº«e´ÁÀˬd©|¥¼¥þ±´¶¤Î¡A¦]¦¹¦b´£°ªÀˬd´¶¤Î²vªº¹Lµ{¤¤¡A·s¼W¯f¨ÒÂX¼W¡A¦Ó¤¦~¦s¬¡¼Æ¦rº¢«á¡CYÂåÀø¤ô·Ç¬Û·í¡A«h·í¤¤°êªº¨ÅÀùÀˬd´¶¤Î¤§«á¡A¦¹¤@¤ñ¨Ò·|³vº¥¦¬ÀĦܵo¹F°ê®a¤ô·Ç¡C 3. ¤j³°ªº¨C¦~¦º¤`¤H¼Æ»P¬ü°ê¬Û·í¡A¦ý»·§C©ó¦L«×¡CY¦Ò¼{¤H¤f¤ñ¨Ò¡A¤j³°¦¹¤@¼Æ¦r»·§C©ó¥@¬É¤ô·Ç¡C¨âÓ¥i¯à¡A¤@¬O¤¤°ê¤Hªº°ò¦]»P¥Í¬¡²ßºD¾ÉP¨ÅÀùµo¯f²v§C¡F¤G¬O¤¤°ê¦³³\¦h¨ÅÀù±wP¦ºªÌ¨ä¯f¦]¥¼³QÀˬd¥X¨Ó¡C¦ý¬O¦L«×ÂåÀø¤ô·Ç¸û¤¤°ê¤j³°¸¨«á¡A©Ò¥H«áªÌªº¾÷²v¤£¤j¡C¤Ï¦Ó¥i¯à¬O¤j³°¦´ÁÀË´ú¤ñ¨Ò°ª©ó¦L«×¡A±Ä¨ú¦´ÁªvÀø¤ñ¨Ò°ª¦Ó¨Ï±o¦º¤`²v°§C¡A¦L«×Y©µ¦Ü¸û±ß´Áµo²{¡A¦º¤`²v»P¦º¤`¤H¼Æ³£·|¼W°ª¡C 4. ¥þ²y¨ÅÀù¦º¤`¤H¼Æ¤@¦~¹F¤¤Q¸U¥H¤W¡A¬ü°ê»P¼Ú·ù°ê®a¶È¥e¤Q¥|¸U¡A¤£¨ì¨ä¤¤ªº¤T¦¨¡A¦Ó¥Ø«e¨ÅÀù¼Ð¹vÃĪ«ªº¥«³õ¤´µM°ª«×¶°¤¤©ó¤Wz¨â¦a¡CÀHµÛ¶}µo¤¤°ê®aªº¸gÀÙµo®i¡A°ê¥Á©Ò±o´£°ª¡A°ª»ù¨ÅÀù¼Ð¹vÃĪ«ªº¥«³õ²×±NÂX´²¦Ü¥@¬É¤W¤j¦h¼Æ¦a¤è¡C¯E¹©°£¤F¶Ç²Îªº¼Ú¬ü¥«³õ¤§¥~¡A¦b¶}µo¤¤°ê®a¨ä¹ê¦³³Ì¤jªº¥«³õ¼ç¤O¡C¡]Y833¶}µo¦¨¥\¡A¤£¦A¨Ï¥Î°ª¦¨¥»ªºKLH³J¥Õ½è¸üÅé¡A»sÃĦ¨¥»©Î¥i§ó¬°°§C¡A¨Ï±o¶}µo¤¤°ê®a¤H¥Á¤]¦³¸û¤jªº¯à¤O¥i¥H¨Ï¥Î¦¹¤@Àøªk¡C¡^ 5. ¶}µo¤¤°ê®a¡]¦p¦L«×»P«D¬w¡^¨C¦~¦]¨ÅÀù¦º¤`¤H¼Æ±µªñ·í¦~·s¼W¯f¨Ò¼Æ¤§¥b¡AÅã¥Ü¨ÅÀù¦h¥b¬O±ß´Á¤~³Qµo²{¡A¦]¦¹P¦º²v°ª¡C³o¤]Åã¥Ü¥¼¨Ó868¦b³o¨Ç¦a¤èªº¥«³õ¾÷·|«Ü¤j¡C¦´Áµo²{¡A¤£¦ý¥i¥H°§CP¦º²v¡A¤]¥i¥H°§C¾ãÅéªvÀø¦¨¥»¡C¹ï¶}µo¤¤°ê®a¬O§C¦¨¥»¤è®×¡C ¥xÁÞ¤j¡A¤p§Ì¦~¨Æ¤w°ª¡AµLªk¥¿¦¡¥Ó½Ð¶i¤J¯E¹©¤u§@¡CY±z¶i¤J¯E¹©¥«³õ³¡¡A¥i§_¬°¤p§Ì³Ð³y¤@Ó¡y°ªÄÖ¹ê²ß¥Í¡zªº®y¦ì¡A¥u¨D¨C¤é¥´µo®É¶¡¡H |
|
|
·|û¡G561910141205 µoªí®É¶¡:2016/4/13 ¤U¤È 07:16:55²Ä 3899 ½g¦^À³
|
ÁÂÁÂ¥xÁÞ¤j´£¨Ñªº¸ê®Æ¡C¨ÅÀùÃĽT¹ê¬O¤jÃÄ¡C¥¼¨Ó´X¦~ªº²Îp¡AÀHµÛ¥Í¬¡¤ô·Ç´£¤É¡A¤¤°ê©M¦L«×ªº¯f±w¼ÆÀ³¸Ó·|¨³³t¼W¥[¡C Ãö©óconditional approvalªº©w¸q¥H¤Î©Mfull approval ªº®t²§,¤p§Ì¦bFDAªºAnimal & Veterinary°Ï¦³§ä¨ì¡A¦bDrugs°Ï«o§ä¤£¨ì¡C¯à§_½Ð±Ð¥xÁÞ¤j©M¹x¥Û¤j¡H |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/4/13 ¤U¤È 05:47:11²Ä 3898 ½g¦^À³
|
¥xÁÞ¤j ±z¹ïÀù¯g¥«³õªº¬ã¨s²`¤J n¤£n¥hÀ³¼x¤½¥qªº¥«½Õ Á`¤§ ·PÁ±zªº¤À¨É |
|
|
·|û¡GLu10141514 µoªí®É¶¡:2016/4/13 ¤W¤È 09:55:38²Ä 3897 ½g¦^À³
|
°ß±©¤j¡B¶O¤j¡G9999¤Î10000¡A§Ąâ¤H´N¦Uµoªí¤@½g§a¡A¤£¤H¨S¤H´±µo¨¥¡I |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/4/13 ¤W¤È 09:03:52²Ä 3896 ½g¦^À³
|
¯E§J¤j ¨ÅÀù¬O¤jÃÄ ¯E¹©°w¹ï¤jÃÄ¥ý¬ãµoªºµ¦²¤¬O¹ï( ¨ÅÀù ªÍÀù ¤j¸zÀù GÀù ) ºë·Çªº¦ôºâ¥þ²y¨ÅÀù¤H¼Æ¬Û·í§xÃø ¥u¯à¬ù²¤¦ôp ¥[¤W¦U°êÂåÀø¤ô¥¤£¤@ ¤]·|¼vÅT§PŪ»P²Îp «e½g¶K¤åªº²Îp¤£¤@©w¨º»òºë½T ,¶È¨Ñ°Ñ¦Ò,¤U±³o¤@«h¸ê°Tªº²Îp¬O¥H2012¦~¨Ó²Îp,À³·|§óºë½T Breast Cancer Estimated Incidence, Mortality and Prevalence Worldwide in 2012 Estimated numbers (¤d thousands) Cases·s¼W®×¨Ò / Deaths¦º¤`¼Æ / 5-year prev.¤¦~ World 1671 522 6232 More developed regions 788 198 3201 Less developed regions 883 324 3032 WHO Africa region (AFRO) 100 49 318 WHO Americas region (PAHO) 408 92 1618 WHO East Mediterranean region (EMRO) 99 42 348 WHO Europe region (EURO) 494 143 1936 WHO South-East Asia region (SEARO) 240 110 735 WHO Western Pacific region (WPRO) 330 86 1276 IARC membership (24 countries) 935 257 3591 United States of America 233 44 971 China 187 48 697 India 145 70 397 European Union (EU-28) 362 92 1444 globocan.iarc.fr/old/FactSheets/cancers/breast-new.asp |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/4/13 ¤W¤È 08:24:22²Ä 3895 ½g¦^À³
|
¥xÁÞ¤jªº¤ÀªR ½T¹ê¬O¨Ì¾Ú±i¸³¦b»¡©ú·|ªº»¡ªk §ÚÌÀ³¸Ó¼ö¤Á´Á«Ý»P±K¤ÁÆ[ |
|
|
·|û¡G·x·x10141215 µoªí®É¶¡:2016/4/13 ¤W¤È 12:15:15²Ä 3894 ½g¦^À³
|
¥xÁÞ¤j¡GÁÂÁ¡I |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/4/12 ¤U¤È 11:58:42²Ä 3893 ½g¦^À³
|
¹x¥Û¤j ²³¤j¤j 1 ¥_¬ü ¥[ ¼Ú·ù ¤é¥» ¥xÆW Áú°ê »´ä ·s¥[©Y ( ¤£¥]¬A¤¤°ê ªF¨ó ¤¤«n¬ü¬w ¦L«× ) Stage 4 ¨ÅÀù¤H¼Æ¬ù50¸U¤H,°²³]·|²£¥Í¦³®Ä§ÜÅé¤ñ²v¬°70% ¬ù¦³35¸U¤H ³oÓ¥«³õ¤w¸g°÷¤j¤F ¤T¦~¦~¤º¯à¹F¨ì8¸U¤H¨Ï¥ÎOBI822 ¤w¸g¬Oªñ800»õÀ禬¤F (¥H¤@¦~3¸U¬üª÷ÃĶO) 2 ¦pªGªk»¡·|°÷¥Î¤ß¥hÅ¥¬ÛÃö»¡©úªº¸Ü,¦U¦ì¤j¤j·|µo²{¯E¹©¥Rº¡¶¯¤ß§§§Ó ¤£¬O¥u¦³·Qnì±o conditional approval ¦Ó¤w 3 ¯E¹©°£¤F¥H³ÌÀu²§¼Æ¾Ú»PFDA·¾³qª½±µ ®Öãconditional approval ¥~,¤]§Æ±æFDA¦P·N§äStage 3 Stage 2 ©Î Stage1 ªº¯f±w¨Ó¶i¦æÁ{§É,©¹«e±À¶i,ÂX¤j¨Ï¥Î¤H¤f 4 °÷¥Î¤ßÅ¥ÁÙ¤£°÷, ÁÙn«ä¦Ò½×z«á±ªº·N¸q 5 °²³]¥½´Á¨ÅÀùªº¯f±w¯à²£¥Í1000³æ¦ìªº§ÜÅé¶q( ²£¥ÍÀø®Äªº°²³]¶q) °²³]Stage 3 Stage2 Stage1 ¥´§¹´ú¸Õ°w ¼Æ«á¤]¯à²£¥Í1000¦ý¦ìªº§ÜÅé¶q©Î¤ñ1000³æ¦ì§ó°ªªº§ÜÅé¶q ¯E¹©¥i¥H»P¬ü°êFDA·¾³qÂX¤j®Öã¨Ï¥Î½d³ò ÁöµM¸³ªº¬O¦b»¡¹w¨¾ ¨ä¹êÅÞ¿è±À²z«á§ÚÓ¤Hµo²{ Stage 3 Stage2 Stage1 ¤]¯à¾A¥Î³oÓ»¡ªk 6 ¥H¥_¬ü »P ¼Ú·ù ¨ÅÀù¤H¼Æ¤ÀªR ( ²Î¤@±i¬ã¨sû¤ÀªR) Stage3 ªº¯f±w¼Æ¬ù¬O Stage 4 ªº2¿¦h¤@ÂI Stage2 ªº¯f±w¼Æ¬ù¬O Stage 4 ªº3¿¦h¤@Áx Stage1 ªº¯f±w¼Æ¬ù¬O Stage 4 ªº10¿ ¥H¤W¤À¨É ¶È¨Ñ°Ñ¦Ò ¦³¨Ç¬OÓ¤H¸ÑŪ ťť´N¦n §ë¸êª`·N·ÀIºÞ±± |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/12 ¤U¤È 10:34:59²Ä 3892 ½g¦^À³
|
¥xÁÞ¤j¡A 822 ¦pªG¯à®³¨ì conditional approval¡AÀ³¸Ó¤]·|ÁY¾AÀ³¯gªº±ø¥ó¡A¦P¼Ë·|¼vÅT¨ì¥«³õªº¤j¤p¡C ¨s³º 822 ªì´Á¾A¥Îªº¯f¤H±Ú¸s¯à¦³¦h¤j¡A¥Ø«e¤£©y¤Ó¼ÖÆ[¦ôp¡C |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/4/12 ¤W¤È 09:48:22²Ä 3891 ½g¦^À³
|
¹x¥Û¤j A Ibrance¥Î©ó¥¼±µ¨ü¹L¨t²ÎªvÀø¥H±±¨î±ß´Á¯f±¡ªºµ´¸g«á¤k©Ê»Û¿E¯À¨üÅ鶧©Ê¡]ER+¡^¡B¤Hªí¥Ö¥Íªø¦]¼Æ¨üÅé2³±¡]HER2-¡^§½³¡±ß´Á©ÎÂಾ©Ê¨Å¸¢ÀùªºªvÀø¡C (¨Ï¥Î½d³ò³QÁY) (°Æ§@¥Î¤è±°ÝÃD¤£¤Ö)(¬Ý¤£¥XÀu²§ªºÁ`¦s¬¡´Á) (¤£¬OÀù¯g§K¬ÌÀøªk) ¥Ñ©ó¥H¤W¨î ©Ò¥H½÷·çªº¾P°â¹Î¶¤¹ïIbrance ¥¼¨Óªº¾P°âÃB¤£´±¦ô¤Ó°ª B ¨ÅÀùOBI822 ¾A¥Î½d³ò¤j, ¥ô¦ó¨ÅÀù¨È«¬³£¥i¥Î, °±¸g«e, °±¸g«á³£¥i¾A¥Î,°ª¦w¥þ©Ê»P¥Í¬¡«~½è, ÄÝ©ó·s¤@¥NÀù¯g¥D°Ê§K¬ÌÀøªkÃĪ«,¨ãÁ`¦s¬¡´ÁÀu¶Õ,®aÄÝ·ÓÅU»P¬I¥´ÃĪ«¬Û·í¤è«K |
|
|
·|û¡Gchen605310138636 µoªí®É¶¡:2016/4/12 ¤W¤È 08:27:00²Ä 3890 ½g¦^À³
|
¤§«eªº·s»D,¦p¤U 辉·ç IBRANCE®¡]palbociclib¡^获±o FDA ¥[³t§åã 2015-02-05 11:57 来·½¡G¤B»û\¦rÊ^¤j¤p-|+ FDA §åãº个细M©P´Á³J¥Õ¨Ì赖©Ê¿E酶 4/6¡]CDK4/6¡^§í¨î剂¡C 现¦b IBRANCE ¥i¥HÉO来¦±Ðü联¦X应¥Î§@为ªv疗 ER 阳©Ê /HER2 阴©Ê绝经¦Z转²¾©Ê¨Å¸¢Àùªº¤@线ªv疗¡C ¬P´Á¤G, 2015 ¦~ 2 ¤ë 3 ¤é 6:00pm EST -- 辉·ç¤½¥q¤µ¤Ñ«Å¥¬¬ü国¹«~ÉO药«~ºÞ²z§½ ¡]FDA¡^¤w经¥[³t§åã¤F IBRANCE® ¡]palbociclib¡^联¦X来¦±Ðü§@为内¤Àªcªv疗为°ò础ªºªì©l¤è®×¥Î¤_ªv疗 ER+/HER2- 绝经¦Z±ß´Á¨Å¸¢Àù¡C FDA ¬O°ò¤_¨äÆÓ进®i¥Í¦s´Á¡]PFS¡^ ¥[³t§åã¤F这¤@Óì应¯g¡C¦P时¤]将®ÚÕu验证临§É¬ã¨s¯à§_验证©M´yz临§É获¯q¦Óú¨©w¬O§_给¤©«ù续§åã¡C¨ä 3 ´Á验证临§É试验, PALOMA-2, ¤w经§¹¦¨¤J组¡C FDA 给¤©¬ð¯}©Êªv疗认©w©Mɬ¥ý审评项¥Ø°ò础¤W审评¦}§åã¤F IBRANCE¡C IBRANCE ¬O°ò¤_ 2 ´Á临§É试验 PALOMA-1 ¬ã¨s³Ì终结ªG´£¥æªº·s药¥Ó请¡C¦b PALOMA-1 ¬ã¨s¤¤³Ì±`见报§iªº¤£¨}¨Æ¥ó为¤¤©Ê²É细Mú£¤Ö¡C¤F¸Ñ IBRANCE 联¦X来¦±Ðüªº§ó¦h关¤_严«©M³Ì±`见ªº°Æ¤Ï应¡A请参见¥»¤å³Ì¦Zªº IBRANCE «nªº¦w¥þ©Ê«H®§¡C ¡§§Ú为 IBRANCE 临§É项¥Ø¦Ó·P¨ì骄¶Æ¡AIBRANCE ¬O¥Ñ辉·ç实验«Ç发现¡A¦}¥B¤µ¤Ñ§Ú们¯àû{将这¤@创·s带给¨Å¸¢Àùªº±wªÌ¡Cª`册试验显¥Ü¡AÉO单药来¦±Ðü¤ñ较¡AIBRANCE 联¦X来¦±Ðüªv疗 ER+/HER2- ±ß´Á¨Å¸¢Àù±wªÌ¯àû{将¦Ü肿½F进®i时间©µ长¤@¿¡A©µ¦Z¤F¦Z续¥]¬A内¤Àªc药ª«©M¤Æ疗ªv疗ªº»Ý¨D¡A¡¨ 辉·ç¤½¥q¸³¨Æ长©M CEO ®Ë·ç¼w¡]Ian Read¡^ªí¥Ü¡C ¡§FDA ¤µ¤Ñ§åã¤F IBRANCE 标§ÓþÓ¤@个«nªº¨½µ{¸O¡C这证实¤F§Ú们学术ªº¤O¶q¡A为±wªÌ´£¨Ñ¤F«nªº药ª«¡A¤]®i现¤F§Ú们¯àû{为ªÀ会©Ò§@贡þY¡C¡¨ IBRANCE¡]palbociclib¡^¤w经¥i¥H¥ß§Y³q过¯S©wªº专业药©Ð订购¡]仅¤_¬ü国¡^¡C PALOMA-1 试验达¨ì¤F¨ä¥Dn¬ã¨s«点¡A证实¤F IBRANCE 联¦X来¦±Ðüªv疗 ER+/HER2- ªìªvªº§½³¡±ß´Á©Î转²¾©Ê¨Å¸¢Àù±wªÌ较单药来¦±Ðü©µ长¤F±wªÌ PFS¡C±µ¨ü IBRANCE 联¦X来¦±Ðüªv疗实质©Êªº§ïµ½¤F±wªÌªº PFS¡A联¦X组±wªÌ¤¤¦ì PFS 为 20.2 ¤ë¡]95% CI: 13.8, 27.5¡^¡A±µ¨ü来¦±Ðü单药ªv疗±wªÌ PFS 为 10.2 ¤ë ¡]95% CI: 5.7, 12.6¡^¡]HR=0.488 [95% CI: 0.319, 0.748]¡^¡C¬ã¨sªÌ评ɲªº¦³¥i测¶q¯f¨_±wªÌ¤¤¡A±µ¨ü IBRANCE 联¦X来¦±Ðüªv疗±wªÌªº总Ê^缓¸Ñ²v显µÛ°ª¤_来¦±Ðü单药组¡]55.4% ¡G 39.4%¡^¡CPALOMA-1 试验¬OÉO Jonsson Àù¯g¤¤¤ßªº Revlon/UCLA 妇¬ìÀù¯g¬ã¨s项¥Ø¦X§@执¦æ¡A¥Ñ Dr. Dennis Slamon 领导¡C ¡§IBRANCE ªº获§å显¥Ü¤F辉·çüL¤jªº学术创·s®Ö¤ß¯à¤O©M稳©Tªº学术¦X§@¡A¥i¥H将¨ô¶Vªº¬ì学进®i转¤Æ为¦³É²Èªºªv疗药ª«¡C§Ú们拥¦³·sªº¤@线ªv疗选择¡A对¤_绝经¦Z ER + / HER2 - 转²¾©Ê¨Å¸¢Àù妇¤k¡A该药ª«较单药来¦±Ðü¯à显µÛªº§ïµ½±wªÌªº预¦Z¡C¡¨辉·ç肿½F³¡临§É开发©M医疗¨Æ务°ª级°Æ总µôݺ®u医学©x Mace Rothenberg ³Õ¤h说¹D¡C¡§IBRANCE ¥Nªí¤F¤@项«nªº¬ì学进¨B, ¥H¤Î§@为²Ä¤@个获±o FDA §å㪺¥þ·s类«¬ªº§ÜÀù剂¡X¡XCDK4/6 §í¨î剂¡C¡¨ ¡§转²¾©Ê¨Å¸¢Àù±wªÌªº¸sÊ^¡A«D±`¢¤Á§Æ±æ¦³·sªºªv疗领°ì进®i从 |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/12 ¤W¤È 08:19:07²Ä 3889 ½g¦^À³
|
¸`¿ý¤µ¤é04:45 µ½¤H¤j¦b§Þ³Nª©ªº¶K¤å¡G ¡y业¬É对Ibranceªº°Ó业«e´º¤]¤Q¤À¬Ý¦n¡C¦¹«e¡A¥þ²y医药¦æ业调¬ãÉóÌÛGlobalData发¥¬报§i«ü¥X¡A辉·çCDK4/6§í¨î剂Ibrance将¥D导HR+¨Å¸¢Àù¥«场¡A¨ä2023¦~ªº销°â额将达¨ì18.5亿¬ü¤¸¡A¦Óªü´µ§Q±dªºPARP§í¨î剂Lynparza将¥D导¤T阴¨Å¸¢Àù¡]TNBC¡^¥«场¡C¡]报§i¡G2023¦~¥þ²yHER2阴©Ê¨Å¸¢Àùªv疗¥«场将达¨ì61亿¬ü¤¸¡^¡z ¨âÓÆ[¹î¡G 1. HER2+ ¯f±wªº¸~½F¼Wªø³t«×¸û§Ö¡A¹ï¥Í©R«Â¯Ù¸û¤j¡A¬O¥HÁöµM¥u¦û¨ÅÀùÁ`±wªÌ¤H¼Æªº23%¡A¦ý¬O¥ÎÃÄ¥«³õ«o¶W¹L¨ÅÀù¼Ð¹vÃĪ«ªº¤@¥b¡C 2. ·sÃĤW¥«¦³¤@©wªº±À¼s¦¨ªø´Á¡A¥H½÷·çªº¾P°â¹Î¶¤¨Ó±ÀIbrance³£ÁÙnªá¤K¦~¤~¯à°µ¨ì18.5»õ¬ü¤¸¾P°âÃB¡A§Ú̹ï¯E¹©ªºÀ禬¼Wªø³t«×¤]¤£¯à¦³¹L«×¹w´Á¡C |
|
|
·|û¡G¦Ñ´10141055 µoªí®É¶¡:2016/4/11 ¤U¤È 09:57:58²Ä 3888 ½g¦^À³
|
¤Ñ©R¤j,¦Ñ´«D¨ÅÀù±M·~,§ó¤£¬OÅv«Â(¤Ï˳̵h«ëÅv«Â),¤£¯à¥H¦Ñ´¤À¨Éªº¬°·Ç,¨º·|¦ºªº«ÜºG!¦]¬°¦Ñ´¬O ¤@ӫܸõToneªº¤H,¦³®ÉÔÁ¿ªº¸Ü¤¤¶¡±`±`¤Ö¤F¤@¥y,n¼ô±x¦Ñ´Ó©Êªº¤H¤~·|§¹¥þ¤F¸ÑnÁ¿ªº·N«ä. ±z¤£¥~¦æ,¦Ñ´¬Ý±z«Ü¤º¦æ,«Ü¬O·q¨Ø! ©Ò¦³ªº¨Æ±¡³£¬On¹ê»Ú¥h«ä¦Ò¥h¤F¸Ñ¥h°µ¤~·|¶V¨Ó¶V²M·¡,¤Ñ©R¤j±z°µªº«D±`¤H¯à°µ! ©Ò¥H¦Ñ´¤~»¡¡¦¦b¤£¦Pªº®É¶¡ÂI´N·|¥X²{¸Ó¥X²{ªº¤H¨Ó¤À¨É«n¸ê°T¡¦!«á¥Í¥i¬È!(¦Ñ´²q±z´Nºâ¤w©¡¤Ñ©R ¤]¤p§Ú´X·³,¤Å¨£©Ç) ¦Ñ´»¡:«Ü¦hÂå®v¤w¸g{¶}©l}¤£¬O«Ü·R¥Îcomplete response, partial response³o¨Çµü·J¤F~~ ¬J¬O¶}©l¤]´N¥Nªí©|«D¥D¬y,¤j¦h¼ÆÁÙ¬O·|¬ÝRECIST,¥u¬OOS,PFS½T¹ê¥i¥H¤ÏÀ³§ó¦hªºÁ{§É·N¸q! ¬Q±ß·Qnªí¹Fªº¨ä¹ê¬OTumor Cell Dormancy(¸~½F²ÓM¥V¯v)ªºÆ[©À! 25¦~ªºÁ{§É¸gÅç,¦Ñ´³Ì·q¬Èªº¤£¬O¯Î°|ªø,§ó¤£¬O±Ð¥D©M·ù¥D,§Ú³Ì·q¬Èªº¬O¡÷tumor cell! ¥¦¤~¬O³Ì¼F®`ªº!¦Ü¤Ö¨ì¥Ø«e¬°¤î¤Ñ¤UµL¼Ä,¨ÓµL¼v¥hµLÂÜ,¯«Às¨£º¤£¨£§À,§A¥Ã»·³£¥u¯à°lµÛ¥¦¶]!¥¦±`Åý §A¥H¬°§AŤF,Äd¨ì¥¦¤F,µ²ªG§AÄd¨ìªº¥u¬O¥Lªº¤Û¼v! ©Ò¥H,¤£ºÞ§K¬ÌÀøªk¦A¼F®`,¥i¥H±þ¦ºÀù·F²ÓM!?§A¯uªº¥H¬°³£³Q±þ¦º¤F¶Ü? ©Î¬O»¡¥un²£¥Í¨¬°÷¶qªºIgG,IgMªº´N¥i¥H§¹¥þ±þ¦º?¨º¬°¤°»ò³Ì«áÁÙ¦³¤H·|PD? ¤S¬O¤°»ò¦]¯À¨M©w¤F,¨º¨Ç¤H·|²£¥Í¨¬°÷¶qªº§ÜÅé?¨º¨Ç¤H¤S¤£·|²£¥Í©Î²£¥Íªº¶q¤£°÷? ¥H¤W,±z·|¤£·|»{¬°¬JµM¦Ñ´³o»ò¤£¬Û«H822,¬°¤°»òÁ٩㨮a? ¦]¬°,¤H©R¬OµL»ùªº!¤£n»¡¥i¯à3¦¨4¦¨ªºÀù¥½¯f¤H¥i¥H©µªø¥Í©R¼Æ¦~¬Æ¦Ü¤Q´X¦~,´Nºâ¥u¦³5%,10%¤]n±Ï! °Ê·n°ê¥»³£n±Ï! ¦A±j½Õ¤@¦¸,tumor cell¯uªº³£³Q±þ¦º¤F¶Ü?------±z»{¬°¤Ñªá¤wµ´¸ñ¤F¶Ü? ¦Ñ´¤£´±°ø±æ,¥u¨D¥¦Ì¯à¥Ã»·¥V¯v!¥Ã»·³£¤£n¿ô¨Ó!´Nºâ»Ýnmetronomic therapy³£¨S¦³Ãö«Y! |
|
|
·|û¡G¤p·s10141589 µoªí®É¶¡:2016/4/11 ¤U¤È 03:22:23²Ä 3887 ½g¦^À³
|
ASCO ·í¤Ñµoªí§¹,°ê¤º·ÑÅéµL½×¼Æ¾Ú¦h¦n¥²·|°Û°I,¯E¹©À³°¨¤Wµoªí ASCO ½Ã¬P·|ij±M®aªº¬Ýªk,©M¥~°ê·ÑÅé±M®aªº¬Ýªkµ¥,¥H¥¿µøÅ¥ |
|
|
·|û¡G¦³«í10141521 µoªí®É¶¡:2016/4/11 ¤U¤È 03:16:12²Ä 3886 ½g¦^À³
|
¹x¥Û¤j.¤Ñ©R¤j ÁÂÁ±z̪º»¡©ú¤Î«ü¾É! ¤p§Ì®ø¤Æ§l¦¬«á,Y¦³°ÝÃD¦A¦V±z̽бÐ,·P®¦! |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/11 ¤U¤È 02:53:34²Ä 3885 ½g¦^À³
|
¦³«í¤j¡A µL½×M PFS©Î¬OM OS³£¬O±q¨CÓ¯f¤H¦¬®×¥ÎÃĶ}©l°_ºâ(¦¬¤F®×´N¥ß§Y¥ÎÃÄ¡A¤£¯àÅý¯f¤Hµ¥)¡A¤£¬O±q³Ì«á¤@Ó¯f¤H¦¬®×°_ºâ¡C ¥t¥~¡A©Ò¿× trending significance ¤£¯àµø¬°OS©|¥¼§C©ó50%¡A¦Ó¬OÀH®É¶¡±À²¾¡A´N¥Ø«e¹êÅç²Õ»P´_µo²Õªº´_µoÁͶըӱÀºâ¡AOS¼Æ¦r±N³vº¥§Î¦¨ÅãµÛ©Ê¡C ¦p¦P¤p©_¤j»P¯E§J¤j©Ò»¡¡An§ä¥X¤@²ÕPFS¦±½u¨Ó¸ÑÄÀ¹êÅç²Õ»P¹ï·Ó²Õªº®t¶Z¨Ã¥B²Å¦X¬Y¨ÇÃöÁä®ÉÂIÃö©ó¾ãÅé´c¤Æ¼Æ¦rªº´yz¡A¬O¿ì±o¨ìªº¡C¦ý¬O³o¼Ëªº±Æ¦C²Õ¦X¥i¯à¦³¤d¦ÊºØ¡A§ÚÌ©Ò§ä¨ìªº¨º¤@²Õ¥¼¥²±µªñ6¤ë¥÷¥i¥H¬Ý¨ìªº¼Æ¦r¡C ³Ì³Â·Ðªº¬O¹êÅç²Õªº´_µo¤H¼Æ¤À¥¬¡A¹w´Á·|¥X²{©úÅ㪺Âù®p¯S©Ê¡A¦Ó³o¨âÓ®pªº¤H¼Æ¤ñ¨Ò¡B¦U¦Ûªº®É¶¡¤À¥¬¡A³£¤£²M·¡¡C©Ò¥H¨Æ¹ê¤W«ÜÃø²q¤¤©Ò¿×¡y¦³§K¬Ì¤ÏÀ³±Ú¸s¡zªºPFS¸òOS¦±½u¨s³ºªø¬Û¦p¦ó¡A¸ò¹ï·Ó²Õ¤S¦³¦h©úÅ㪺®t¶Z¡C Lu¤j¡A ¬Û«H¨ì®ÉÔ¤S·|¦³¡y¤@ºØ¼Æ¾Ú¡B¨âºØ§PÂ_¡zªº°ÝÃD¡CµL½×¼Æ¾Ú¦h¦n¡A³ÛªÅªºµ´¹ï·|»¡n«°µ¤T´Á¡C¦pªG¼Æ¾Ú¤£°÷¦n¡A¦ý¬O¸ò·íªìKytruda®t¤£¦h¡A¬Ý¦hªº¤@©w¤]·|»¡FDA·|µ¹¦³±ø¥ó³\¥i¡C ÁÙ¬O¦^Âk¨ì¦U¤H¤ß¤¤n¦³¤@§â¤Ø¡A¤£¯àÁ`¬OÀH¥~¬Éªºµ¼Ö°_»R¡C |
|
|
·|û¡GLu10141514 µoªí®É¶¡:2016/4/11 ¤U¤È 02:37:14²Ä 3884 ½g¦^À³
|
¦U¦ì¤j¤j¡G ASCOµoªí«á¡A§Úı±o³Ì«nªº¬O¡G ¨º¨Ç¼Æ¾Ú¡A¯à¤£¯àª½¨ú¬ü°êÃÄÃÒ¡H ¯à¤£¯à»¡ªA¥xÆWTFDAµ¹ÃÄÃÒ¡H ¦pªGÁÙn°µ3´Á¡A¨ºªÑ»ùªÖ©w·|¶^¡C¦]¬°¡A°µ3´Á¡A³Ì§Ö¤]n3¦~¡I ª½¨ú¬ü°êÃÄÃÒªº±ø¥ó¬O¡G ®ÄªG¦n¢w¢w®ÄªG¦n¬O¦³30%¥H¤Wªº4´Á¨ÅÀù¯f¤H¡A§¹¥þ³Qªv¦n(§YOS¤j©ó4¦~)¡C °Æ§@¥Î§C¢w¢w§Y349¤H³£¨Sµo²{©úÅã°Æ§@¥Î¡A¹ï4´Á¨ÅÀù¯f¤Hªº¥Í¬¡«~½è¡A¦³«Ü¤jªº§ïµ½¡C ¥t¥~ÁÙnª`·N¤@¤U¡A¥´OBI-822«á¡AÀù²Õ´¸~¤j¡A³Q»~§P¦¨PDªº¤ñ¨Ò¦³¦h¤Ö¡H ¹ï©ó¡u¬d¼t¡v©Î¡u¥Ó½ÐÃÄÃÒ¡v¡A¤@©wnÀ´±o¡u¦Û¶ê¨ä»¡¡v¡A¦pªG³oÂI³£¤£À´¡A¨º¦Ñ¤Ñ·Ý¨Ó¼»¿ú¡A³£·|¤£ª¾¹D«ç»ò´z©O¡I |
|
|
·|û¡G¦³«í10141521 µoªí®É¶¡:2016/4/11 ¤U¤È 01:41:32²Ä 3883 ½g¦^À³
|
¤Ñ©R¤j ¤p§Ìı±o³Ìºë½Tªº¸ÑŪÀ³¬°^¤åªº³o¬q¸ÜHowever, patients who demonstrated an immune response (IgG or IgM) showed highly significant improvement in progression-free survival and the secondary endpoint of overall survival is trending towards statistical significance.(2/21^¤å»¡©ú) ¤p§Ì»{¬°ºI¦Ü2015/10/31 DATA LOCK¬°¤î¹êÅç²Õ¦³§K¬Ì¤ÏÀ³±Ú¸s»PµL§K¬Ì¤ÏÀ³±Ú¸sPFS¤w½T¥ß(¥H¹L¥h§¹¦¨¦¡ªí¹F)¡A¥t¹êÅç²Õ¦³§K¬Ì¤ÏÀ³±Ú¸s»PµL§K¬Ì¤ÏÀ³±Ú¸sºI¦Ü2/21 MOS©|¥¼¥X²{¡A¥u¬OÁͦV²Îp·N¸q(¥H^¤å²{¦b¶i¦æ¦¡ªí¹F)¡A3/31ªk»¡·|¤W»¡¸ê®Æ©|¥¼¦¨¼ô¡A©Ò¥H¤S¸û¤p§Ì¤W¤ë¹w¦ô¦h¥[¤@Ó¤ë ¤p§Ì¤W¤ë¹w¦ô¦p¤U: 2012/7~47¤H(¥H2016/2/29pºâ¦@p43¤ë) 2012/12~19¤H(38¤ë) 2013/6~67¤H(32¤ë) 2013/12~46¤H(26¤ë) 2014/5~27¤H(21¤ë) 2014/7~27¤H(19¤ë) ¤p§Ì³Ì«O¦uªº±À·Q,°²³]2/22·í¤Ñ¦³§K¬Ì¤ÏÀ³²ÕÃöÁäMOS²£¥Í¥B2014/7/31³Ì«á¤@Ó¯f¤H¦¬®×¡A«h©Ò±o¥X¤§ MOS¼Æ¾Ú¬O18Ó¤ë¤S22¤Ñ¡C MOS18.5¤ë¬O³Ì³Ì«O¦uªº¦ôºâ¡A»Ý¦A¥[¤W±q2/21«á¨ìÃöÁäA¥X²{ªº®É¶¡(3/31©|¥¼¥X²{¡A©Ò¥H¦A¥[¤@Ӥ묰19.5Ó¤ë¡A§óºë½TÁ¿À³¬°2014/7/31~2016/3/31ªk»¡·|¤îÀ³¬°20Ó¤ë¾ã)¡AYÃöÁäA¨Ã«D¬O2014/7¤ë¦¬®×¯f±w,¦Ó¬O«e´Á¦¬®×¯f±w«h¬O¦ó®É¦¬®×¯f±w¦Ó©w¤À§O¥[2~19Ó¤ë¡A¥t¥H¦¬®×¤é´Á³Ì«á¤@¤Ñ°µ°²³]¡A¯u¹êª¬ªp¤]¥i¯à¦b¥[0-6Ó¤ë¡AÁÙ¦³ÃöÁäA«e³]¸ê®Æ¤]¦³¥i¯à¼W¥[®É¶¡¡C ¥t°w¹ï¸Ñª¼«á·s¶i³õ©Î쥻®M¨c¤§§ë¸ê¤H¦Ó¨¥¡AY©óASCO«e¹ï¼Æ¾Ú§Î¦¨¹L°ª¹w´Á¡A Y¼Æ¾Ú´¶³q(¥¼¤½¥¬,µL¤H¥iª¾)¨Ã¤£¯à±Æ°£YOSÃöÁäAªñ´Á¥X²{¥B¬O2014/7¤ë³Ì«á¤@§å¦¬®×¯f±w¡A «hMOS¥i¯à´N¥u¦³20´XÓ¤ë¡A(·íµM¤p§Ì¤£§Æ±æ¥Lµo¥Í)¡AY¤j®a¹w´Á³£¬O30´XӤ몺MOS¡A ¤p§Ì¾á¤ß±Ó·Pªº§ë¸ê¥«³õ·|¥H¤£¦p¹w´Á°µ¸ÑŪ¡A¥i¯à³y¦¨¥t¤@ªiªº½æÀ£¡A³o¬O¤p§Ì¤£¼Ö¨£ªº¡C ¥t¤p§Ì«D¥Í§Þ¤Î²Îp±M·~¡A±À½×¤£ª¾¬O§_¦³¤£¦XÅ޿褧³B¡A¤]½Ð¤Ñ©R¤j¤Î²³¤j¤£§[«ü¥¿¡A¥H¤W¤p§Ì©å¨£¡A¶È¨Ñ°Ñ¦Ò |
|
|
·|û¡Gkokfish10140320 µoªí®É¶¡:2016/4/11 ¤U¤È 12:31:59²Ä 3882 ½g¦^À³
|
·PÁÂ¥xÁÞ¤j¡BQQ¤j¡B¤Ñ©R¦^À³¡G ´Á«Ý¤»¤ëASCOªº¼Æ¦r¥i¥H²M·¡¸ÑÄÀ¦h«¦]¯À¼vÅTpfs¥¼¹F¼Ðªº¦]ªGÃö¨t¡A ¥t¦A½Ð±Ð¤»¤ë±i¸³»¡©ú¦basco·|ij¤W±N°w¹ï¨ä¥¦¾AÀ³¯gn±Ò°Ê¦hºØÀù¯gÁ{§É¦X§@¡A ¦pªGMOA¬O½T»{ªº¡A¨ä¥¦¾AÀ³¯gªºÁ{§É¬O¥i¥Hª½±µ¸õ2b³W®æ¶Ü?ÁÙ¬On±q¤@´Á°µ°_??? |
|
|
·|û¡G¦³«í10141521 µoªí®É¶¡:2016/4/11 ¤W¤È 11:56:03²Ä 3881 ½g¦^À³
|
¤Ñ©R¤j ¹ï©ó±z´£¨Ñ¦p¦¹¦h¸ÔºÉ¸ê®Æ¤Î¤ÀªR¡A¤p§Ì·P¿E¤£ºÉ¡I¤p§Ì¬O¬Ýªø¦h¡A¹ï¯Eô¦³µ´¹ïªº«H¤ß¡I ¤p§Ì¤]ı±o¸g¾ú¥ý«e¸Ñª¼¥¢±Ñªº±Ð°V¡A¤Z¬O§ÚÌÁÙ¬O«O¦uð·¬°©y¡A¥H§K³y¦¨§ë¸êªÌ¹L«×¹w´Á¡AY©¡®É¤½¥¬¼Æ¾Ú¤£¦p¹w´Á¡A¤Ï¦Ó¹ïªÑ»ù³y¦¨¤£§Q¼vÅT¡I ¥H¤U¬O¤p§Ì¬Ýªk 1¦Ñ´¤j¤å¤¤¦³´£¤Î¡y³o27Ӹ̱22Ó¦bªvÀøªº¦P®É¤]±µ¨ühormone therapy,©Ò¥H37%NED¬O½Öªº¥\³Ò©|¥¼¯àÂ_©w!¡z 2±z©Ò´£¦]¬°OBI-822¹êÅç²ÕOS«ü¼Ð¤¤¦ì¼Æ¨ì¦b2016¦~3¤ë®É¤~¹F33Ó¤ë¡AÀ³¸Ó¬O¥§¡¼Æ¦Ó«DMOS¡A ¦]¬°´N3/31ªk»¡·|Á`©Ò´£§K¬ÌÀøªk¬O¹ï¯f¤Hªºªø´Á¦s¬¡¼vÅT¸û¤j¡A822¦b¦¹¦¸Á{§É¸ÕÅç¤] show¥X³oÓÁͶաA´N¬O»¡¥undata¦¨¼ô¡AÀ³¸Ó¥i¥H¬Ý¨ì¥L¹ï¯f¤Hªºos¡A¯f¤Hªºªø´Á¦s¬¡À³¸Ó¤@¼Ë¥i¥H¬°¯f¤H±a¨Ó¦n³B ©Ò¥HÃöÁäA©|¥¼¥X²{¡AY¥H¤p§Ì¥ý«e³Ì«O¦u¦ôp18.5+1¡×19.5¤ë¬°¥Ø«e³Ì«O¦uªº¹w¦ô 3¥t¥xÁÞ¤j©Ò¨¥¶P¯e§´56.5Ó¤ë 3ÃĦX¤@»ù®æ12¸U¬ü¤¸ 23% HER2¶§©Ê¤~¾A¥Î 77%Âಾ©Ê¨ÅÀù¯f±w·¥«×¯Ê¥F¦nÃÄ¡A ¤p§Ì»{¬°À³¸Ó¤]¬O¡AMOS¬°56.5Ó¤ë¡A©Ò¥HY¥H¥Ø«e«O¦u¹w¦ô¤§822³æÃÄMOS¤´¦³¬Û·í¤j¸¨®t¡A¦ýY´N¦w¥þ©Ê¤Î°Æ§@¥Î¤ÎÃÄ»ù¦Ó¨¥¡A¨ã¬Û·íÄvª§Àu¶Õ¡A¤p§Ì¤Ñ¯uªº§Æ±æ5¦~Æ[¹î´ÁÃöÁäA¤@ª½¤£¥X²{¡A¤@Á|§¹³Ó¶P¯e§´56.5Ó¤ë¡A¦ý²{¶¥¬q¤p§ÌÁÙ¬O«O¦u»{¬°¥i¥ý®³¤U¤T³±©ÊÀù¥½¯f±w¡A»²¥H«áÄòÁp¦X¥ÎÃÄÁ{§É³v¨BÅú¹¨ä¥L¨ÅÀù¨È«¬Àù¥½¥«³õ¤Î«e´Á¨ÅÀù¥«³õ¡C ¥H¤W¤p§Ì¤£¦¨¼ôªº·N¨£¡AY¦³«_¥Ç¡A·q½Ð¨£½Ì¡A¤p§Ì©å¨£¨Ñ°Ñ¡I |
|
|
·|û¡Gchen605310138636 µoªí®É¶¡:2016/4/11 ¤W¤È 11:19:14²Ä 3880 ½g¦^À³
|
¤§«e¤@¦ì¤j¤j,±N¿ýµÀɤå¦r¤Æ,ªº¤@³¡¤À ²Ä¤GÓ´N¬O§Ú̱N¨Ó°µÁ{§Éªº®ÉÔ¡A¤]µo²{¤@Ó«Ü«nªº«ÂI¡AÁöµM¦b©Ò¦³ªº¥½´Á¨ÅÀù¯f¤H¨¤W¡AGLOBO Hªºªí²{¤£¬O100%¡A³Ì°ªªºªí²{¤j·§¦³60%-65%¡A¦¸¤@µ¥ªº¡A¤W±ªí²{¤£¬O¯S¦hªº¡AÁÙ¦³ªí²{«Ü¤Ö¥i¬O¦³ªº¡A¥[¦b¤@°_¤j·§¦³80%¥H¤W¡A¥i¬O§Ú̵o²{§Ú̪º¬Ì]¡A¤£¦ý·|»{±oGLOBO H¡A ¥¦¤]·|°w¹ïGLOBO H SERISE¥t¥~¨âÓSSEA3 SSEA4¡A¦pªG§A¥h¬ÝÀù²ÓMªí±¤W¡A©ÎªÌ¦³GLOBO¡A©ÎªÌ¦³SSEA3¡ASSEA4¡A°ò¥»¤W¬O100%¡A´«¥y¸Ü»¡¡A§Ú̱N¨Ó¦bÁ{§É¹êÅç¡A©Î±N¨Ó¦b¥ÎÃĪº®ÉÔ¤£¥²¥h´úGLOBO H¡Aª½±µ¥i¥H¥Î¡A¦]¬°§Ú̪º¬Ì]¥´¥X¨Ó²£¥Íªº§ÜÅé¤TºØ³£¥i¥H°w¹ï¡A©Ò¥H±N¨Ó°w¹ïªº±Ú¸s«D±`¼sªx¡A¤U±¤@ÂI«ÂI¬O»¡¡A¦]¬°¥un§ä¨ìGLOBO Hªº¼Ðªº¡A¥¦¤]·|§â¥¦±þ¦º(§ä¨ìSSEA4¥¦´N§â¥¦±þ¦º¡A§ä¨ìSSEA3§â¥¦±þ¦º)¡A©Ò¥H¥ÎÃÄ«e¤£»Ýn¨Æ¥ý¥h°»´ú¬O§_¦³GLOBO H ³o¼ËªºANTIGEN¡C |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/4/11 ¤W¤È 11:03:59²Ä 3879 ½g¦^À³
|
kokfish¤j §d©v¯q³Õ¤h»¡©ú»P±i¸³ªº»¡ªk¤@ÂI¤]¤£½Ä¬ðªº 1¼vÅT¹êÅç¬O§_¦³®ÄÃöÁä¥D¦]¦A©ó¯à§_²£¥Í¨¬°÷ªº§ÜÅé:¤£½×¥ô¦ó«¬ºAªº¨ÅÀù¯f±wª`®g¬Ì]«á¥un¯à²£¥Í¨¬°÷ªº§ÜÅé¡A¬Ò¯àÅã²{¨¬°÷ªºÀø®Ä,(©Ò¥H¯E¹©§ä¨ì¤@Ó²³æ¤èªk´N¥i¿z¿ï¯f¤H:¬O§_¯à¯à²£¥Í¨¬°÷ªº§ÜÅé) 2³¡¥÷¯f¤H§¹¥þ¨S¦³gh§Üì¤ñ²vÁö¤Ö±i¸³¤]·|§â¥ô¦ó¼vÅT¦]¯À³£¦C¥X ,³o¤£¬O¥D¦],©Ò¥H¶ÀÁ`¤~·|»¡«Ü³£¦]¯À¥[¦b¤@°_ ªºµ²ªG(§K¬Ì©µ¿ð,¹ï§ÜÀù²ÓMªºµoª¢¤ÏÀ³³Q»~§P,³¡¥÷¯f¤H§¹¥þ¨S¦³gh§Üì,¦³§Üì¦ý²£¥Í§ÜÅé¶q¤£¨¬µ¥¦h«¦]¯À) 2§d¬ã¨sû´£¨ì§Ú̵o²{¨ÅÀù¤Î¨ä¥L14ºØÀù²ÓM¤W¶W¹L98%¬Ò¦Ü¤Ö§t¦³¦¹¤TºØÁÞ¤À¤lªº¨ä¤¤¤@ºØ¡]PNAS 2014¡^¡A¦Ó¦b¨ÅÀù·F²ÓM¤W¡A§Ú̬Ʀܵo²{´X¥G100%¬Ò¦Ü¤Ö§t¦³¦¹¤TºØÁÞ¤À¤lªº¨ä¤¤¤@ºØ¡A¤]´N¬O»¡¦¹¬Ì]²£¥Íªº§ÜÅ馳¾÷·|±þ¦º¥þ¼ÆªºÀù²ÓM©ÎÀù·F²ÓM¡A¦Ó«D§@ªÌ©Òz³Ì¦h¶È¯à±þ¦º¤@¥b¡C 3¤£n§Ñ°O¨ÅÀùOBI822¦³¤TÓÁÞ줣¬O¥u¦³¦bGlobo - Hªí²{ (ÁÙ¦³SSEA-3 SSEA-4 ) ¤TÓÁp¶°±µªñ100% ¤TÓÁÞ§Üì°£¤F¦³¦b¨Å¬ãÀù²ÓMªí²{¥~, ¤]¦³¦b¨ÅÀù·F²ÓMªí²{ 4 ¨ÅÀùOBI822¥t¤@Ó¯S®íªºÀu¶Õ¦b©ó¤£»ÝÀËÅç¨ÅÀùÃþ«¬(¨È«¬) ±qªk»¡·|¤½¥qªº»¡©ú,§Úªº²z¸Ñ¬O¹ï¤£¦P¨ÅÀùÃþ«¬ (¨È«¬)¥un¯f±wª`®g¬Ì]«á¯à²£¥Í¨¬°÷ªº§ÜÅé¡A¬Ò¯à²£¥Í«D±`Åã²{ªºÀø®Ä |
|
|
·|û¡GQQ10140589 µoªí®É¶¡:2016/4/11 ¤W¤È 11:01:52²Ä 3878 ½g¦^À³
|
Kokfish¤j: ¸`¿ýªk»¡·|«á¦³¤H½Ð±Ð±i¸³ªº¹ï½Í: ¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K. ¹ï·Ó²Õ¦w¼¢¾¯²£¥Íªº§ÜÅé¤H¼Æ«Ü¦h¶Ü ? ¨S¦³, «Ü¤Ö. ¦ý¹ï§Ú̲£¥Í«Ü¤jªº¼vÅT? ·íµM, ¤@Ó¤H´N®t«Ü¦h¤F. ³Ì²×ªº¼Æ¦r¬O¬Ýmedian¤¤¶¡ªº¨ºÓ¤H, ¤@ÂIÂI´N³´«Ü¦h¤F. ¤£¬O¥§¡È, ¬O¤¤¶¡È, ®t¤@ÂI´N®t«Ü¦h¤F. ¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K ¥H¦¹±À¦ô±zªº°ÝÃDÀ³ÄݦP¼ËÅÞ¿è: ¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K ·|û¡Gkokfish10140320 µoªí®É¶¡:2016/4/11 ¤W¤È 09:41:41 §d©v¯q³Õ¤h»¡©úgloobhªºªí²{²v·¥°ª¡A¥i¬O±i¸³¦b¹êÅ祼¹F¼Ðªº²Ä¤G¦]¯À´£¨ì³¡¥÷¯f¤H§¹¥þ¨S¦³gh¥HP¨SµLÀø®Ä¡C³o¨âÓ»¡ªkÁ`ı±o¬O½Ä¬ðªº~ ³¡¥÷¯f¤H«ö§d©v¯q»¡ªkÀ³¬O·¥¤Öªº¡A¤£P¼vÅT¹êÅç¤~¹ï¡K ¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K.. ¶È¨Ñ°Ñ¦Ò. ¤]§Æ±æ¨ä¥L¤j¤j¯à´£¨Ñ¬Ýªk. |
|
|
·|û¡G§d½n¶¯10142119 µoªí®É¶¡:2016/4/11 ¤W¤È 10:31:24²Ä 3877 ½g¦^À³
|
²{¦bªºªÑ»ù¬O§_¤w¸g¤ÏÀ³ASCOªº´Á«Ý¡H¡H°£«D¼Æ¾Ú¯uªº¸ò¤ÖªL¥\¤ÒÅKÀY¥\¡Bª÷è»L...¯u¬O´Î...¥[¤W«áÄò¤jÃļtªº¥[«ù¡BÃÄÃÒ...¤~¯àÄ~Äò±À°Ê¡A´Á«Ý¤¤¤]n¤p¤ßÀ³¹ï.... |
|
|
·|û¡G¦Ñ¥v10140531 µoªí®É¶¡:2016/4/11 ¤W¤È 10:22:10²Ä 3876 ½g¦^À³
|
¤Ñ©R¤j 2013¦~3/7ªk»¡·|´N¦³¤@´Áªº¦s¬¡¸ê®Æ ²q·Q¤jô¦³¶K¹L ªì©lµ¹ÃÄ¤é ¦s¬¡²{ªp ¦s¬¡¦~¼Æ 1998.02.04 Alive------ 10 + 1998.10.05 --------------3 1998.08.17 --------------1 1998.09.23 --------------1 1997.09.11 Alive ------10 + 1998.10.21 Alive------ 3 + 1998.10.05 --------------3 1998.06.24 Alive------ 10 + 1998.08.17 Alive------ 10 + 1998.10.21 Alive------ 10 + 1997.09.10 --------------7 1997.10.01 Alive------ 9 + 1998.09.16 Alive------ 9 + 1997.10.22 ------------- 6 1998.06.06 Alive------ 10 + 1998.11.09 --------------6 1998.04.14 ------------- 2 1998.06.17 Alive------ 9 + 1998.08.12 ------------- 8 1998.10.21 Alive------ 9 + 1998.06.22 ------------- 7 1998.11.08 Alive------ 8 + 1998.06.10 ------------- 2 1998.09.01 Alive------ 9 + 1998.10.05 Alive------ 9 + 1998.10.15 Alive------ 5 + 1999.04.14 Alive------ 9 + §Ú¬Oı±o¼È¥ý¤£n¹L«×¸ÑŪ ¥H§K¹ïASCOªº¼Æ¾Ú¹L«×´Á«Ý....... |
|
|
·|û¡Gkokfish10140320 µoªí®É¶¡:2016/4/11 ¤W¤È 09:41:41²Ä 3875 ½g¦^À³
|
½Ð±Ð¥xÁÞ¤j¡G §d©v¯q³Õ¤h»¡©úgloobhªºªí²{²v·¥°ª¡A¥i¬O±i¸³¦b¹êÅ祼¹F¼Ðªº²Ä¤G¦]¯À´£¨ì³¡¥÷¯f¤H§¹¥þ¨S¦³gh¥HP¨SµLÀø®Ä¡C³o¨âÓ»¡ªkÁ`ı±o¬O½Ä¬ðªº~ ³¡¥÷¯f¤H«ö§d©v¯q»¡ªkÀ³¬O·¥¤Öªº¡A¤£P¼vÅT¹êÅç¤~¹ï¡K ¥¼¨Ó¹êÅ礴¤£¿z¿ïgloobh¡A¦Ó¬O¥H4¿§ÜÅé¶q¬°§PÂ_¡A¦ý¦pªGµLgloobhªº¯f¤H¡A¦³°ª§ÜÅé¶q¤]¬OµL®Äªº¡K ¨º³o¼Ë¹ï¹êÅç¼vÅTªº²Ä¤G¦]¤l¨Ã¨S¦³±Æ°£°Ú¡A ³o³¡¥÷§ÚÁ`ı±o©Ç©Çªº¡AÁÙ½ÐÄÀºÃ |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/4/11 ¤W¤È 09:08:49²Ä 3874 ½g¦^À³
|
¬ì¾Ç¬O¨D¯u¡A¯u²z¨Ó¦Û§V¤O±´¯Áªºµ²ªG¡A¦³¨Ç«D¬ã¨sÁÞ¤À¤l¬Ì]ªº±Ð±Â¡AµLªk´x´¤¯u¹êªº·s¸ê°T¡A´N¯àµoªíµû½×¡A³o¤]¤Ó©_©Ç¤F,³oÃþ¤å³¹¡A¦]¬°»P¨Æ¹ê¤£²Å¡A nŪ´NŪ³Ì¯u¹êªº¸ê°T¡C ·j´M: §d©v¯q ¬°¯E¹©ÄÀºÃ ±MºëÁÞ¬ã¨sªº¤¤¬ã°|°ò¦]Åé¬ã¨s¤¤¤ß°Æ¬ã¨sû§d©v¯q¡A·í¿ï¬ü°ê¤Æ¾Ç·|2014¦~ÁÞ¬ì¾Ç¦~»´¬ã¨s¾ÇªÌ¼ú¡A ¬O¥þ²y²Ä12¤H¡B¥xÆW²Ä1¦ìÀò¼úªº¾ÇªÌ¡C |
|
|
·|û¡GLeo10142037 µoªí®É¶¡:2016/4/11 ¤W¤È 08:39:53²Ä 3873 ½g¦^À³
|
·PÁ¦ѷ¨¤j»P¤Ñ©R¤j ±M·~ªº¤ÀªR»P¸ê®Æ |
|
|
·|û¡Gsuperjoe10141522 µoªí®É¶¡:2016/4/10 ¤U¤È 11:43:16²Ä 3872 ½g¦^À³
|
ÁÂÁ¹x¥Û¤jªº¤ÀªR, ¯uªº§Æ±æ¦³¨º»ò¤@¤Ñ¯à¯Eô¦¨¥@¬É²Ä¤@! ¤£¹L§Ṳ́j³¡¥÷¯E¤Í¥u¯à©ê20¦~§a(³£60-70·³¤F) ¥u§Æ±æ¨ì®É«áÁÙ¦³Åé¤O¥h¹C¤sª±¤ô,«¢! ¦Ü©ó¥«È¦h¤Ö?¬O§ÚªºÄ@±æ! Åý¹x¥Û¤j,¶O¤ßpºâ,¤£¦n·N«ä! |
|
|
·|û¡G¦Ñ´10141055 µoªí®É¶¡:2016/4/10 ¤U¤È 11:32:27²Ä 3871 ½g¦^À³
|
¤Ñ©R¤j,ÁÂÁ¸ɥR~~ ¯E¹©ªº¥¿®ð´N¬O·|§l¤Þ«Ü¦h¥¿¯à¶qªº¤H¥[¤J,Á`·|¦b¤£¦Pªº®É¶¡ÂI´N·|¥X²{¸Ó¥X²{ªº¤H¨Ó¤À¨É«n¸ê°T,Æg! ¦Ñ´·Q½Ð±Ð¥H¤U´XÂI: 1. ±À´ú·í¦~¦b²Ä¤@´ÁÁ{§É¹êÅç¸g2¦~ªÌªºÆ[¹î¸~½F¤ÏÀ³¹F§¹¥þ¤ÏÀ³(complete response);100%®ø¥¢ªÌ ¥i¯à©M48% ¬Û·í¦Ó¯à¦s¬¡ 9-10¦~----¦L¶H¤¤phase I¦³´£¨ìNED,¨S¦³´£¨ìcomplete response,¨âªÌÁö±µªñ ÁÙ¬ONED¸ûÄYÂÔ,¦]¬°¤p©ó¤@¤½¤Àªº¸~½F«ÜÃø¦b¼v¹³¾Ç¤W½×Â_,NEDÁÙ¥]¬A¤F¨ä¥L¾¹©x¤]¨S¦³°ÝÃD ¤º¤åÀ³¸Ó¬O... 15Ó¤@¶}©lNED(without evidence of disease)ªº¯f¤H,median follow up 107.5wks«á10ÓNED,5ÓPD 12Ó¤@¶}©lstable diseaseªº¯f¤H,median follow up 111wks«á5Óstable disease,7ÓPD ©Ò¥Hn»¡NEDªº¸Ü¬O10/27=37%------«ÂI¬O ³o27Ӹ̱22Ó¦bªvÀøªº¦P®É¤]±µ¨ühormone therapy,©Ò¥H37%NED¬O½Öªº¥\³Ò©|¥¼¯àÂ_©w! 2.¦Ñ´Ë¬O»{¬°complete response, partial response¨S¦³¨º»ò«n,¸~½F³oºØªF¦è,n´_µo¥un1~2wk,¤ñ §Aì¨Óªº¤j¨â¿!!!---------©Ò¥H¥un¦³«~½èªº¬¡µÛ(stable disease)´N°÷¤F!©M¥¦@³B,¥L±j¥Ñ¥L±j,¥L®z ¥Ñ¥L®z......¥unOS and quality of life......ºÞ§A½Ö®a¿³¼o½Ö¦¨±Ñ! 3.±Ð¥D»¡¡u¸~½F³¡¥÷ÁY¤p¤ñ²v(<100%)¤£¬OOBI-822°l¨Dªº¥Ø¼Ð¡v------¦Ñ´ªº¸ÑŪÀ³¸Ó¬OOS¤~¬O¥Ø¼Ð,¦Ó¤£¬O tumor complete response,¦bÁ{§É¤Wtumor complete response¦ý«ometa expiredªº¤j¦³¤H¦b!³o´N¹³¥~¬ì»¡ ªº¤â³N«Ü¦¨¥\,¯f¤HÜЧ¾¤F¦³²§¦±¦P¤u¤§§®! ²{¦b«Ü¦hÂå®v¤w¸g¶}©l¤£¬O«Ü·R¥Îcomplete response, partial response³o¨Çµü·J¤F~~ ¥H¤W¨Ñ±z°Ñ¦Ò~~ ±ß¤F,¦b¦¹¦^À³°ß¤j,»¡¦Ñ´Á¾,±z°Z¤£§óÁ¾?±z¦r¦r¯u¨¥,¥y¥y¤¤¦Ñ´ªº¤º¤ß²`³B!·Q·í³B¦Ñ´²Ä¤@Ó²q¤¤±z ªº¼ÊºÙ,¯u¬O½t¥÷!-----¥u¥i±¤±z©M¶O¤j¤wq²×¨(haha.....) ¶O¤j,©ñ¦Ñ´¤@°¨§a,¤d¦r¤å,ÄÆC¤¤......ÀrÆj§Þ½a°Õ! |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2016/4/10 ¤U¤È 10:16:42²Ä 3870 ½g¦^À³
|
Åó±ø±ø¤j¡A±zªº´£Ä³¬Æ¦n¡A¶q¤Æªºµû¤Àªí¤è¦¡¡A¤]¥iÂç²M§ë¸ê»ùȪº¸¨ÂI¡AASCO«e¨s³º¬O©ãÄ_©ÎÁ×ÀI¡AÓ¤H¥i¶q¤Æ»ùȨӵû¦ô¡C |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2016/4/10 ¤U¤È 09:33:18²Ä 3869 ½g¦^À³
|
±Û«a¤j¡A5619¤j: ·PÁ¤À¨É"»ùȵû¦ô"¼Ò¦¡¡A §Ú¦b·Q¡A¦pªG¨C¤@Ó¶µ¥Ø§â¥L¤À¦¨5,4,3,2,1Ãþ¦üKPIªºµû¤À¤è¦¡¡A©Î¬O¥ý«e¥xÁÞ¤jªºµû¤Àªí¤è¦¡ ³o¼Ë¤]¯à°÷§@¬°¤@ºØ¶q¤Æ»ùȪº¤è¦¡ ¤µ¤Ñ¤U¤È¦b¬Ý¤@¦¸¸Ñª¼«áªk»¡·|ªº¼v¤ù¡A¬ÝMichael, YK, Amyªºªí¹F¤º®e¡A ı±o¦bASCO¤§«e¡A«Ü¦³¥i¯à³£¬O¦nªº¥[½X®É¶¡ÂI¡Aµ¥ASCO¼Æ¾Ú¤½¥¬¡A°ò¥»±ªº»ùȯB²{¥X¨Óªº¬O§ó²M·¡ªº½ü¹ø¤F ¤£¹L³o¬O¤@±øº©º©ªø¸ô¡A©êºòµ¥822¹L¤Ãö±Ù¤»±N§a |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2016/4/10 ¤U¤È 08:48:58²Ä 3868 ½g¦^À³
|
5619¤j¡AÕY§Úªº½×ÂI¯àÀ°§U¨ì¤H¡A§ÚªºÆF»î·|·P¨ì«D±`³ß®®¡A¤]ÁÂÁ±z¡I |
|
|
·|û¡G561910141205 µoªí®É¶¡:2016/4/10 ¤U¤È 07:33:55²Ä 3867 ½g¦^À³
|
Âà¶K±Û«a¤j¦bÄw½Xª©ªºµo¤å¡C¸Ó¤å´£¨Ñ¯E¹©¤Î¨ä¥L·sÃĪѪº¡§»ùȵû¦ô¡¨¼Ò¦¡¡A«Üȱo©ñ¦b¥»ª©¡A¨Ñª©¤Í°Ñ¦Ò¡A¥H¤Î¤é«á¬d¸ß¡C±Û«a¤j¡A¤p§Ì²`PÁ·N»P·q·N¡C ------------------------- ·|û¡G±Û«a10139522 µoªí®É¶¡:2016/4/10 ¤W¤È 11:18:38²Ä 5023 ½g¦^À³ ¾å¦à¤j¡A¥xÆW·sÃĬãµo¬OÂê©w¬ü¤è¥«³õ¡AÁ{§É¸ÕÅ秡«öFDAªº¼Ð·Ç¬ãµo¬yµ{¡A±ÂÅv¹ï¶H¥Dn¬O°ê»Ú¶¡¤j¤pÃļt¡A¦]¦¹¥xÆWªº·sÃĤ½¥qÀ³¸Ó¥H°ê»Ú¥Í§ÞÃļtªºµû¦ô»ùȬۤñ¡A¦Ó«D°ê¤º¶Ç²£¤Î¹q¤lªÑªº¥»¯q¤ñ¼Ò¦¡¡C ¥H§Ú¦Û¤v¥é·ÓNBI§ë¸ê»ùȵû¦ô¡A¤j¬ù¤À¥X¥H¤U´XºØ¼Ò¦¡¡G 1. NPV¡G¹w¦ô¥¼¨Ó´X¦~ªºÀ禬¡A¦©°£Àç·~¦¨¥»¤Î¤À°t§Q¼í¡A¦A¥H§é»ù²v±Àºâ²{¦b»ùÈ¡A°£ªÑ¥»±o¥XEPS«á¡A¥H¦P·~¥»¯q¤ñ°Ï¶¡°ª§C¡A·§ºâ¤µ¦~ªºªÑ»ù¡C¯ÊÂI¬O¦³¤Ó¦hªº°²³]¼Æ¦r¡A¸û®e©ö¥¢¯u¡C 2. ±ÂÅvª÷ªº¤ñ»ù¼Ò¦¡¡G§ä¥X¦PÃþªº·sÃIJ£«~¡Añ¬ù±ÂÅvª÷«áªº¥«³õµ¹¤©»ùÈ¡A¦A®Ú¾ÚÃÄ«~ªº¥«³õ³W¼Ò¡AÄvª§¤O¡A¥¼¨Ó»ùȵ¥¡A¨Ó½Õ¤É©Î½Õ°·sÃĪº¥«È¡C¯ÊÂI¬O·s³ÐÃÄ«~¤£®e©ö¦³¦PÃþ·sÃÄ¥i¨Ñ¤ñ»ù¡A©ÎªÌ¬O¼Ë¥»¼Æ¤£¨¬¡A®e©ö¥¢¯u¡C 3. ÃĪ«²£«~¨ã®t²§¤Æªº¤½¥qµ¹¤©°ªµû»ù¡G·sÃĪº¬ãµo°Ê»³10¾l¦~¡AÃĪ«¥H²Å¦XUnment medical needs¬°Àu¥ý¡A¦A¨Ó¨D±oÃĪ«®t²§¤Æ¡A¥H¤Î¬O§_§G§½§¹¾ãpipeline¡C 4. ¸gÀç¹Î¶¤¨}æÕ¡G¬O§_¨ã±M·~»â¾É¡A¬O§_¾A¥ô©Ê¡A¬O§_¬Ýµu¤£¬Ýªø¡A©Î¬O¬Ý«ªÑ»ù¤j©ó¥¼¨Ó©Ê¡C 5. ®É¶¡»ùÈ¡G¨C¤@¶¥¬qªºÁ{§É¸ÕÅç³£¦³¨C¤@¶¥¬qªº»ùȵû¦ô¡A¤£©y¤@¨ý°¾¦V¼ÖÆ[©Î´dÆ[¡A²¦³ºÃÄ«~º«¦w¥þ¡A¨ä¦¸¤~¬OÀø®Ä¡A©Ò¥Hµ¥«Ý¤Î@¤O¬O·sÃħë¸êªº¥²µM¥\¤Ò¡A®É¶¡¥¼¨ì¤£©yµ¹¤©¹L°ªªºªÑ»ù¡A¦ý¤]¤£¥²¦Û¤vÀ~¦Û¤v¡A·sÃĪºªÑ»ù¬Oµ¥¥X¨Óªº¡A¤£¬O¤@Ãà¥i´Xªº¡C 6. ±M§Q§G§½¬O§_§¹¾ã¡G·sÃĤ½¥q±M§Q§G§½»Ý¦³¥þ½L©Ê³W¹º¤Î¦æ°Ê¡A¨Ã¯à³q½LÀË°Q¡AÀH®Éª`·NÄvª§ªÌ«IÅv¤Î¥é«_ÁͶաC 7. MOA½T»{¡G¤G´ÁÁ{§É¥Dn¬O°µÃĪ«·§©ÀÅçÃÒ¡]Proof of concept¡^¡APOC¦Ü¤Ön±o¨ìÃÒ¹ê¡AY¯à¶i¤@¨B½T»{MOA¡A³Ì¦n¬O¥þ¥@¬Éº³Ð¿W¤@ªºÃĪ«¡A·sÃĪº»ùȱN¯S§OµL¥i¶q¡C 8. ÁÞ¤À¤lÃĪ«¡Ö¤j¤À¤lÃĪ«¡]³J¥Õ½è©Î³æ®è§ÜÅéÃĪ«¡^¡Ö¤p¤À¤lÃĪ«¡]¤Æ¾ÇÃĪ«¡^¡G¤p¤À¤lÃĪ«¶}µo¾ú¥v¤w¶W¹L¦Ê¦~¡A¤j³¡¤À¤w¹L¤F±M§Q´Á¦ÓÅܦ¨¾Ç¦WÃÄ¡A¥Ø«e¬O¤j¤À¤l«½SÃĪ«¡A¤×¨ä¬O³æ®è§ÜÅ骺¤Ñ¤U¡C¦pªG¥¼¨ÓÁÞ¤À¤lÃĪ«ªºMOA³Q½T»{¥B¯à¶q²£¡AÁÞ¤À¤lÃĪ«¶Õ¥²¥i¥H»P³æ®è§ÜÅé¡]¤´¦³°Æ§@¥Î¡^¤À®x§ÜÅé¡A¬Æ¦Ü·íÀù¯gªvÀø¬Ì]¬ãµo¨ì¹w¨¾¬Ì]«á¡AÁÞ¤À¤lÃĪ«¨ú¥N³æ®è§ÜÅéÃĪ«±N¬O«ü¤é¥i«Ý¡C ³o¬O§Ú¦Û¤vµû»ù·sÃÄ¿ïªÑªº¤è¦¡¡Aµ¹¤j®a°µ°Ñ¦Ò¡A¦U¦ì¦pªG¨Ì·Ó§Úªº¿ïªÑ»ùȵû¦ô¡A¯E¹©¨s³º¬O²Å¦X´X¶µ©O¡H²{¦b¯E¹©ªºªÑ»ù¦X¤£¦X²z¡A¦ÛµM¦³µª®×¡C |
|
|
·|û¡GLIN10137582 µoªí®É¶¡:2016/4/10 ¤U¤È 05:22:25²Ä 3866 ½g¦^À³
|
ÁÂÁ¤ѩR¤jªº ¤ÀªR ¦ý±z«ü¥X: OBI-822Á{§É¥u¦¬²Ä¥|´ÁMBC¥B 2¦¸¥H¤W¤ÆÀø¥¢±ÑªÌ ¦b¡u¥xÆWÃÄ«~Á{§É¸ÕÅç¸ê°Tºô¡v¤½§i OBI-822*¥Dn¯Ç¤J±ø¥ó¡G 2.±wªÌ¶·¬°Âಾ©Ê¨ÅÀù±wªÌ¥B¦b±µ¨ü¦Ü¤Ö¤@½uªº¤ÆÀøÃĪ«(¦p¤Æ¾ÇªvÀø¡B¼Ð¹vªvÀø©Î²üº¸»XªvÀø¡A³æ¿WªvÀø©Î¨Ï¥Î¨âºØ¥H¤WÃĪ«ªvÀø¬Ò¥i)«á¹F¨ì§¹¥þ½w¸Ñ¡A³¡¤À½w¸Ñ¡A©Î¯e¯féwªºª¬ºA¡C *¥Dn±Æ°£±ø¥ó¡G 2. ±wªÌ±w¦³Âಾ©Ê¨ÅÀù«á¡Aµo¥Í¶W¹L¤G¦¸ªº¯e¯f´c¤Æ¡C ½Ð±Ð¤Ñ©R¤j: ¦b¥Dn¯Ç¤J±ø¥ó¨ÃµL´£¨ì¥u¦¬2¦¸¥H¤W¤ÆÀø¥¢±ÑªÌ ¦Ó¥B¥Dn±Æ°£±ø¥ó¡Gµo¥Í¶W¹L¤G¦¸ªº¯e¯f´c¤Æ ¬O§_¦b¨ä¥L¦a¤è¦³´£¨ìOBI-822Á{§É¥u¦¬²Ä¥|´ÁMBC¥B 2¦¸¥H¤W¤ÆÀø¥¢±ÑªÌ ·q½Ð«ü±ÐÁÂÁÂ! |
|
|
·|û¡GLu10141514 µoªí®É¶¡:2016/4/10 ¤U¤È 05:20:15²Ä 3865 ½g¦^À³
|
¹x¥Û¤j¤Î¦U¦ì¤j¤j¡A§A̦n¡G pcmc.uni-psg.com/vip/20160226-01.pdf 1¡B²Î¤@§ëÅUªº³o¥÷³ø§i¡u²Î¤@§ëÅU¥Í§Þ²£·~¡v¡AP7¤¤¦³´£¨ì¡Aù¤óªºÀù«ä°±(Avastin)¡A¬O°µ§¹Phase 2«á¡A´Nª½±µ®³¬ü°êÃÄÃÒ¡C ©Ò¥H¡A§Ú¤ñ¸û¼ÖÆ[¹w¦ô¡A¯E¹©ªºOBI-822¡A®ÄªG§ó¦n¡A¥B´X¥GµL°Æ§@¥Î¡A§ó¦³¾÷·|ª½±µ®³¬ü°êÃÄÃÒ¡A¤£¥²¦A°µ3´ÁÁ{§É¡C 2¡B¦pªGOBI-833¥Î¦bGÀù¡B¤j¸zÀù©ÎªÍÀù¡An®³ÃÄÃÒ¡A¤]·|«Ü§Ö¡A¥unÃÒ©ú¦³Àø®Ä§Y¥i¡A¥i¯à2-3¦~¡A´N¥i®³¨ì¬ü°êÃÄÃÒ¡C 3¡B¯E¹©ªº¡uOBI-868ÁÞ´¹¤ù¡v¥«³õ¤]«Ü¤j¡A³o³¡¥÷¥þ¥@¬É¤@¦~°²¦p¦³1»õ¤HÀˬd¡A¨C¤H1000¤¸¥x¹ô¡A¨º´«ºâ¤U¨Ó·|¦³1000»õ¥x¹ô¦¬¤J¡C ¡i¯Î±Ò´f¤£¦^¨Ó¡A³o®×¤l¡A¤£ª¾¹D¯à¦A°õ¦æ¤U¥h¶Ü¡H¡j OBIµo®iªºÁÞÃþ¦X¦¨¨t²ÎOBI-868¡A«Y¥Ñ¤¤¥¡¬ã¨s°|¯Î±Ò´f°|ªø¹êÅç«Ç§ÞÂà¦Ü¥xÆW¯E¹©¡A ¥H¦hÁÞµ²ºc·í§@¶EÂ_Àù²ÓM©ÎÀù¯gªvÀøªº¼Ð¹v¡A§Q¥Î¯S©wÁÞÃþ¤À¤l·í§@±´°w¡A¨Ó±´´M¤HÅé²ÓM¥i¯à¦s¦bªºÀù¯fÅÜ¡A ¨ä²³æ¡B«D«I¤J©Ê¡B§ó¦´ÁÀË´úÀù¯gªº¯S©Ê¡A¥¿²Å¦XÀù¯g¶EÂ_ªº´Á«Ý»P¥D¬y¡F³oÓ¥¥x¤wµo®i¬°Åé¥~ÀË´ú¸Õ¾¯¡A ¦W¬°OBI-868¡A¥Ø«e¤w¶i¤JÁ{§É«e¸ÕÅ綥¬q¡C ¥t¡A²Î¤@§ëÅU ¯E¹©³X½Í³ø§i¡AP13¤¤¦³´£¨ì¡G pcmc.uni-psg.com/vip/20160222-4174.pdf ¹w¦ô¤µ¦~¯E¹©¥iÀò±o40»õ¥x¹ôªº±ÂÅvª÷¡A³o³¡¥÷¦pªG´«ºâ¦¨EPS¡A¬O23¤¸¡A §Æ±æ³o³¡¥÷¯u¯à®³¨ì¡A¦p¯E¹©©ú¦~¯àµo©ñªÑ²¼ªÑ§Q¡A¨CªÑµoÓ5¤¸¡A¨º´N«Ü°g¤H¡I ¦¨¥\»Ýn¤Ñ®É¡B¦a§Q¡B¤H©M¡A¦ýn®ø·À¯Î±Ò´f¡A¥un¤@Ó´¿X©v¡I¶R½æ«e½Ð¼f·Vµû¦ô¡A§ë¸ê¤H¶·¦Ût§ë¸ê·ÀI¡I |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/10 ¤U¤È 01:43:38²Ä 3864 ½g¦^À³
|
Lu¤j¡A Roche¬ù550E USDªºÀ禬·í¤¤¡A¥u¦³¬ù200E¨Ó¦Û©óÀù¯g¬ÛÃö¡A³o200E·í¤¤¡A¤S¦³¬ù1/3¨Ó¦Û©ó«D¹êÅé¸~½F¡C¤]´N¬O»¡¡ARocheªº¹êÅé¸~½F¬ÛÃö¦¬¤J¥u¦ûÁ`¦¬¤Jªº1/4¤£¨ì¡C¦ÓGlobo HÁö¦s¦b©ó14¸~Àù²ÓMªí±¡A¦ý³£¬O¹êÅé¸~½F¡A¤£¥]§t¦åÀù¡B²O¤ÚÀù¡C ¥ý¤£»¡822¬O§_¯uªº¯à¡y§¹³Ó¡z¶PÀù¥¡C§Y¨Ï¯à§¹³Ó¡A¤]»Ýnªá¬Û·íªº®É¶¡¨Ó°µ¥«³õ±À¼s¡C¦pªG³oÓ¯f¹L¥hµLÃÄ¥iÂå¡AÂå¥Í±µ¨ü³t«×¸û§Ö¡F¦ý¬O¦pªG¥«³õ¤¤¤w¸g¦³¤FÃÄ¡A¤×¨ä¬O¥D¾É©Êªº¤jÃÄ¡A·Qn´À´«¥¦¥i¬OÓÁ}¹dªº¤uµ{¡C¶PÀù¥¤W¥«¤w¶W¹L¤Q¤¦~¡AÂå¥Íªº¼ô±x«×¥H¤Î¦UºØÁp¦X¥ÎÃĪº¬ã¨s»PÁ{§É¡A³£¬O¥¦¥Î®É¶¡²Ö¿n¥X¨Óªº¥«³õ§Q¾¹¡C822´Nºâ¯uªº¦p§ÚÌ©Ò·Q¹³ªº¨º»ò¦n¡A¶PÀù¥©Ò¨«¹Lªº¸ô¡A¥¼¨Ó822¬O¤@¨B¤]¬Ù¤£¤F¡C¤]´N¬O»¡¡A§Y¨Ï¡y¤@±ì¶i¬}¡zÅý822¯à¦b2017¦~®³¨ì¨ÅÀùÃÄÃÒ¡A¨ì2025¦~¡A822ªv¨ÅÀù¯à¦³60E¬ü¤¸ªº¾P°âÃB¤w¸g¬O¶W¯Å§Öªº¶i«×¡C¦ÓRoche©ó2015¦~ªº¾P°âÃB¬O550E¬ü¤¸¡A¤j¬ù¤Q¿©ó¦¹¼Æ¦r¡C ¥Ø«e822ªº²Ä¤GÓ¾AÀ³¯g¤~èè¦b¥xÆW¶}©l¦¬®×¡Anµ¥¨ì°ê»Ú¤T´Áµ²§ôªÖ©w¬On2020¦~¤§«á¡C¨ä¥L¾AÀ³¯g«h¦Ü¤Ön¨ì2020¦~¤~¯à°µ§¹¤G´Á¡A¨ä¤¤©Î³\¦³³¡¤Àµ²ªG¯SÀu¥i¥Hª½±µ¥Ó½ÐÃÄÃÒ¡A¦ý§Ú̵Lªk¦p¦¹´Á«Ý¡An¬Oµ¥°µ§¹¤T´Á´Nn2025¦~¤§«á¤F¡C±i¸³¤§©Ò¥H»¡¤£±Æ°£¦P®É±ÂÅv¤Q´XÓ¤pÃļt¥h°µÁ{§É¹êÅç¡A¦]¬°¥L«Ü²M·¡¯E¹©¯Ê¤H¡A¸êª÷¤]¤£¤¹³\¥L¤Q±¶}¾Ô¡C·sÃĤW¥«n·m®É¶¡¡A±i¸³ªº»¡ªk¬JÅã¥Ü822¦b¤£¦P¾AÀ³¯g³£¦³¨¬°÷¼ç¤O¨Ó§l¤Þ¨ä¥LÃļt¦X§@¡A¤]Åã¥Ü®É¶¡ªº«æ¢©Ê¡A¤£¯à³£ÃöµÛªù¤@Ó¤@Ó¦Û¤v°µ¡C²¦³º¡A§O¤H¤]¨C¤Ñ³£¦b¶i¨B¡A°µ±ß¤F´Nµ¥©ó¨S°µ¥X¨Ó¡C ¤W±ªºpºâ¡A¨ä¹ê³£¤w¸g¬O·¥¬°¼ÖÆ[ªº¦ôp¡A¬J¨Sºâ¶i«×©ì©µ¡B¤]¨Sºâ¥¢±Ñ·ÀI¡C ¦Ü©ó¨ä¥LªºÃĪ«¡A833ÁÙ¨S¶iÁ{§É¡A§Öªº¸Ü©Î³\2025¦³¾÷·|®³¨ì²Ä¤@Ó¾AÀ³¯g¡F888ÁÙ¦b°µ¦X¦¨¹êÅç¡A¦ó®É¯à¶iÁ{§ÉÁÙ¨SÓ©³¡C ¤½¥qÄ@´ºnµe¨ì2035¦~¤~¹F¦¨¥@¬É²Ä¤@¡A¤£¬O¥Nªí¤½¥q¨S§Ó®ð¡A¦Ó¬O¨ü©óÂåÃĦæ·~µLªk§Ö³t¨D¦¨ªº²{¹ê¡C ¤p§Ì»{¦Psuperjoe¤jªº¬Ýªk¡An¬O2025¦~¯à°µ¨ì200»õ¬ü¤¸¥«È¡A¤w¬O¤£¦P¤ZÅT¡C³oÓ»ù¿ú«ê¦n¬OPharmacyclics³Q¨ÖÁʪº»ù®æ¡A¤@ӤƦXª«¡A¤TÓBTD¡A¨ä¤¤¨âÓ®³¨ìÃÄÃÒ¡C±i¸g²z´¿¦C¥X200»õ¬ü¤¸¥«È©Ò»Ýn¹F¦¨ªº¨Æ¶µ¡A¸ò³oÓ¤]®t¤£¦h¡C |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/4/10 ¤U¤È 01:02:07²Ä 3863 ½g¦^À³
|
¤Ñ©R¤j ¤ÀªRªº¯u¬O²`¤J »â±Ð¤F |
|
|
·|û¡G¦Ñ´10141055 µoªí®É¶¡:2016/4/10 ¤W¤È 10:22:22²Ä 3862 ½g¦^À³
|
Leo¤j,¤£¥Î¾á¤ß,ª©¤W³o»ò¦h¤j¤j,¤@©w·|²M·¡ªº¸ÑŪ³o¨Ç¼Æ¾Úªº! ¥Dn´N¬O¬Ý¹êÅç²ÕªºOS!MOA!¨ä¦¸´N¬O¦U¦¸±Ú¸sªº¤ÀªR - Global H negative´X% - IgG,IgM¦b²Ä´X°w²Ä´X¶g¤W¤É¦h¤Öªº¶q - ¦]¬°delay response´£¦¤T®¶¥X§½ªº¤H¼Æ - ¹êÅç²Õ³Q»~§P¬°PDªº¤H¼Æ - ¹ï·Ó²Õ²£¥ÍIgG,IgMªº¶q,MPFS - ¥´Ãī᪺°Æ§@¥Î - ¹êÅç²Õ¯uªºPDªº³Ì«á¥§¡¼µ¤F¦h¤[ ASCO«áªº¼Æ¾ÚÀ³¸Ó¥H¤Wªº¼Æ¾Ú³£¥i¥Hª¾¹D,¦ý¬O¨C¤@¶µ¸Ô²Óªº¨ÓÀs¥h¯ßÀ³¸Ó¬Onµ¥½×¤åµoªí¥X¨Ó,ªí®æ³£¾ã²z ¦n«á¤~§ó¦nŪ. |
|
|
·|û¡GLu10141514 µoªí®É¶¡:2016/4/10 ¤W¤È 04:36:15²Ä 3861 ½g¦^À³
|
¹x¥Û¤j¡A§Úı±o¯E¹©·|¡u°l¤W¡vù¤ó(Roche)¬O«Ø¥ß¦b¡G 1¡BOBI-822ªvÀø¨ÅÀùªº®ÄªG«Ü¦n¡A «Ü¦nªº©w¸q¬O¡G100Ó¨ÅÀù4´Á¯f¤H¡A¤j¬ù¦³25-35¤H¡A¥i¥H§¹¥þªv¦n¡C ¥BOBI-822¦pªGÂX¤j¹B¥Î¡A¥i¥Î¦b¨ÅÀù3´Á¯f¤HªºªvÀø¤Î¹w¨¾½Æµo¡C ¦ý¡A¶PÀù¥(Herceptin)¥u¬O¹ï20-25%ªº¨ÅÀù¯f¤H¦³®Ä¡A¥B´X¥G¨S¿ìªk§¹¥þªv¦n¡C(ºô¸ô¤W¸ê®Æ«Ü¦h) ©Ò¥H¡A¥Ñ¥Ø«e©Ò¯à±o¨ìªº¸ê®Æ¨Ó¬Ý¡AOBI-822¬O¡u§¹³Ó¡v¶PÀù¥¡C¦ý¦³«ÝASCO¤§«áªºÅçÃÒ¡C 2¡B¥t¥~14ºØÀù¯g¤¤¡AOBI-822³Ì¤Ö¯àªvÀøÓ3ºØÀù¯g¡A¦ý³o³¡¥÷ÁÙn°µÁ{§É¡A¤j¬ùn4¦~¡C ¦pªG¯àªvÀø¤j¸zÀù¡A¨ºÃ¹¤óªºÀù«ä°±(Avastin)´N§¹¤F¡A¦]¬°Àù«ä°±ªºÃĮĤ£ºâ«Ü¦n¡A¥B°Æ§@¥Î¤Ó¤j¡C 3¡BOBI-822³Ìº}«Gªº¦a¤è¦b¥¦ªº§@¥Î¾÷Âà(MOA)¡A³oÓ§@¥Î¾÷Âà¡A¥Ø«e¬O¤Ñ¤UµL¼Äªº¡C §Ú¤~·|»¡¡G¡u¯E¹©·|¶W¹Lù¤ó¡v¡Aì¦]´N¦b©ó¦¹¡C ©Ò¥H¡A¤U±³o¤T¥y¸Ü¡A§Ú»{¬°¤£¸Ø¤j¡A§ó¤£¬O¼s§iµü¡A¬O¯uªº·|¹ê²{¡I¡I ¯E¹©¸³¨Æªø±i©À·O¥H¡u¥X¥G·N®Æ¡B¶^¯}²´Ã誺¦¨¥\¡v¨Ó¸àÄÀ¡C ¯E¹©´£¨ÑªºÂ²³ø¤º®e¡A¤º³¡³]©w2025¦~¦¨¬°¥xÆW¥Í§Þ²Ä¤@«~µP¡A2035¦~¦¨¬°¥þ²yÀù¯gªvÀø»â¾ÉªÌ¡C ¯E¹©±N¬O¥xÆWªÑ²¼¥«³õ¤¤¡A¦Ê¦~Ãø±o¤@¨£ªº¶W¯Å¥¨¬P¡C §Ú¥Ø«e¥Ñ¦h¤è±ªº»{ª¾¡A¦bÀù¯gªºªvÀø¤W¡AÁ٧䤣¨ì¤ñOBI-822§ó¦nªº§@¥Î¾÷Âà¡A¤£ª¾¹D¦U¬°¤j¤j»{¬°©O¡H ¯E¹©·|¡u°l¤W¡vù¤ó(Roche)¡A³Ì«nªºì¦]¬O¡G¯E¹©»Pù¤óªº²£«~¡A«Å|«Ü¦h¡A¯E¹©·|·m¨«Ã¹¤óªºÀç·~ÃB¡I ¹ï³¡¥÷¼ç¤ôªº¤j¤j¡A§Ú¬O¯Â¬ì¾Çªº°Q½×¡A¨S¦³n¥ô¦ó¤H¶RªÑ²¼ªº·N«ä¡I |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/10 ¤W¤È 12:13:51²Ä 3860 ½g¦^À³
|
superjoe¤j¡A 2025¦~¡A¤¤°ê¤j³°ªºGDP¤j¬ù18.5¥ü¬ü¤¸¡A¸ò¤µ¤Ñªº¬ü°ê®t¤£¦h¡A¤H§¡GDP¤j¬ù1.3¸U¬ü¤¸¡C¤p§Ì±À¦ô¡A¦pªG¥uºâ«e¤@¥b¦¬¤Jªº¤H¤f(¤C»õ¤H)¡A³o³¡¤À¤H§¡GDPn¨ì18000¬ü¤¸À³¸Ó¤£¬O°ÝÃD¡C·N«ä´N¬O»¡¡A2025¦~¤¤°ê¦³¤»õ¤H¥H¤W¦³¯à¤O®ø¶O°ªÀɪºÂåÃÄ¡C³oӼƦr¬ù·í©ó¤µ¤Ñ¥þ²y¤w¶}µo°ê®a¤H¤fªº¤@¥b¡C ¤]´N¬O»¡¡A½Ö¯à¦¨¬°¤¤°ê¤j³°Àù¯gÃÄ«~ªº»â¾ÉªÌ¡A´N¨ú±o¬Û·í©ó¤µ¤éRoche¥«³õ¥÷ÃBªº¤@¥b¡CRoche¥h¦~ªºÀù¯gÃĪ«¦¬¤J¤j¬ù200»õ¤¸¡C ÁöµM¥xÆW¤½¥q¦b¤j³°ªº²´¤¤¨ÌµM¬O¡y¥~¤H¡z¡A¤£¹L²¦³º³o¬O¤@Ó°ª³t¼Wªøªº¥«³õ¡A¥B¨ä¥L°ê»Ú¤jÃļtªº¦a¦ì¨Ã¤£¦p¥L̦b¨ä¥»°ê³o»òéT¡A¯E¹©ªºµo®i¾÷·|¬Û¹ï¸û¤j¡C ¤¤°ê¤w¸g¦¨¬°Ä«ªG¤½¥qªº³Ì¤jÀ禬¨Ó·½¡A¹ï©ó»sÃĤ½¥q¡A¤×¨ä¬O¥x°Ó¡A³o¤@¤Ñ¤]·|«Ü§Ö¨ì¨Ó¡C¦ý¬O·í§ÚÌ¥H¤µ¤ÑªºRoche°µ¼Ð¬ñ¤§®É¡A¨ä¹ê¤¤°êªºÀ禬¦¨¤ÀÁÙ¬O«Ü¤pªº¡C¤¤°ê¥«³õ¦]¯À¡A·|¬O¯E¹©¥¼¨Ó¦¨ªø³t«×ªº³Ì¤j wildcard¡C |
|
|
·|û¡Gsuperjoe10141522 µoªí®É¶¡:2016/4/9 ¤U¤È 09:46:50²Ä 3859 ½g¦^À³
|
¹x¥Û¤j, ½T¹ê,20¦~¤º½T¹êÃø¥H°l»°ROCHEªºÀç·~ÃB!¦ý¦pªGÀç·~ÃB¹F¨ì¨ä1/10,10¦~À³¸Ó¬O¦³¾÷·|ªº,¤£¥Î¦k¦ÛµáÁ¡,¤]¤£¥²¦n°ªÄE»·! ¤@¨B¤@¸}¦L,¥un¤½¥q¤è¦V¹ï,¦¨¥\»P§_¦Û¦³¤Ñ¼Æ!§A§Ú¥un¼ÖÆ[¨ä¦¨,¤£¬O¶Ü? |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/9 ¤U¤È 09:21:42²Ä 3858 ½g¦^À³
|
¬Ý¨ìLu¤jªº¶K¤å¡A¤p§Ì§ä¤F¤@¤URocheªº²£«~»P°]°È¸ê®Æ¡A²n¦p¤U¡G Roche sales in 2015: 550 E USD (5% growth from 2014) ¥D¤OÃĪ« ¦~«×¾P°âÃB»P¾AÀ³¯g Rituxan 73E¡G²O¤ÚÀù¡AºC©Ê²O¤Ú²ÓM¥Õ¦å¯f¡AÃþ·Àã©ÊÃö¸`ª¢¡Aµ¥µ¥ Avastin 66E¡G¤j¸zª½¸zÀù Herceptin 64E¡GHER-2¹L«×ªí²{¤§¨ÅÀù Lucentis 18E¡G¦Ñ¤H¶À´³©Ê¯fÅÜ Xeoloda 16E¡G¤fªA¤ÆÀøÃÄ (¤j¸zª½¸zÀù¡B¨ÅÀù) ¶EÀø³]³Æ Âå°|¥Î³]³Æ 56E ®a¥Î¦å¿}¾÷ 23E ¨ä¥LÀ禬¡G 230E (¤½¥qºô¯¸¨Ã¥¼»¡©ú²Ó¶µ¡A¦ôp±ÚÁc¤£¤Î³Æ¸ü) ¤ò§Q¡G 368E Àç·~¶O¥Î¡G 183E §éÂÂÅu´£¡G 40E Àç·~§Q¯q¡G 145E µ|«á²b§Q¡G 121E ¦Û¥Ñ²{ª÷¬y¶q¡G 117E (after 43E ¸ê¥»¤ä¥X) ¤ä¥I²{ª÷ªÑ§Q¡G 87E ÀvÁÙÉ´Ú¡G 23E 2016¦~¤¤¦³¾÷·|®³¨ìFDA¤TÓ·sÃÄÃҮѡG Venetoclax¡G¤p¤À¤lÃÄ¡AªvÀøºC©Ê²O¤Ú²ÓM¥Õ¦å¯f Ocrelizumab¡GÀ³¸Ó¬O·Ç³Æ¨ú¥NRituxanªº¤U¤@¥NmAbÃĪ« Atezolizumab¡G¤@ºØ°w¹ïPD-L1ªºmAb, ¥¿¦b°µ¦hºØÀù¯gªºÁ{§É¹êÅç¡A[¤@´ÁÁ{§ÉÅã¥Ü¹ï¤T³±©Ê²¾Âà©Ê¨ÅÀù±wªÌ¦³19%ªºORR] ®Ú¾Ú¥H¤W¼Æ¦r¡A¤p§Ì¯uªº¤£»{¬°¯E¹©»PRocheªº®t¶Z¬O¦b¤Q¦~¤§¤º¥i¥H°l»°ªº¡C¤G¤Q¦~¤Ó¤[¤F¡A²{¦b¬Ý¤£²M·¡¡A¦ý¬O¦pªG³æ¾a¤@Ó§Þ³N¥¥x¬O¤£¥i¯àªº¡C ¯E¹©·Qn°l»°Roche¡A¹F¦¨¥@¬É²Ä¤@¡An¦b³\¦h¤è±²æL´«°©¡C±q²{¦bªº¹Î¶¤¨¤WÁ٬ݤ£¥X³oÓ¥i¯à©Ê¡C |
|
|
·|û¡GLeo10142037 µoªí®É¶¡:2016/4/9 ¤U¤È 08:35:18²Ä 3857 ½g¦^À³
|
¦Ñ·¨¤j ½Ð°Ý¤@Ó°ÝÃD ASCO«á¼Æ¾Ú¥X¨Ó¤F §ÚÌn¬Ý¨º¨Ç¼Æ¾Ú ¥i¥H«ü¾É¤@¤U¤p§Ì¶Ü? ¨ì®ÉÔª©¤Wªº¯«¤H¶Ü? ·|¤@°_¸ÑŪ³o¨Ç¼Æ¾Ú¶Ü? ·PÁÂ!! |
|
|
·|û¡G§d½n¶¯10142119 µoªí®É¶¡:2016/4/9 ¤U¤È 07:01:48²Ä 3856 ½g¦^À³
|
»{¬°10¦~«á¡A¯E¹©ªº¥«È·|°l¤Wù¤ó(Roche)Ãļt²{¦bªº¥«È¬ù2010»õ¬ü¤¸¡A ¥Ø«e¯E¹©ªº¥«È¥u¦³23»õ¬ü¤¸¡AÁÙ¦³80¿ªº¦¨ªø¼ç¤O ----------------------------------------- ³o¬O«Ü§¹¬üªº·Qªk¡A¦ý¬O²{¦bÂåÀø§Þ³N«ùÄò¤£Â_¶i«×¡A¦pªGÁÞÃþ¬O¤@±ø¸ô®|¡A¨ä¥L°ê®a¬ã¨s³æ¦ì¬ÛÄ~§ë¤J¤§«á¡A©Î³\¦³§ó¦nªºÃĪ«©ÎªvÀø¤èªk¥X²{¡A¤Ó»»»·ªº¨Æ·Q·Q´N¦n...·íµM¦pªG¦¨¯u¡A¤]¬O«Ü¦nªº¨Æ..... |
|
|
·|û¡GLu10141514 µoªí®É¶¡:2016/4/9 ¤W¤È 10:35:26²Ä 3855 ½g¦^À³
|
ÁÂÁ¹x¥Û¤j¡A¬Q¤Ñ¦]¬°ÁI¤j¦b¨ºÃäµo¨¥¡A©Ò¥H§Ú¤~¦b¨ºÃä¦^¡A¦b³o¸Ì«¶K¤@¦¸¡G ¹q°Ê¨®¬O¡G¥un·|°µ¹q¦À¡A¨C¤@®a¨T¨®¼t³£¯à°µªº¡A§Þ³NªùÂe¤£°ª¡C ¯S´µ©Ô²Ä2¥N¹q°Ê¨®¡A´N°¨ì¤@½ø3.5¸U¬ü¤¸¡A¯à¦³¦h¤Ö§Q¼í¡H¯à¦ûÀu¶Õ¦h¤[¡HȱoÃhºÃ¡I §Ú̧ë¸ê¯E¹©¡A¬O¬Ý¨ìOBI-822ªº®ÄªG«Ü¦n¡I OBI-822¥i¥H«Ü©úÅ㪺¨ú¥Nù¤ó(Roche)Ãļtªº¶PÀù¥(Herceptin)¡A ¤Î«Ü¦³¥i¯à¨ã¦³¨ú¥NÀù«ä°±(Avastin¡AªvÀøÂಾ©Ê¤j¸zª½¸zÀù) ªº¯à¤O¡C »{¬°10¦~«á¡A¯E¹©ªº¥«È·|°l¤Wù¤ó(Roche)Ãļt²{¦bªº¥«È¬ù2010»õ¬ü¤¸¡A ¥Ø«e¯E¹©ªº¥«È¥u¦³23»õ¬ü¤¸¡AÁÙ¦³80¿ªº¦¨ªø¼ç¤O¡A ¤]´N¬O»¡¡G²{¦b¯E¹©ªºªÑ»ù¡A¦A¼¥H80¿¡A³o¤~¬O§Ú̯E¤Í°l¨Dªº¥Ø¼Ð¡I |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/9 ¤W¤È 12:06:17²Ä 3854 ½g¦^À³
|
¥H¤U±q²Ä¤Q¤Hª©Âà¶K¦³Ãö822/833¥]»q±ÂÅv¥i¯à©Ê¤§°Q½×¡G ¦V«e¤j µo¨¥¡G ¥tÃþ«ä¦Ò §Y¨Ï822¦¨¥\(¦h¤Ö¦~«á?)«á±ÁÙ¦³833¤§¨ú¥N «á®ö±À«e®ö,«e®ö¦º¦b¨FÅy¤W ¬JµM¤H®a¬Ý¹L¸Ñª¼¸ê®Æ«áÄ@·N¨ú±o±ÂÅv ·íµM¬O¹ï822Àø®Ä¤§I®Ñ ¯Eô¥Ø«e¤£¬O³Ì¤í¯Ê¿EÀyªº¶Ü? ¤j¼t·|¤£·|¾á¤ß¥@¥N¨ú¥N°ÝÃD¦Ó¤£´±ªá¤j¿ú¨ú±ÂÅv? ³Í¤l³Í¤j µo¨¥¡G ¨â¦ìªºÆ[ÂI¥u¬O¦b¦Û¤vÁȤñ¸û¦h¸òµ¹¥~°êÃļt ¤p§Ì¤£¹³©p̳o»ò¼ÖÆ[¡A¬Q¤Ñªº±M®a·|ij§óÅý¤p§Ì½T©w¤½¥qÀ³¸Ó¬On°µ¥þ²y¤T´Á ¥þ²y¤T´Ánªáªº¿ú¥i¬O«D±`®£©Æªº ¯E¹©²{¦bªºª¬ªp¡A¨S¦³¨º»ò¦h¿ú¿N ¥«³õ¶Ò¸ê¦b³oºØª^³ò¤U¡A¤Sn®³ªÑ²¼´«¶r²¼¡A®Ú¥»¬O¤£¥i¯à ¥~°ê¨º¨ÇÃļt¤]ª¾¹D³o±¡ªp¡A¥L̤£«æ ÁöµMÃĦ³®Ä¡A¦ý¬O²{¦b¨S¦³ÃÄÃÒ´NÁÙ¬O¦b¿N¿ú §Úı±o«á±ªº±ÂÅv¦X§@¡A¯E¹©¬O¦b®z¶Õ¤è ¥i¯à¤£·|¹³§Ṳ́@¶}©l´Á±æªº°ª±ÂÅvª÷ APK¤j µo¨¥¡G ³Í¤l³Í¤j¡A §A³oÓ»¡ªk¹ï¡A¤]¤£¹ï ÃöÁä¦b©ó¹Î¶¤¤¤¦³¨S¦³¾Õªø°ê»Ú½Í§Pªº°ª¤â¡A ¦pªG¤£À´±oÀç³y¤@ӼƮaÃļt·mªº§½±¡A ·íµM¬O®z¶Õ¤è¡A ¦ý¦pªG¦³³¢¸³¹Î¶¤¤¤¨ººØ°ª¤â¡A ¬O«Ü¦³¾÷·|ªº¡C ¹x¥Û µo¨¥¡G 833¥un¤£¥ý°µ¨ÅÀùÁ{§É¡A¸ò822´N¤£·|¦³½Ä¬ð¡C¬O§_¦³«á®ö«e®öªº°ÝÃD¡A¯E¹©¥i¥H¸Ñ¨M¡C °ê»Ú¤T´ÁÁ{§É¿N¿úªº°ÝÃD¡A¤p§Ì»{¬°ÁÙ¦n¡C¦h¦~¥H«e¡AÀq§J°µ¤F¤@Ó¥D°Ê§K¬Ìªº¨ÅÀù¤T´Á¡A¦¬¤F¤T¤d¦hÓ¯f¤H¡Aªá¶O¦ÛµM¬O¤Ñ¤å¼Æ¦r¡C¤§©Ò¥Hn¦¬³o»ò¦h¯f¤H¡A¬O¦]¬°¹ïÀø®Ä¨S§â´¤¡An¾a¯f¨Ò¼Æ¥Ø¨Ó¹F¨ì²Îp¤WªºÅãµÛ©Ê¡Cµ²ªGÁÙ¬O¥¢±Ñ¡C ¶ÀÁ`ªk»¡·|®É´¿»¡¡A¬Ý¨ìµ²ªGµÎ¤F¤f®ð¡A¦]¬°¤T´Á¤£¶·n°µ¤G´Á³o»ò¦h¯f¨Ò´NÀ³¸Ó¥i¥H¹F¨ìÅãµÛ©Ê¡C¦pªG¤T´Á¥u°µ300¨Ò¡A´Nºâ¦b¬ü°ê°µ¡A¯E¹©¸êª÷¤]°÷¡C Iriswu¤j µo¨¥¡G Y¬O300¨Ò,¥HÁ{§É¤@Ó¤¸U¬üª÷pºâ,¤j¬ù¬O1500¸U¬üª÷,³o¼Ëªºªá¶O¹ï¯E¹©ÁÙ¤£¬O°ÝÃD,¥u¬O¥i¯à®É¶¡n¦AªáÓ2-3¦~. ¦³«í¤j µo¨¥¡G ¤p§ÌY¥Nªí°ê»Ú¤j¼t¡A§ÚÅK©w¬O§Æ±æ822.¤ÎÁp¦X¥ÎÃÄ.833¬Æ¦Ü³s888³£¥]»q±ÂÅv ¡A¦ý¥H¯E¹©ªº¥ß³õ822¦¨¥\¡A¨Æ¹ê¤W¤]¥NªíµÛÁp¦X¥ÎÃÄ.833.888¥¼¨Ó¦¨¥\ªº¾÷²v¤j¼W¡A ®t§O¦b©ó¥¼¨ÓÁ{§É±À¶i®Éµ{¥i¯à²£¥Í°ê»Ú¤j¼t«á¨Ó©~¤Wªº·ÀI¡AY¯E¹©¤£Ä@·N ¥uÄ@·N³æÃĤÎÁp¦X¥ÎÃıÂÅv¡A¦Ü¤Ö´Nn¦p¦Pmerck¨ú±oÀu¥ýij¬ùÅv¤@¼Ë¡A¦Ü¤Ö¨ú±o ¥¼¨Ó833²Ä¤@¶¶¦ì½Í§PÅv§Q¡A·íµMYÃĮīD±`¦n¡A°ê»Ú³W®æªº°ªÃB±ÂÅvª÷À³¸Ó¬O¥i¥H´Á«Ýªº¡A ¥xÁÞ¤j µo¨¥¡G 822 merck¨ú±oÀu¥ýij¬ùÅv ¦ýn¥X³Ì°ª»ù ,§O®a¥X»ù¤ñmerck°ª, ¯E¹©¥i¥H±ÂÅvµ¹§O®a 833¨S¤]³oÓ°ÝÃDn±ÂÅvµ¹½Ö´Nµ¹½Ö §¹¥þ¦Û¥D 1¯E¹©ªº¿ú¨¬°÷¤]¦³¯à¤O°µ¥þ²y¤T´Á,¥þ²y¤T´Á¤H¼Æ·|¤ñ¥xÆW¤T´Á¤Ö«Ü¦h ¤w¸g¦³¤f¸O¦³¥R¤À·Ç³Æ ¦¬®×³t«×·|¤ñ¥xÆW§Ö«Ü¦h,¤H¼Æ¤Ö ,¦¬®×§Ö 3ªk»¡·|«á°Ýµª¤j®a¤£¬O°Q½×¹LN¦¸,¥Ø«e±¡ªp¬O±qYK¸Ñª¼4±¡ªp Åܦ¨Michael ¸Ñª¼3¥i¯à ¦³«í¤j µo¨¥¡G ¤p§Ìªº·Qªk¬O¡A½Í§Pªº¹Lµ{¤¤¦]¬°°ê»Ú¤j¼t¾á¤ß¥¼¨Ó833¥i¯à¨ú¥N822¬J¦³¥«³õ¦Ón¨D¤½¥q³s¦P833¥]»q±ÂÅvªº¸Ü¡A ¤½¥q©Î³\¥i¥H822³æÃıÂÅv¥[¤W¥¼833¥¼¨ÓÀu¥ý½Í§Pªº¿ï¾ÜÅv§@¬°§é½Ä±ø¥ó¡A«O¦³¥¼¨Ó833ªº¥D°ÊÅv¡A³Ð³y§ó°ªªºªþ¥[»ùÈ ¦P®É¤]¥i´£°ª822³æÃıÂÅvªº±ÂÅv»ù½X¡C ·P°Ê£®¤j µo¨¥¡G ²z½×¤W¦pªG¥i¥H»{¦P¢·¢±¢±ªºÃļtÀ³¸Ó´N§ó¯à»{¦P¢·¢²¢² ¦Ó¯E¹©²{¦b¦b°ê¤º¦³¤@°ït±ªºÁÖ½×À£¤O ÁÙ¦³·|p¨î«×±N¦b¢°¢·¦~§ïÅܪº¼Æ¦rÀ£¤O ¥¼¨Ó¬ü°êªº§K¬Ì°ê®a¶¤¤]¬O¤@Ó¤jÅÜ¼Æ ¥H¤½¥q¸gÀç¦Ó¨¥ ¤£±Æ°£§ïÅܤ覡ª½±µ±ÂÅv¡A´î¤Ö¤À¼í ¥H´î»´°ê¤º¥~ªºÀ£¤O ¬JµM°ê¤º´CÅé»P¬FÄÒ³£¤wµø¯E¹©¬°§Q¯q¿é°e¤Uªº¤£¨v¼t°Ó ¯Î°|ªø¤]³Q¹G¤U¥x¤F §Ú·Q¤½¥q¤]¤£¤@©wn¦³®Ú¯d¥xÆW¡An±N¤jÃįd¦b¥xÆWªº¥´ºâ¤F ½ÍÓ¦n»ù®æ§â²{¦³²£«~±ÂÅv¥X¥h ¤À¼í¤Ö¤@ÂI¡A¥ý§â¦¨¥»¦^¦¬ ¤]¬O²{¶¥¬q«Ü¦nªº¸gÀ礧¹D¡I ¹x¥Û µo¨¥¡G ¤p§Ì»{¬°833»P822¥]»q±ÂÅvªº¥i¯à©Ê«Ü§C¡C¦]¬°Âù¤è¹ï833»ùȪº»{ª¾®t²§¹L¤j¡C ¯¸¦b¯E¹©¥ß³õ¡A833¥i¯à¦³§ó§Ö§ó°ªªº§K¬Ì¤ÏÀ³®ÄªG¡C¯¸¦b¹ï¤è¥ß³õ¡A¦w¥þ©Ê»PÀø®Ä¬O§_¯à¹F¨ì³Ì§C¼Ð·Ç³£¦³°ÝÃD¡C©Ò¥HYn¥]»q±ÂÅv¡A¹ï¤èªº¥X»ùÅãµM¤£·|²Å¦X¯E¹©ªº´Á«Ý¡C 833ÁÙ¥¼¶iÁ{§É¡An¯à°µ¦¨»s¾¯¨ú±oÃÄÃÒ¡A¤Ö»¡¤»¦Ü¤K¦~¡A¦Ó¥B»¡¤£©w¤@´Áªº¦w¥þ©Ê´N¥X§½¤F¡C ·sÃĤ½¥q¦b°µ»ùȵû¦ô®É¡A¥¼¶i¤JÁ{§Éªº³q±`¤£¦ô¡C²z¥Ñ¦b¦¹¡C |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/4/8 ¤U¤È 05:51:48²Ä 3853 ½g¦^À³
|
Åó±ø±ø¤j ±z«È®ð¤F ¤p§ÌÁÙnÄ~Äò«ôŪ±z»P¥xÁÞ¤jªº¤À¨É©O |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2016/4/8 ¤U¤È 04:44:48²Ä 3852 ½g¦^À³
|
ª©¥D¤j¤j, ¥»ª©¼ÐÃD¦h¥´¤F¤@Ó¤¾¦r--> "ªº", ³Â·Ð½Ð¼·ªÅ²¾°£, ¥¿½T¦WºÙÀ³¸Ó¬° "¯E¹©Ä@´º»P»ùȵû¦ô" ¸U¤À·PÁ ¡ã¡ã |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2016/4/8 ¤U¤È 02:53:19²Ä 3851 ½g¦^À³
|
¥xÁÞ¤j,¯E§J¤j,¤pªü«¼¤j,³p»»¤j,¥Ó¥|®ü¤j,²L¯ó¦Ï¤j,¤Ñ©R¤j ÁÂÁ±z ¡ã¡ã http://udn.com/news/story/9523/1615361-%E6%B5%A9%E9%BC%8E%E6%A1%88-%E7%BF%81%E5%95%9F%E6%83%A0%E5%9B%9B%E9%BB%9E%E9%87%8B%E7%96%91 ¤¤¬ã°|°|ªø¯Î±Ò´f±²¤J¯E¹©·¼É¥Bº¢¬ü¥¼Âk¡A¥L¬Q¡]7¡^¤é¦V¥ßªk°|´£¥X®Ñ±³ø§i¸ÑÄÀ¡A±j½Õ¥X°â¯E¹©«ùªÑ¯Âºé¬O¨ó§U¤k¨à²z°]¡A°w¹ï¯E¹©¸Ñª¼µ²ªGªºµo¨¥¤]µL¼vÅTªÑ»ù·N¹Ï¡A¥L·|°t¦X¥qªk½Õ¬d¡A¨Ã¹ï¥L¦b¦¹®×¤¤ªº²¨¥¢¤Þµoª§Ä³¡A¦V°ê¤HPºp¡C ¥ß°|±Ð¨|¤å¤Æ©eû·|¤W©Pn¨D¯Î±Ò´f¦Ü°ê·|³ø§i³Æ¸ß¡A¯Î¥H°·±d¦]¯À¬°¥Ñ½Ð°²¨â©P¡A¥L¥»©P¥H®Ñ±³ø§i®Ñ¦^ÂСA´£¥X¥|ÂI»¡©ú¯E¹©®×¡A¥]¬A¡u¯E¹©ªÑÅv½t¥Ñ¡v¡B¡u2¤ë18¤é¥X°â¤Q±i¯E¹©ªÑ²¼½t¥Ñ¡v¡B¡uÓ¤H¹ï¯E¹©¸Ñª¼µû½×¡v©M¡u¤¤¬ã°|§ÞÂà¯E¹©¡v¡C ¯Î±Ò´f¦b³ø§i¤¤©Z©Ó¡AÁöµM¦W¤UµL¯E¹©ªÑ²¼¡A¦ý¹L¥h½T¹ê¨ó§U¯Î§Öq»{ÁʯE¹©3,000±i¡A¨Ã¦b±µ¥ô¤¤¬ã°|ªø«á³°Äò»P¥L¤Ó¤Ó¨Ì¬ü°êªk«ß¡A¦b§Kµ|ÃB«×¤ºÃØ»P¤l¤kªÑ²¼¤Î²{ª÷¡C¯Î±Ò´f¦b³ø§i¤¤ºÙ¡A¥L´¿¦b³X°Ý¤¤»¡¦Û¤v¨S¦³¯E¹©«ùªÑ¡A¨ÃµLÁô¿f¤k¨à«ù¦³¯E¹©ªÑ²¼¤§·N¡C ¹ï©ó¤k¨à«ù¦³¯E¹©ªÑ²¼¡A¯Î±Ò´fªí¥Ü¡A¬O·í¦~³Ð¿ìOptimerªº¬J¦³§Q¯q¡A·í¦~¼í®õ¶°¹Î¦VOptimerÁʦ^¯E¹©6,000¸UªÑ«á¡A¤À§Oµ¹¤©¤T¦ì³Ð¿ì¤H»{ªÑÅv¡A¥L¦]¦¹¨ó§U¤k¨à»{ÁÊ¡C¹ï©ó¯E¹©¸Ñª¼«e¡A¥L¥N¤k¥X°â¤Q±i¯E¹©ªÑ²¼¡A¯Î±Ò´f»¡¡A¬O·~°Èû¥D°Ê¬¢¸ß¡A¥L¨Æ¥ý¤£ª¾¸Ñª¼µ²ªG¡A¯Â«Y¶¶À³·~°Èû«Øijªº²z°]¦æ¬°¡C ¦Ü©ó¯E¹©¸Ñª¼«á¡A¯Î±Ò´f¹ï¸Ñª¼µ²ªGªí¥Ü¬Ýªk¡A¥Lªí¥Ü¯Â«Y¬ì¾Ç¤Wªº·N¨£¡A¨S¦³¼vÅTªÑ»ùªº·N¹Ï¡A¦ý¹ï©ó¥L´N§Q®`½Ä¬ð¨Æ±¡²¨¥¼°jÁשҧ@µo¨¥¡A³y¦¨¤¤¬ã°|¤ÎªÀ·|¤j²³ºÃ¼{¡A¥L¥»¤H²`·P©êºp¡C ¯Î±Ò´fªí¥Ü¡A¤¤¬ã°|¨â¦¸§ÞÂà¯E¹©¡A¥LÓ¤H¬O§_¹H¤Ï°|¤º¬ì§Þ²¾Âà§Q¯q½Ä¬ð°jÁ×ì«h¡AÄ@·N±µ¨üÛ²z©eû·|½Õ¬d¡A¦P®É¹ï©ó©Ò¤Þµoªº¬ÛÃöªk«ßª§Ä³¡A¥¼¨Ó¥L¤]·|¥þ¤O°t¦X¥qªk½Õ¬d¡C |
|
|
·|û¡G¥¤ß¦Ó½×10139639 µoªí®É¶¡:2016/4/8 ¤W¤È 01:25:11²Ä 3850 ½g¦^À³
|
µo²{¤@½g«Ü¦nªº¤å³¹¡A¸ò¦U¦ìªB¤Í¤À¨É ¥i¥HÂç²M³\¦h¹ï¯Î°|ªø»P822Àø®ÄªººÃ¼{ adisintegrinandmetalloproteinase17.blogspot.tw/2016/04/blog-post.html?m=1 |
|
|
·|û¡G²L¯ó¦Ï10141546 µoªí®É¶¡:2016/4/7 ¤U¤È 11:57:38²Ä 3849 ½g¦^À³
|
®¥³ß·sª©§ó¦W¶êº¡~ ±ø¤jªº¯E¹©°O¬ö¿ý¤F¯E¹©¤@¸ô¥H¨Óªº°ª¼é§C¨¦¡B³±´¸·«B¡A ¥¼¨Ó¦¹ª©ªº©Ò¦³¬ö¿ý±N¬O¯E¹©¦^¾Ð¿ýªº¬Ã¶Q¸ê®Æ~ ¦A¦¸·PÁ©Ҧ³¤j¤j̪º¯Ñ¯Ð»P ¥I¥X~ |
|
|
·|û¡G¥Ó¥|®ü10139653 µoªí®É¶¡:2016/4/7 ¤U¤È 10:04:39²Ä 3848 ½g¦^À³
|
®¥³ß±ø¤j´«¬KÁp §Æ±æ³o·sªº¶}©l ¯à±a¨Ó¯E¹©ªº¦n¹B ȱo©ñÃ@¬¶¼y¯¬ ¤]§Æ±æ¯à§Ö§Ö»°¨«¯E¹©ªº´c¹B |
|
|
·|û¡G³p»»10141999 µoªí®É¶¡:2016/4/7 ¤U¤È 09:18:05²Ä 3847 ½g¦^À³
|
ÁÂÁ¹ǧAÅó±ø±ø¤j¤Î¦U¦ì¤j¤jªº¥Î¤ß |
|
|
·|û¡G¤pªü«¼10141843 µoªí®É¶¡:2016/4/7 ¤U¤È 09:14:09²Ä 3846 ½g¦^À³
|
¹Ç§AÅó±ø±ø¤j ÁÂÁ±z! |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/4/7 ¤U¤È 08:33:54²Ä 3845 ½g¦^À³
|
Åó±ø±ø¤j ·PÁ±zªº¶}©« ¤p§Ì¤ä«ù¨Ã«ô½Ð¦U¦ì¯E¤Í¶°Åé°^Äm¥»©« ·P®¦ |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/4/7 ¤U¤È 08:13:54²Ä 3844 ½g¦^À³
|
Åó±ø±ø¤j: ¯E¹©°O¼gªº«Ü¦³·P,¯uª÷¤£©È¤õ·Ò,¤£¥²¨£¤F¼v¤l§Ñ¨ä¥»½è,¯E¹©¸g¹Lºé·Ò«á¥²±N¯D¤õ«¥Í |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2016/4/7 ¤U¤È 05:45:04²Ä 3843 ½g¦^À³
|
·q·Rªºª©¥D¤j¤j, ¤]ÁÂÁÂ¥xÁÞ¤j»P¹x¥Û¤jªºÄ_¶Q«Øij ¼ÐÃD´N½Ð§ï¬°¡G¯E¹©ªºÄ@´º»P»ùȵû¦ô ª©ÀY¤å³¹½Ð§ï¬°¥H¤U¤º®e¡G ¯E¹©°O¡G 1. ¯E¹©2015¦~3¤ë¥¿¦¡±q¿³ÂdÂà¤WÂd,«o±q400¤¸¶^¨ì250¤¸ 2. ÀHµÛ¸Ñª¼®É¶¡±µªñ,¥«³õ¤W°ª«×ªºÃöª`»P°l±·,¿v©³Ãk¤É¨ì750¤¸ªº¤Ñ»ù 3. 2016/2/21¸Ñª¼«á, ¥Ñ©ó¸Ñª¼¥¼¹F¹w¥ý³]©wªº¥Ø¼Ð, ¦A¥[¤W¦W¼L¥ß©e´CÅé½Ñ¦h¥H³_¶Ç³_,¥H°¾·§¥þ, ¥B¥¼¸gÃҹꪺ«ü±± ÁöµM¤½¥q»¡¯à°÷²£¥Í§ÜÅ骺±Ú¸s´N¯à°÷²£¥ÍÁ{§É¤WªºÀø®Ä,©ó¬O¦³©Ò¿×ªº"¤@ӸѪ¼,¨âºØ¸ÑŪ,¦U¦Ûªíz" ¤@¸ô¤U¶^¨ì350¤¸¥ª¥k 4. ¦ý¦b2016/3/31²×©óªï¨ÓÀò±oASCO Oral presentationªº®¶¾Ä®ø®§,4¤ë1¤é·M¤H¸`·í¤Ñ,ªï¨Ó¤F¤[¹Hªº¤@¸ôº¦°±ªO 5. 6¤ëªìªºASCO, ÁÞ¤k§Y±N´¦¶}¦oªº¯«¯µ±¯½ ¨Ì¾Ú²Î¤@§ëÅU±i¥ß¸s¤ÀªR®v¬ã¨s¡G https://www.google.com.tw/url?sa=t&rct=j&q=&esrc=s&source=web&cd=2&cad=rja&uact=8&ved=0ahUKEwins9egnPzLAhVikIMKHcc1DN8QFgggMAE&url=http%3A%2F%2Fpcmc.uni-psg.com%2Fvip%2F20160226-01.pdf&usg=AFQjCNHCCWDKl493HzcquFVIcJoolRPgnQ »PµL±¡¤jªº¤ÀªR¡G http://tsjh301.blogspot.tw/2014/08/obipharma.html ¥»µÛªø´Á§ë¸ê, °l®Ú¨s©³ªººë¯«¨Ó±´¯Á¯E¹©ªº§ë¸ê»ùÈ, ¤£¦]µu´ÁªÑ»ùªi°Ê°_¥ñ¦Ó¼vÅT¹ï "¥þ²y²Ä¤@ÁûFirst in class, Best in classªº§ÜÀùÁÞ¤À¤l¥þ·sÃĪ«"§ë¸êªº¼ö±¡ ¨ÃÅé²{¤½¥qÄ@´º: "³Ð³y¥xÆW¥Í§Þ«~µP,¦¨¬°Àù¯gÀøªkªº¥þ²y»â¯èªÌ" "2025¦~¦¨¬°¥xÆW¥Í§Þ²Ä¤@«~µP, 2035¦~¦¨¬°¥þ²yÀù¯gªvÀø»â¾É¤½¥q" Åwªï¤À¨É¥ô¦ó¹ï¯E¹©Ä@´º»P»ùȵû¦ôªº¬Ýªk»P°ª¨£~~ |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/4/7 ¤U¤È 04:49:13²Ä 3842 ½g¦^À³
|
¹x¥Û¤jªº¼ÐÃD«Ü´Î +1 |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/7 ¤U¤È 02:46:48²Ä 3841 ½g¦^À³
|
±ø¤j¡A ¤p§Ìµo¤å®É¶¡±ß±z35¬í¡A©Ò¥H¨S¬Ý¨ì±zªº¶K¤å¡C ´Nµ¥±z³oª©¥H·s±¥Ø±a»â²³¯E¤Í̤@°_¨£ÃÒ¯E¹©¹ê²{¥¦ªºÄ@´º¥Ø¼Ð¡A¦P®É¤]¹ê²{Ó¤HÀò§Q¡C |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/7 ¤U¤È 02:28:15²Ä 3840 ½g¦^À³
|
«ö·Ó¥xÁÞ¤jªº«Øij¤è¦V¡A¼ÐÃD·|¦³ÂIÃþ¦ü ¡§¯E¹©ªº¥@¬É²Ä¤@¤§¸ô»P¥ø·~»ùȵû¦ô¡¨¡C ¦n³B¬OÄ@´ºªºªÅ¶¡«Ü¤j¡A¯ÊÂI¬OÄ@´º³oÓªF¦è¨Sªk±`±`°Q½×©ÎÀËÅç¡C¯à°÷Åý¯E¤Í®É®ÉÃöª`»P¤À¨ÉÆ[ÂIªºÁÙ¬O¦b¥ø·~»ùȵû¦ô³o¤@³¡¥÷¡C ©ÎªÌ¬O«ö±ø¤jªº¼ÐÃD¡A§âÄ@´º»P¥ø·~»ùȪºÃö«Y©ñ¦bª©ÀY¤å·í¤¤¡A¦bªÑ»ù¤W¤£©w¥Ø¼Ð¡B¤£«Ê³»¡H ¦U¦ì¤j¤j«Øij¦p¦ó¡H |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2016/4/7 ¤U¤È 02:27:40²Ä 3839 ½g¦^À³
|
ª©¥D¤j¤j, ±Ä¯Ç¥xÁÞ¤j»P²³¤j¤j«Øij, »EµJ¦b¯E¹©ªºÄ@´º»P»ùȤW ½Ð§ó§ï¥»ª©¼ÐÃD¬°¡G¯E¹©Ä@´º»P»ùȵû¦ô ÁÂÁ ¡ã¡ã ¤]ÁÂÁ²³¤j¤jªº±¡¸q¬Û®¼, ¥¼¨Óªºº©º©ªø¸ô¤W, ¥²±N³vº¥®iÅS¥ú¨~, Åã²{¶Æ¤Hªº»ùÈ ¯EÃv·sÃÄ, ¹©¥ß¤Ñ¤U, ¦¨´N«D¤Z, ¥\¹M¾È¦t ¥u§ï¼ÐÃD¡A¤£§ïª©ÀY¤å³¹¬O¶Ü¡HY¬O¡A«Ý§Ú±ßÂI¦^¤½¥q«á«K³B²z¡AÁÂÁÂÅo~ BYª©¥D |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/4/7 ¤U¤È 12:57:54²Ä 3838 ½g¦^À³
|
«Øij¥Î¯E¹©ªºÄ@´º°µ¼ÐÃD ¥i½Íªº½d³ò¸û¤j¡A¼ÐÃD³]¡A«ÜÃø¶K¤å |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/4/7 ¤U¤È 12:44:25²Ä 3837 ½g¦^À³
|
ÁÂÁ¤j®aªº¤À¨É ·P®¦! ¥»ª©¨ì©³n°Q½×¤°»ò¤è¦V ? ¯à§_§ó©ú½T¤@ÂI,«Øij¤£n«Å| ÁÂÁ |
|
|
·|û¡Gwalker10141977 µoªí®É¶¡:2016/4/7 ¤U¤È 12:31:29²Ä 3836 ½g¦^À³
|
news.ltn.com.tw/news/business/paper/431178 ºô¸ô¥@¬É¡AµL»·¥±©¡¡A¦ý¨Ã«DµLªk¥iºÞªº¦Ç¦â¦a±a¡AY¬O³z¹Lºô¸ô³ø©úµP¡B°µ¼s§i©ÛÅ󦬶O·|û¡A³£¦³Ä²ªk¤§¸·¡F¤£¹L¡A¤@¯ë¥Á²³¤]¤£¥Î¾á¤ß§¹¥þ¥¢¥h¨¥½×¦Û¥Ñ¡A¥un¤£¯A¤Î±ÀÂËӪѡB«Øij¶R½æ»ù¦ì¡B¤£¦¬¨ú³ø¹S¡B¤£ª£§@ªÑ»ù¡A¤£·VIJªk¾÷²v´N¤j¤j°§C¡C ºô¸ô³ø©úµP¡B¤j§@¼s§iÅó«Èªº±¡ªp¡A¦¤w¹ð¨£¤£ÂA¡A±`¨£ªº®×¨Ò¬O¡A¦³¤H¦bºô¸ô¯d¨¥¡A¦ÛºÙ¬OªÑ¥«°ª¤â¡A¤é¶i¤æª÷¡A¨Ã¥B±ÀÂ˪Ѳ¼¡B¸Ñ½L¡AÄF¤£ª¾±¡ªººô¤Í«H¥H¬°¯u¡Aª§¬ÛÁpµ¸¡A¶i¦ÓÄF¨ú·|û¶O¡B¥N¾Þ¶O¡B¶}§Þ³N¤ÀªR¯Z±Â½Ò¶Oµ¥¡C ³o¼ËªºÄF³N¡A¨Ã«DµLªk¥iºÞ¡Cª÷ºÞ·|ÃÒ´Á§½«ü¥X¡A¥un¬OÃÒ¨éª÷¿Ä·~±q·~¤Hû¡A¦pªG¤£¨ã¦³¤ÀªR®v¸ê®æ¡A«o¹ï¤£¯S©w¤H±ÀÂ˯S©wªÑ²¼¡B«Øij¶R½æ»ù®æ¡B¦¬¶O©ÛÅó·|û¡A³£¦³«Dªk¦a¤U§ëÅU¤§¶û¡A¹H¤Ï§ë«H§ëÅUªk¡F¦p´²¥¬¤£¹ê®ø®§¡Aª£§@ªÑ²¼¡B¾Þ±±ªÑ»ù¡A¼vÅT¥«³õ¯´§Ç¡A¤]¦³¹H¤ÏÃÒ¥æªk¤§¸·¡C Y¬O¤@¯ë¥Á²³¡AÁö¤ñ¸û¦³¨¥½×¦Û¥ÑªÅ¶¡¡A¥i¥H¤ÀªR¦æ±¡¡A¦ýY¯A¤Î¤º½u¥æ©ö¡Bª£§@ªÑ»ù¡A¤]¥i¯à³Q²¾°eªk¿ì¡F¥t¡AÃÒ´Á§½©xû¤]´£¿ô¡AYÂǺô¸ôµo¨¥µ¥¤è¦¡¦¬¨ú³ø¹S¡AµL½×ª½±µ¶¡±µ³£¬O¹Hªk¡A¨Ò¦p¦¬·|û¶O©Î½æÂI¼Æ¡A³£´¿¦³³Q²¾°e°»¿ì«e¨Ò¡C ©xû¤ÀªR¡A³z¹Lºô¸ô¹ï¤j²³¤½¥¬Ápµ¸¹q¸Ü¡A©ÛÅó·|û¡AÃþ¦ü°µ¼s§i¡A¤]¦³Ä²ªk¤§¸·¡Aªk°|·|¨Ì¾Ú¬O§_°w¹ï¤£¯S©w¤H±ÀÂ˪Ѳ¼¡B±ÀÂˤH¼Æ¦h¹è¡B¤ÏÂЫ¾Þ·~¡A¨Ó»{©w¬O§_¥H¦¹¬°·~¡C ¤Ï¹L¨Ó»¡¡AY°w¹ï²£·~§@¼sªx¤ÀªR¡A¤£°w¹ïӪѫØij¶R½æ¡B»ù®æ¡A¥B¤£¦¬¶O¤£ÁȨú³ø¹S¡A©xû»{¬°¤ñ¸û¤£·|IJªk¡C |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/7 ¤U¤È 12:19:07²Ä 3835 ½g¦^À³
|
¥xÁÞ¤j¡A ¤ä«ù¡I¤p§Ì¤w¸g´£¹L¤¦ì¼Æ»P¤»¦ì¼Æªº¥ý¨M±ø¥ó¡C·íµM³o¨Ç±¡§Î³£ÁÙ¥u¯à¥H¶Â¤ÑÃZ¨Æ¥óµø¤§¡A¤£¯à°µ¬°¹w´ú¡C ¤Ñ©R¤jªº´£¿ô¡A¬O§_þ¦ìÀ´±o¬ÛÃöªk¥Oªº¯E¤Í¦^À³¤@¤U¡A¤j¥ë¤]¥iª¾¬õ½u¹º¦bþ¸Ì¡C |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/7 ¤W¤È 11:41:30²Ä 3834 ½g¦^À³
|
±ø¤j¡A ª©ÀY¤å«ç»ò§ï¡H¬O¥[¤W´X¥yÁÙ¬O¾ãÓ´«±¼¡H |
|
|
·|û¡Gnina999910139545 µoªí®É¶¡:2016/4/7 ¤W¤È 11:32:11²Ä 3833 ½g¦^À³
|
¹Ç§AÅó±ø±ø¤j: «Øij¬° "¯E¹©´Á±æªÑ»ù»P»ùȵû¦ô" |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2016/4/7 ¤W¤È 11:16:35²Ä 3832 ½g¦^À³
|
ª©¥D¤j¤j, è¤~´£ªº¼ÐÃD"¯E¹©ªº»ùȵû¦ô»P´Á±æªÑ»ù"¦³ÂI¤Óªø ½Ð§ï¬° "¯E¹©´Á±æªÑ»ù»ùȵû¦ô" ÁÂÁ ¡ã¡ã ±z¬O»¡¦¹ª©¤]n§ï¼ÐÃD¶Ü¡HY¬O¡A«Ý§Ú±ßÂIÀ°±zקïò~ BYª©¥D |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2016/4/7 ¤W¤È 11:02:53²Ä 3831 ½g¦^À³
|
¹x¥Û¤j, ÁÂÁ±zªºÆg³\,ÀrÆj§Þ½a¤F°Õ ¦³Ãö¼ÐÃD,½Ðª©¥D§ï¦¨"¯E¹©ªº»ùȵû¦ô»P´Á±æªÑ»ù", ÁÂÁª©¥D¤j¤j ¤]©IÀ³µL±¡¤j·sªº½×z,¤j®a¥i¥H°Ñ¦Ò¤@¤U,¤×¨ä¬O´Á±æªÑ»ùªº»¡ªk "5112¬°¤é²±§ëÅU¨ÌPSR¡]¥«Àç¤ñ¡^¦ôp¤§¼ç¤OªÑ»ù¡A¿ï¾Ü5112ªº°²³]¥i¯à»P¨ä¥L°²³]±o¨ì¤£¦PªºªÑ»ù¡C ´£¿ô¡G¯E¹©ªº¡y´Á±æªÑ»ù¡z¶È¨Ñ°Ñ¦Ò¡I" http://tsjh301.blogspot.tw/2014/08/obipharma.html ¤Ñ©R¤j, ±z¯u¬O¯E¹©¸Ñª¼¼Æ¾Ú¨Æ¥óªº¬_«n,©Ò¦³µïµ·°¨¸ñªºÂIºw³£Ãø°k±zªºªk²´, ¦³±zªº¤j¤O¥[«ù, °ò¥»±´NµL¶·¾á¤ß¤F |
|
|
·|û¡G§g10000178 µoªí®É¶¡:2016/4/6 ¤U¤È 11:30:19²Ä 3830 ½g¦^À³
|
ÏÚ¤j §A´£¨Ñªº¥H¦â¦C·R¦]´µ©ZÁ¿®y¤º°£¤F±z»¡ªº¨º±i§ë¼v¤ù¡A¤U¤@±i§ë¼v¤ù¤]¥O¤H¿³¾Ä¡A»P·s»D¥æ¬Û¤ñ¹ï¡A§ó¥i¥Hª¾¹D¬°¦ó¤½¥qªº»¡ªk¬O¥O¤H¿³¾Äªºµ²ªG¡C |
|
|
·|û¡Gyuki10141394 µoªí®É¶¡:2016/4/6 ¤U¤È 10:12:59²Ä 3829 ½g¦^À³
|
¹Ç§AÅó±ø±ø¤j¤j~§A¤Ó¦³¤~¤F¡A¸àÄÀªº¤Ó¦n¤F~~ |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/6 ¤U¤È 09:20:32²Ä 3828 ½g¦^À³
|
±ø¤j¡A Cliff¤jn§ïª©ÀY¤å¤F¡C±z³oª©ªºª©ÀY¤å¦n¹³¤]¤Ó¸ò¤£¤WÅܤƤF¡A¬O§_¤]§ï¼g¤@¤U¡H ÁÙ¦³¡A³oÓª©¤]¶}¤Fº¡¤@¦~¤F¡A±z¤]¨Ó¬q¶g¦~·P¨¥¦p¦ó¡H |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/6 ¤U¤È 06:13:58²Ä 3827 ½g¦^À³
|
±ø¤jµ½Ä´¡C |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2016/4/6 ¤U¤È 03:58:51²Ä 3826 ½g¦^À³
|
´«ÓÁ¿ªk¡A¤ñ³ë²{¦b4174³B¹Ò ¦³Ó¾Ç¥Í¤É¨ì°ª¤T¤F¡A¥H«e¦¨ÁZ³£«Ü¦n¡A²Ä¤@¦¸¦Ò¤]ªí²{«Ü¦n¡A²Ä¤G¦¸¦Ò«o¨S¦³¹LÃö¡A¦Ñ®v¶}©lÃhºÃ¥L¥H«e¦Ò¸Õ³£§@¹ú ¶}©l§ä©Ò¦³ªº"ºÃÂI"¦Ó«D"ÃÒ¾Ú"¡A°È¥²n¥´À»³oӾǥ͡A»¡¥L¦¨ÁZ¨ä¹ê¨Ã¤£¦n¡A¦Ó¥B¤H«~¤]¤£¦n¡A¦]¬°¦Ò¸Õ§@¹ú¡A¥B¤@ª½»¡ÁÀ ¤p«Ä³Q¤@¸ô°l±þ¡A«oµL±qÅG¸Ñ¡A¶ý¶ýÁöµM¬Û«H¤p«Ä¡AÀ°¦£ÅG¸Ñ¡A¯h©ó©b©R«o¤´µMÃø¼Ä±y±y²³¤f «á¨Ó¦Ñ®vµo²{¤p«Ä¸ò®Õªø«Ü¼ô¡A¶}©lÃhºÃ¤p«Ä¥H«e¦¨ÁZ¦n¬O®Õªø¬ªÃDÀ°§U¤p«Ä§@¹ú ©ó¬O¶}©l½Õ¬d®Õªø¡Aµo²{®Õªø¦³¤@¥÷100ÃD®w¡A¸Ì±¦³1ÃD¸ò¦Ò¸ÕÃD«Ü¹³¡A´N§ìµÛ³o1ÃD»¡®Õªø¬ªÃD ®Õªø«ÜµL©`¡A»¡¬ªÃDþ¦³¥u¬ª¤@ÃDªº¹D²z¡A³o¤@ÃD¯uªº¥u¬O¥©¦X, ¦ý¦Ñ®v¤£¬Û«H¡Aµw¬O¸ò¥þ®Õ¦Ñ®v»¡®Õªø¬O°µ¹ú¶°¹Îº¸£¡AnÃ㾤U¥x¡A¥Bn½ÐÀ˽սլd¬Æ¦Ü¶e®·¨ì®× ¤p«Ä¦¨ÁZ¦n´N·|»¡¬O¾a®ÕªøªºÃö«Y»P«ü¾É¤~·|¦n, ®Õªø¸ò¤p«ÄÃö«Y¤Ó¦n¤]¦³°ÝÃD ¤p«Ä¦¨ÁZ¤£¦n´N»¡¥ý«eªº³£¬O¾a§@¹ú, ¥B¤@ª½»¡ÁÀ, ¦Ó¥BÁÙ¬O®Õªø¬ªÃD ®ÕªøµL½×À°¤£À°¦£, ¦³µLÀ°¨ì¦£³£¤£¹ï, ³Ì¦n®Õªø¤°»ò¨Æ³£¤£n°µ, ¥un»âÁ~¤ô´N¥i¥H ³o¦¸¦Ò, ¥uª¾¹D¦Ò¸ÕÁ`¤À¥¼¹F¿ý¨ú¼Ð·Ç ¤p«Ä¹ï¤F¤@¤Uµª®×¡Aµo²{¦³´X¬ì³ºµMº¡¤À¡A¦³¾÷·|ª½±µ«O°e¥x¤j ¡]µù¡G¥x¤j¦³³»¦y¤H¤~«O°e¨î«×¡^¦ý¦U¬ì¦¨ÁZn¨ì6¤ëªì¦¨ÁZ¤~·|¥¿¦¡¤½¥¬ µL½×¤p«Ä«ç»ò¸ÑÄÀ¦Ñ®v¤£¬Û«H, ¥un6¤ëªì¦¨ÁZ¥¿¦¡¤½¥¬¡A´Nª¾¹D¤p«Ä¦³µL¾÷·|ª½±µ«O°e¥x¤j ~~ |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/6 ¤W¤È 10:57:27²Ä 3825 ½g¦^À³
|
¥xÁÞ¤j¡A ¤£¥]¬A²{ª÷ªÑ§Q(¤£²M·¡¦³¨S¦³µo©ñ)¡AGOOGLE IPO¦Ü¤µªÑ»ù¤W¤É17¿¡C ¤£¹L¦Ò¼{¥¦¤W¥«¤§®É¤w¸g¬O¥«³õ¤@ô¡A·í®É¥«È´N¶W¹L200»õ¬ü¤¸¡C¦Ü¤µÁٯ຦³o»ò¦h¿¡A¯u¬O¥»¨Æ¡C |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/4/6 ¤W¤È 08:34:45²Ä 3824 ½g¦^À³
|
¹x¥Û¤j ÁÂÁ´£¨Ñ¸ê°T ¦pªG2004¦~Google IPO ®É¥H85¬ü¤¸¼Ð¶i1000ªÑ (¤@±i) ©ñ¨ì¬Q¤Ñ¦¬½L»ù Àò§Q´X¿?¹ï©ó¤@®a¦¨ªø©Ê ¦³Ävª§¤Oªº¤½¥q, §Ú·Qª¾¹Dªø´Á§ë¸êªºÀò§Q¿¼Æ ? ·PÁ§A¥H«e©Ò´£¨ÑªºÄ_¶Q¸ê°T ¤Ñ©R¤j: ·PÁ§Aªñ´Á©Ò´£¨Ñªº±À¦ô¸ê°T ·P°Ê¤j ÁÂÁ·P°Ê¤jªº¹ªÀy §ï¤Ñ§ä¤@¨Ç¸ê°T¯S§O¬°§A¶K¤@½g |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/6 ¤W¤È 08:13:23²Ä 3823 ½g¦^À³
|
¥xÁÞ¤j¡A GOOGLEªÑ²¼¦³¹L¤@¦¸¤À©î¡A¤@©î¤G¡A©Ò¥H¥«È¦¨ªø22¿¡AªÑ»ù¥u¦¨ªø8¿¡CÁÙì¤À©î¡AªÑ»ùÀ³¸Óº¦¤F16¿¡C¦Ó¥«È¦¨ªø§ó¤j¡A¬O¦]¬°¤@¸ô¤Wªº¨ÖÁʮשҳy¦¨ªºªÑÅvµ}ÄÀ¡C (¥«È¬OªÑ¼Æ¼¥HªÑ»ù¡A©Ò¥H196¿¨ºÓ¼Æ¦r¬O¨S¦³·N¸qªº¡A¦]¬°ªÑ»ù¼Wªø¦Û¤v¼¤F¨â¦¸) |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/4/6 ¤W¤È 07:13:02²Ä 3822 ½g¦^À³
|
7 ¤½¥q¬ãµo¹Î¶¤¡AºÞ²z¹Î¶¤«H¤ß¤j¼W: ¥»¦¸¤T´ÁÁ{§É¸ÕÅ窺«¤jµo²{¹ï©ó¥Ø«e¶i¦æ¤¤©Î·Ç³Æ¶i¦æªºªºOBI822,OBI833¨â¤j¨t¦CÁ{§É¸ÕÅ窺«H¤ß¥²µM¤j¼W¡A¦]¬°822¨t¦C²£«~¸üÅé³J¥Õ»P¦õ¾¯¤@¼Ë¡A§ÜÀù¾÷¨î¬Û¦P¡A833¨t¦C§ó§ï¸üÅé³J¥Õ¡A¤£§ï¦õ¾¯¡A·í¦³²Ä¤@Ó²£¥Í¦¨¥\ªº¸gÅç¡A³o¹ï¨ä¾lªº¨t¦C²£«~¬ãµo«H¤ß¬Û·í¦³§U¯q¡C §ó¥¿¿ù»~:ASCO¦~·|¶}·|¦aÂI¥ì§Q¿Õ¦{ ªÛ¥[ô «D¸t¦a¤úô |
|
|
·|û¡GLin10142144 µoªí®É¶¡:2016/4/5 ¤U¤È 11:23:44²Ä 3821 ½g¦^À³
|
¥xÁÞ¤j¤Ñ©R¤j¦h¬O¯«¤H¯Å讃ÁÂÁ |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/4/5 ¤U¤È 11:12:27²Ä 3820 ½g¦^À³
|
¦U¦ì¤j¤j±ß¦w: ·PÁ²³¤j¤j¦b¦Uª©ªº¤À¨É ªñ´Á¤ß±o¦p¤U 1«õ¤«ªºÁp·Q: ¤@¦ì¹A¤Ò§V¤O«õ¤@¤f¤«¨ÓÄéµ@¹A¥Ð,«õ¨ì30¤½¤ØÁÙ¨S¬Ý¨ì¤«¤ô«_¥X,,²´¨£¨¯W§V¤O§Y±N¥I¤§¬y¤ô,³o¦ì¹A¤Ò¨Ã¨S¦³¦Ç¤ß,¤£²z·|§N¨¥§N»y¡B³Ì«á«õ¨ì50¤½¤Ø²`¬Ý¨ì«_¥Xªº¤«¤ô,«õ¨ì30¤½¤Ø¨S¬Ý¨ì¤«¤ô«_¥X,(¦³«õ¨S«õ¤@¼Ë , ¦³¥ÎÃĨS¥ÎÃĤ@¼Ë¨S®t²§)³Ì«á¦b50¤½¤Ø²`¬Ý¨ì¤«¤ô«_¥X, ´N¬O©¹¤U«õ±¸,¶i¦æÁ{§É¼Æ¾Ú²Ó³¡¤ÀªR,³Ì«áµo²{¥O¤HÅå³ßªº¦³®Ä±Ú¸s 2 ±qGoogle ¶Ç©_¨ì¯E¹©¶Ç©_: ¯E¹©¬O§_¯à¼g¤U¶Ç©_¦³¿à©ó³Ð·s»PÃø¥H¶W¶Vªº§Þ³N 2004 ¦~ 8¤ë20¤éGoogle (IPO)»ù®æ¨CªÑ¤K¤Q¤¬ü¤¸Äv¼Ð¡A·í¤Ñ³o®a¥þ²y³Ì¨üÅwªïºô»Úºô¸ô·j´M¤ÞÀºªºÁ`È¡A¤j¬ù230»õ¬ü¤¸11¦~7Ó¤ë¤S15¤Ñ«á¤µ¤ÑÁ`¥«È¬ù5108»õ¬ü¤¸ ¦¨ªø22.2¿ ªÑ»ùº¦8.7¿ 742.69 /85 =8.7 22.2x8.7 =193¿ ¤ñGoogleº¦´T¤jªºªÑ²¼ÁÙ¤£¤Ö Regeneron Pharmaceuticals ³Ð³y¤F¶Ç©_ www.marketwatch.com/investing/stock/regn Google¡¦s IPO, 10 Years Later: Just 10 Stocks Beat It blogs.wsj.com/moneybeat/2014/08/19/googles-ipo-10-years-later-just-10-stocks-beat-it/ 3¬ì¾Çªº¯u »ùȪºµ½ ·N§Óªº§Ô: ¤»¤ëªì¬ì¾Çªº¯u±N¦b¬ü°ê¸t¦a¤úôASCO¦~·|»P¥xÆW¦P¨B§e²{(Á{§É¼Æ¾Ú»P¦s¬¡¦±½u) ¥xÆW¯E¹©¥Í§Þ¤w¸g¦b¬°³h§x¯f±w¦ù¥XÃöÃhªºµ½Á|,¯E¹©³o¬q®É¤é§Ô°dt«,Á|¿ìªk»¡·|´£¨Ñ»¡©ú, Ó¤H»{¬°¦³¨â¥y^¤å®æ¨¥»¡ªº«Ü¦n Actions speak louder than words.(¨Æ¹ê³Ó©ó¶¯ÅG) The end justifies the means.(µ²ªG¨M©w¤â¬q¬O§_¥¿·í) ¤@¤Á¯ÉÂZ±N²×¤î©ó¤»¤ëªì¬ì¾Çªº¯u¤§§e²{ 4 Æ[·Lª¾µÛ ¤@¸ª¾¬î (A straw shows which way the wind blows.) : ¯Î°|ªøºaÀò2016¦~·R¦]´µ©ZÁ¿®yºtÁ¿ÃD¥Ø¬O¡uBiological Glycosylation: from Understanding to Problem Solving (¥Íª«Å骺ÁޤƤÏÀ³¡G±q»{ÃѨì¸Ñ¨M°ÝÃD) ¥Íª«Å骺ÁޤƤÏÀ³¡G±q»{ÃѨì¸Ñ¨M°ÝÃDfrom Understanding to Problem Solving »{ÃѨ줰»ò? ¸Ñ¨M¤F¤°»ò°ÝÃD ? (¦³¸Ñ¨MÀù¯g°ÝÃDªº¼ç¤O) A¸Ñ¶}ÁÞ¤À¤l¦b¥Íª«Å餤¤Î¯e¯fºtÅܤW©Ò§êºtªº¨¤¦â¡A¨Ã¬°¥HÁÞ¤À¤l¬°°ò¦ªº·sÃĶ}µo«Ø¥ß¹ñ·s«´¾÷ B¶}µo¦Û°Ê¤Æ°ª³t¤Æ¾Ç¦X¦¨¤Î¤j¶q»Ã¯Àªk¥Î©óÁÞ¤À¤l¤ÎÁÞ³J¥Õªº¦X¦¨¡Bµo®iÁÞ´¹¤ù¥Î©ó¸ÑªR³J¥Õ½è¤ÎÁÞ¤À¤lªº¥æ¤¬§@¥Î¡B³]pÁÞ¤À¤l±´°w¥Î©ó¥Íª«ÅéÁޤƹLµ{ªº¼v¹³¤ÀªRµ¥¬ã¨s¦¨ªG¡A³Ì¨ü¬ì¾Ç¬ÉªºÆf¥Ø»PÆg½à C¥HÁÞ¤À¤l¬°°ò¦ªº¬Ì]¡B§¡¬Û¤ÆÁÞ³J¥Õ¤Î§ÜÅ骺»s³Æ¡BÁÞÃþ¬ÛÃö»Ã¯Àªº¤p¤À¤l§í¨î¾¯µ¥¡A¨Ï±o¦´Á¶EÂ_Àù¯g¤Î·P¬V©Ê¯e¯fªº¾÷²v¤j´T¼W°ª¡C Biological Glycosylation: from Understanding to Problem Solving : °²¦p¥u½ÍOBI822 ¤½¥qªk»¡·|´£¨ìªº·|²£¥Í§ÜÅ骺¯f±w´N·|¦³«D±`ÅãµÛªºÀø®Äªº½×z¥i«H«×«D±`°ª (¦³¸Ñ¨MÀù¯g°ÝÃDªº¼ç¤O) 5¥»¦¸Á{§É¸ÕÅ窺µ²ªG¹w§i Àù¯g³æ®è§ÜÅé§K¬ÌÀøªk(OBI-888)¼ç¤OµL½a A OBI-888ÄÝ©óÀù¯g³Q°Ê§K¬ÌÀøªk¡A¬O§ÜGlobo H³æ®è§ÜÅé·sÃÄ¡A°w¹ïÀù²ÓMªí±¹L«×ªí²{¤§Globo HÁÞ§Üì¡A§Q¥Î³æ®è§ÜÅéÃĪ«¨ä°ª±M¤@©Ê¡B°ªµ²¦X¤Oªº¯S©Ê¡A¿Eµo§K¬Ì¨t²Î¡AÄè·ÀÀù²ÓM¡A¤j´T´£¤ÉÀù¯gªvÀø®ÄªG¡COBI-888 Globo H³æ®è§ÜÅé·sÃÄ¥Dn¬O±Ò°ÊÅ餺¨âºØ§K¬Ì¤ÏÀ³: ÂǥѧÜÅé¨Ì¿à©Ê²ÓM¬r©Ê(ADCC)¤ÏÀ³¡B¬¡¤Æ¦ÛµM±þ¤â²ÓM¡A¥H¤Î¸ÉÅé¨Ì¿à©Ê²ÓM¬r©Ê(CDC) ¤ÏÀ³¡A¥H¹F¨ì¬r±þÀù²ÓMªº®ÄªG¡C B ¥un¯f±w¯à²£¥Í§Ü¨¬°÷Åé´N·|¦³«D±`ÅãµÛªºÀø®Ä, Àù¯g³æ®è§ÜÅé§K¬ÌÀøªk(OBI-888)¤ñ¸û¨S¦³§ÜÅé¶q¤£¨¬ªº°ÝÃD, ¥¼¨Ó»P822 833Áp¦X¨Ï¥Î,¬Û»²¬Û¦¨,©Î³æ¿W¥ÎÃÄ ,¼ç¤OµL½a c¥þ²yÃÄ«~«ùÄò¦¨ªø¡A¥Ø«e¤w¶W¹L¤@¥ü¬ü¤¸¤§³W¼Ò¡A¨ä¤¤¥H³æ®è§ÜÅéÃĪ«³Ì¨ãÄvª§¤O¡A¥B¥¿¦bµo®i¤¤ªº·sÃĦ³60%¥H¤W¬O³æ®è§ÜÅé 6 ¤@¦¸Á{§É¸ÕÅ禬캡º¡: ÁÞ¬ì¾Ç»PÁ{§ÉÂå¾Çªº°¶¤j¦¨´N: a¥un¯f±w¯à²£¥Í§Ü¨¬°÷Åé´N·|¦³«D±`ÅãµÛªºÀø®Ä ( PFS & OS ) b¥H¤TÓÁÞ¤À¤l¬°¼Ð¹v¡A¥u°w¹ïÀù²ÓMM»PÀù¯g·F²ÓM¡A¤£¶Ë¥¿±`²ÓM ,ÃÄ»ù°ª¶Q¤£¶Q, ¬I¥´¤è«K , ®aÄÝ·ÓÅU¤è«K ,§C°Æ§@¥Î°ª¦w¥þ©Ê»P¦³®Ä©Ê¡A¥Í¬¡«~½è·¥¬°Àu²§ c¬O¥þ²y²Ä¤@Áû¨ÅÀù¥D°Ê§K¬ÌÀøªkªºÃĪ«¡A¥xÆW°µ¨ì¤F! d¤£»ÝÅç¨ÅÀù¨È«¬ ¤]¤£»ÝÅçGlobo H ¨t¦CÁÞ§Üì ¥u»ÝÅç§ÜÅé¶q¬O§_¨¬°÷ ¤èªk²³æ¬Ù®É¬Ù¿ú e¥xÆW¥HÁÞ¤À¤l¬°¼Ð¹vªºÃĪ«±N¶}±ÒªvÀø16ºØÀù¯gªº·s¬ö¤¸.³o¬OÂå¾Ç¤Wªºªº¦¨´N,¤]¬O²³¦hÀù¯g¯f±wªº´Á¬ß ¥H¤W¤À¨É ¶È¨Ñ°Ñ¦Ò ½Ð¿W¥ß«ä¦Ò ²z©Ê¬ã§P |
|
|
·|û¡GLu10141514 µoªí®É¶¡:2016/4/5 ¤U¤È 10:25:58²Ä 3819 ½g¦^À³
|
¤µ¤Ñ¬Ý¤Fù¤ó(Roche)Ãļt2014¦~ªº¦~³ø www.roche.com/med-cor-2015-01-28-e.pdf ù¤ó(Roche)Ãļt2014¦~ªºÁ`À禬¡G264.5»õ¬ü¤¸¡CP.6 Herceptin¶PÀù¥2014¦~¾P°â62.8»õ¬ü¤¸¡A¦ûù¤óÃļtÁ`À禬264.5»õªº23.7%¡C Avastin Àù«ä°±(ªvÀøÂಾ©Ê¤j¸zª½¸zÀù) 2014¦~¾P°â64.2»õ¬ü¤¸¡A¦ûù¤óÁ`À禬264.5»õªº24.3%¡C ¤S¬d¤Fù¤óªºªÑ»ù¡G finance.yahoo.com/q?s=ROG.VX&ql=0 ù¤óÃļtªÑ»ù234.7¬ü¤¸¡AEPS=10.53¤¸¡A ù¤óÃļt¥«È(Market Cap)è¦n¡×200 B¬ü¤¸¡×2000»õ¬ü¤¸ ºâºâ§Ú̪º¯E¹©¡G ¯E¹©4/3¸¹ªÑ»ù434.5¥x¹ô¡A¥«È¡×743»õ¥x¹ô¡×22.9»õ¬ü¤¸ ¯E¹©¥«È¬Où¤óÃļtªº87¤À¤§1 |
|
|
·|û¡GLIN10137582 µoªí®É¶¡:2016/4/5 ¤W¤È 08:56:19²Ä 3818 ½g¦^À³
|
¤Ñ©R¤j ·PÁ±zªº¦^ÂÐ! |
|
|
·|û¡G¤ß»·¦a¦Û°¾10141241 µoªí®É¶¡:2016/4/4 ¤U¤È 10:20:13²Ä 3817 ½g¦^À³
|
ÏÚ¤j, §Ú¬d¤F¤@¤U. ¿Õ¨©º¸±o¥D¨ººtÁ¿¬O¥h¦~ªº. |
|
|
·|û¡G561910141205 µoªí®É¶¡:2016/4/4 ¤U¤È 09:09:56²Ä 3816 ½g¦^À³
|
ÁÂÁÂÏÚ¤j©M¤Ñ©R¤j¡C±z̯u¥Î¤ß¡C¦³¨S¦³§K¬Ì¤ÏÀ³¡AÀø®Ä¬O¤ÑÄ[¤§§O¡C Lu¤j¡A¬G·N§á¦±³yÁÁ¦ÃöGªº´CÅé¬F«È¤ÀªR®v¡A¥LÌ¥\½Ò°µ«Ü¦h¡A¥L̤]³£«Ü¥Î¤ß - ¶Â¤ß¡A爲¤F¦U¦ÛÀò§Q¡C |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/4 ¤U¤È 08:59:03²Ä 3815 ½g¦^À³
|
ÏÚ¤j¡A¹xµ£¤j¡A ¨º±i§ë¼v¤ù¸Ì¡A¥D°Ê¦³§K¬Ì¤ÏÀ³ªº¹Ï¸ò³Q°Ê§K¬Ì¤ÏÀ³ªº¹Ï¡A¦n¹³®Ú¥»´N¬O¦P¤@Ó«þ¨©¡C©Ò¥H·íµM¬O¥Ü·N¹Ï°Ú¡C ³Q°Ê§K¬Ìªº¨Ò¤l¡A¶PÀù¥¡A¨â±ø¥Í¦s¦±½uþ¦³©Ô³o»ò¶}¡H ASCO³ø§i¸Ìªº¹Ï¡Aªø±oµ´¹ï¤£¬O§ë¼v¤ù¸Ìªº¼Ë¤l¡C©Ò¥H¤£·|¦³Á{§É¼Æ¦r´£«e¥~¬ªªº·ÀI¡C |
|
|
·|û¡GLu10141514 µoªí®É¶¡:2016/4/4 ¤U¤È 08:49:23²Ä 3814 ½g¦^À³
|
·PÁ¤ѩR¤j´£¨ÑÄ_¶Q¸ê®Æ¡I ¯E¹©¤½¥q¡A¬O¤@®a¥xÆWªº¥Íª«¬ì§Þ¤W¥«¤½¥q¡A¦¨¥ß©ó 2002 ¦~¡C³o®a¤½¥qªº¥Dn·~°È¦b©ó¬ãµoªvÀøÂಾ©Ê¨ÅÀù¬Ì] OBI-822/821¡A¦pªG¬ãµo¦¨¥\¡A¤j·§·|¬O¥xÆW¥Í§Þµo®i¥v¤Wªº³Ì¤j¦¨´N¡C ¬ì¾Ç¼Æ¾Ú´N¬O³Ì¦nªºÅçÃÒ¡A´Á«Ý6¤ë4¤éªº¨ÓÁ{¡C ¦³¤ÀªR®v»¡¡G¡u¯E¹©¡v´N¬O¡u°ò¨È¡vªºÂ½ª©¡A¥i¯à¶Ü¡H¤£°µ¥\½Ò¡A¯º¦º¤H¡I¡I |
|
|
·|û¡GLIN10137582 µoªí®É¶¡:2016/4/4 ¤U¤È 08:27:15²Ä 3813 ½g¦^À³
|
¤Ñ©R¤j ¤Q¤À·PÁ±zªº¤À¨É¡A ¦ý§Úı±o³Ì«á¥¼´c¤Æ,cyclophosphamide 2014.5¤ë¥¼º¡2¦~À³¥H18%pºâÀ³¦A¥[4¤H¸û¦X²z |
|
|
·|û¡G¤p¹xµ£10141398 µoªí®É¶¡:2016/4/4 ¤U¤È 06:11:27²Ä 3812 ½g¦^À³
|
ÏÚ¤j±z¦n¡G ÁÂÁ±zªº¤À¨É¡I¦n²Ó¤ß§r¡I §Úè«·s¬Ý¤F¨º±i¹Ï¡A¤pªº¦b·Q¡A·|¤£·|¨º¥u¬OӥܷN¹Ï¡H ³Q°Ê§K¬Ì¨º±i¹Ï¬Ý¨Ósurvival rate¤]«Ü°ª»¡¡A¤£ª¾¹D¨äX¶b®É¶¡¶bªº¨è«×¦p¦ó´N¬O ¤£¹L´Nºâ¬O¥Ü·N¹Ï¡A¤]°÷¤F¡CÅý§Ú̪¾¹D·N«ä´N°÷ ÁÂÁ±z¤À¨É¡I¡I |
|
|
·|û¡G12310132455 µoªí®É¶¡:2016/4/4 ¤U¤È 05:00:56²Ä 3811 ½g¦^À³
|
¤p¤s¥J¤j ¬O¤Ñ©R¤j¥ýpo¥Xªº ¤£nºò¡A¬Q¤Ñ§Ú¦³¸òmobile01§@ªÌÁpµ¸¡A¥L¦³»¡·|§â¤å³¹Âಾ¡A¥L¤]¬O³o¸ÌªºªB¤Í¡C |
|
|
·|û¡GÏÚ10136839 µoªí®É¶¡:2016/4/4 ¤U¤È 04:34:17²Ä 3810 ½g¦^À³
|
¨ä¹ê¯Î°|ªø¦b3/15¥H¦â¦C·R¦]´µ©ZÁ¿®y®É¡A´N¤w¸g¬ªÅS¤F¤@¨Ç¯E¹©¼Æ¾Ú¤F¡A¦b®É¶¡¬ù1:00:58ªº¨º±i§ë¼v¤ù¡A°w¹ïª`®gVaccine¥B¦³²£¥Íimmune response(§K¬Ì¤ÏÀ³)ªºSurvival(¦s¬¡²v)¤@ª½ºû«ù¦b°ªÀÉ(±µªñ100%)¡A¬Æ¦Ü¤ñ¤W±¥ÎAntibodyªºHerceptin(¶PÀù¥)ªº¦s¬¡²vÁÙ¦n¡C¦ý¦b¨S¦³immune responseªº³¡¥÷¡A«h§¹¥þ¨S¦³®ÄªG¡C©Ò¥H¦pªG«ö¶Ç²ÎÃĪ«®ÄªGµû¶q¤è¦¡¡A§â¦³§K¬Ì¤ÏÀ³»P¨S§K¬Ì¤ÏÀ³ªº¼Ë¥»¥[°_¨Ó¤@°_¬Ý¡A´N¬O§ë¼v¤ù³Ì¤U±¨ºÓ¹Ï¡ASurvival(¦s¬¡²v)¥u¦³¬ù60%-70%¦Ó¤w¡AµLªk¹FÅãµÛ¤ô·Ç¡C www.youtube.com/watch?v=wxBu2QvD_KQ «á¨Ó3/18¦b¬ü°êUniversity of California at Davis¬ö©À¿Õ¨©º¸¼ú±o¥DBryan MillerªººtÁ¿¤¤¡A¨º±i§ë¼v¤ù´N®³±¼¤F¡A¥i¯à¬O¾á¤ß¼vÅT¦bascoªºµoªí§a! video.ucdavis.edu/media/Chi-Huey+Wong-15th+Annual+R.+Bryan+Miller+Symposium/0_d8i9fx2b |
|
|
·|û¡G¤p¤s¥J10142063 µoªí®É¶¡:2016/4/4 ¤U¤È 04:17:41²Ä 3809 ½g¦^À³
|
°Ú, ©êºp, ¦n¹³¬O¤Ñ©R¤j¥ý´£¨Ñªº.. ¦p¦³§Ë¿ù, ¥ý¸ò¨â¦ì¤j¤j©êºp... |
|
|
·|û¡G¤p¤s¥J10142063 µoªí®É¶¡:2016/4/4 ¤U¤È 04:08:02²Ä 3808 ½g¦^À³
|
123¤jì´£¨Ñ¦bmobile01ªº¨º½g¤å³¹(ìºô§}www.mobile01.com/topicdetail.php?f=132&t=4756958) §@ªÌ¤wÂಾ¨ìestock.marbo.com.tw/ASP/BOARD/v_subject.asp?BoardID=1&ID=7628324, ¦³¿³½ìªº¯E¤Í¥i¥H¬Ý¤@¬Ý.. :-) |
|
|
·|û¡G¥m¾´10141821 µoªí®É¶¡:2016/4/4 ¤U¤È 12:35:25²Ä 3807 ½g¦^À³
|
seafood¤j ÁÂÁ§Aªº´£¿ô¡A¬O¦h¬OªÅ§Ú¤£¦b·N¡A§Ú¥u·Q±}±}ªº¬Ý¬ÝÀ¸¡C ¦Û¤v¤@Ó¤HÁÙ®¼µL²áªº¡C |
|
|
·|û¡Gseafood10141960 µoªí®É¶¡:2016/4/4 ¤W¤È 10:53:27²Ä 3806 ½g¦^À³
|
¥m¾´¤j §Ú¥u¬O·QÂû±Cªº´£¿ôªO¤Í ¥i¥H¬ÝÀ¸(¨ä¹êÁÙ¯uªºÆZ¹³¦b¬Ý¼@¥»,¤]®¼¦³½ìªº) ¦ý¤d¸U¤£n¤JÀ¸ ¦Û¤vªº²ü¥]¦Û¤vÅU «nªº¬O¦hªÅ°T®§³£n§l¦¬ §PÂ_þ¨ÇÄÝ©ó±M·~«ÈÆ[¤ÀªR þ¨ÇÄÝ©ó¥DÆ[±¡·P»¡ªA©Î©Ù¶Â³yÁÁ¥´À£©Î§O¦³¥Øªºªºµo¤å ¦Û¥D§PÂ_ ¸Ó½æ®Én½æ ¸Ó¶R®Én¶R ¤~¯à©úõ«O¨ Áפ¿ÁͦN |
|
|
·|û¡G¥m¾´10141821 µoªí®É¶¡:2016/4/4 ¤W¤È 09:28:34²Ä 3805 ½g¦^À³
|
seafood¤j,¦P·P,¦Ó¥B§Úı±o¨º¬O¦hªÅ¤ÏÂ઺°T¸¹,«e¤@ªiªÅÀY¤wºÉ,¦³¤Hn¶}©l¾i¦Ï°µ¦h¤F¡C¯Â²q´ú,ºCºCÆ[¹î§a¡I¡I |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/4 ¤W¤È 12:53:43²Ä 3804 ½g¦^À³
|
Lu¤j¡A ÁöµM¤p§Ì¤£»{¬°822¯à°÷¨ú¥N¶PÀù¥¡A¤£¹L¨ÅÀùªº¥«³õ½T¹ê«Ü¤j¡A822¥un¦³¤@¦¨ªº¥|´Á¨ÅÀù±wªÌ¨Ï¥Î¥¦¡AªÑ»ù´NÀ³¸Ó¯}2000¤F¡C¦Ü©ó822¯à§_¥Î¨ì¨ä¥Lªº¾AÀ³¯g(¨Ò¦p§Z±_Àùµ¥)¡A¨º¬On¬D¾Ô5000¤¸ªºÃöÁä¡C ¦pªGn¬Ý1000¤¸¡A¥un¦³¤@ӫܦnªº±ÂÅv¦X¬ù´N¦³§Æ±æ(¬Ý¨Ó¬O¼Ú¬w¥i¯à©Ê¤j¡A¦]¬°¬ü°ê¥«³õ¥´ºâ¦Û¤v°µ)¡C ¤½¥q¤W¦^»¡¥i¯à·|¦P®Éñq¼ÆÓ±ÂÅv¦X¬ù¡A¦P®É°õ¦æ¦hÓÁ{§É¹êÅç¡A¥H¥[³t¦hÓÃĪ«ªº¥þ²y±À¼s¡C³oÓ°µªk¸ò¥_·¥¬PÃþ¦ü¡C6¤ë¥÷¦bASCO¤j·|´Á¶¡¡A¯E¹©·|ÁܽЦ³¿³½ì°µ¨ÅÀù¥H¥~ªºÀù¯g¬ã¨sªº±M®a¡A¬ã¨s¦p¦ó±À¶i¨ä¥LÀù¯gªºÁ{§É¹êÅç¡C ¹ï¤ñ©óPharmacyclics¡A¤@ÓÃĪ«°µ¤TÓ¾AÀ³¯g¡A¥h¦~¥H200¦h»õ¬ü¤¸°â¥X¡C¯E¹©¥¼¨Ó¤]¦³³oÓ¾÷·|¡C |
|
|
·|û¡G¿jÀY10141896 µoªí®É¶¡:2016/4/4 ¤W¤È 12:38:09²Ä 3803 ½g¦^À³
|
¤Ñ©R¤j ¤Q¤À·PÁ±zªº¤À¨É¡A ´£¨Ñ³o½g¸û²L¥Õªº¤å³¹¡A Åý¤p§Ì§Ú³oӥͧުù¥~º~¡A ¯à°÷¤@¿sobi-822ªº¿W¯S¤§³B¡C ¡]¤j¤j̪º¤å³¹§Ú³£¦³¬Ý¡A¦ý±`±`¦³¬Ý¨S¦³À´¡A¦½ÃC¡^ µo¤åÂÔªí·PÁ¤§±¡¡A µL¶·³Ò·Ð¤Ñ©R¤j¦^ÂСC |
|
|
·|û¡Gseafood10141960 µoªí®É¶¡:2016/4/3 ¤U¤È 11:36:54²Ä 3802 ½g¦^À³
|
®¦ ÁÙ¬O¥»ª©¤ñ¸û°È¹ê©Z²v ¤£¹³¹j¾À²á¤Ñª©¦Û±q¤G¤j¦^¨Ó«á ¤S«ì´_¥H©¹¨ººØ¶Ç²Î¤¤°ê©x³õ°ª¨Ó°ª¥hªºÁB±¡¤KªÑ¤å· ¦n¹³¬Ý¨ì¤@°ï½Æ»s¤H¯ë¦Û¨¥¦Û»y ü |
|
|
·|û¡GLin10142144 µoªí®É¶¡:2016/4/3 ¤U¤È 09:50:47²Ä 3801 ½g¦^À³
|
¤Ñ©R¤j¡G¥i¥Hºâ¬O§Ú̪º¦Ñ®v¤F ¥xÁÞ¤j¤Î¦U¤j¤j¯uªº¦h«Ü讃¡AÅý§Ú̦¨ªø«Ü§Ö¡A¥[ªoÁÂÁ |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/4/3 ¤U¤È 09:11:10²Ä 3800 ½g¦^À³
|
¤p§Ì«Ü´Á«Ý¦Ñ´¤jªº¤À¨É³á |
|
|
·|û¡G¦Ñ´10141055 µoªí®É¶¡:2016/4/3 ¤U¤È 09:07:30²Ä 3799 ½g¦^À³
|
¯E«È¤j¡A¤p©_¤j¡A¦Ñ´³o´X¤ÑÀR¤U¨Ó«á¡A·Q¨ì¤@ÂI¡A¹êÅç²Õ´Nºâ³QPD¤F¡AOS¤@¼Ë«Ü¦nªº¤]¤j¦³¤H¦b!¨ä¹ê§Ṳ́@ª½³£·QµÛOS(¤U·NÃѸÌ)¡A¥i¯à¬Ophase Iªºµ²ªG¤ßµ²¡A«o¤@ª½¥hºâPFS!¹L´X¤Ñ¦A¦n¦n²á¡C |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/4/3 ¤U¤È 08:20:03²Ä 3798 ½g¦^À³
|
¤Ñ©R¤j ¨ä¹ê§Ú¸ò¤p©_¤jªº¼ÒÀÀ µo²{«Ü¥i¯à ±±¨î²Õ¥ÎÃÄÀù¼w¬P¬Oµu¶]°·±N ©Ò¥H¹êÅç²ÕªºMPFS ¬O¤Ö©ó±±¨î²Õ³á ©Ò¥H «Ü¦h¤H±À´ú¹êÅç²ÕMPFSµy¤j©Î¬Û¦P©ó±±¨î²Õ ¦ý¬O¥¼ÅãµÛ ¥i¯à¦³»~ ³o¤]´£¿ô§ÚÌ ASCOY¥X¨Ó³o¼Ëµ²ªG §O³Y²§ ¦]¬°¨ß¤l¯uªº°_¨B§Ö ¤]¬O¦]¬°KAPLAN MEIER CURVE«p§ÀªºÃö«Y ¨Ï±o«á±³o¸s¤HMPFS¯S§Oªø OS¤]¬O ¬Æ¦ÜNED ³o¤~¬OFDA·|ª`·Nªº¦a¤è |
|
|
·|û¡G¤p¦Ì¦à10141842 µoªí®É¶¡:2016/4/3 ¤U¤È 05:21:56²Ä 3797 ½g¦^À³
|
123¤j¡A«¢¡ã¤£¯à»{©w¬O¤Ñ©R¤j¼gªº¡A¤£¦n·N«ä»~»{¤F¡C |
|
|
·|û¡G12310132455 µoªí®É¶¡:2016/4/3 ¤U¤È 04:55:31²Ä 3796 ½g¦^À³
|
¤p¦Ì¦à¤j¡A¨º½g¤å³¹¤£¬O¤Ñ©R¤j¼gªº¡A¬O¦³¤H¦bMOBILE01¼gªº¡A¦ý¬O³Q§R°£¤F¡Aì¦]¦]¬°¹H¤Ïª©³W¡A¦Ü©ó¬°Ô£¹H¤Ïª©³W¡A§AÌ¥i¥H±q§Úªººô§}¶i¥h¬Ý¡C ì§@ªÌ§Æ±æ¥Î²LÅã©öÀ´ªº¤è¦¡¡AÅý¤j®a¤F¸Ñ¯E¹©ªº¬ÛÃö¸ê®Æ¡A¦ý¬OÁÙ¬O¦³¥¿¤Ï¨â±·N¨£¡C §ë¸ê¦³·ÀI¡A¤×¨ä¬O¥Í§ÞªÑ¡A¦b§ë¸ê¤U³æ«e¡A°È¥²°µ¦n¼f·V¦Ò¶q¡C |
|
|
·|û¡G¤p¦Ì¦à10141842 µoªí®É¶¡:2016/4/3 ¤U¤È 04:36:17²Ä 3795 ½g¦^À³
|
ÁÂÁ¤ѩR¤j±M·~ªºÁ¿¸Ñ¡A²`¤J²L¥X¡AnÀ´¤£Ãø¡A´N©È¦³¨Ç¤H¨£³o»ò¦h¤å¦r´NÀY¤j¡A¸ò¥»¤£¦n¦n¾\Ū¡A¥u·Q¥´¤f¤ô¾Ô¡C |
|
|
·|û¡G©`¦Ì¤p¤k¤l10141142 µoªí®É¶¡:2016/4/3 ¤U¤È 03:44:18²Ä 3794 ½g¦^À³
|
¤Ñ©R¤j: ±z»¡ªº¬O. ³o½g¤å³¹¹ïOBI-822ªº»¡©ú¬yºZ§ãn,±Ôz¥©öªñ¤H,¬O³s©`¦Ì¤§¬y¤]¥i»´ÃP²z¸Ñªº.¬Û«H¹ï¤@¯ë¤j²³¤]·|¦³¬Û·íµ{«×ÄÀºÃ! ¦A¦¸ÁÂÁ§@ªÌ»P¤Ñ©R¤jªº´£¨Ñ. |
|
|
·|û¡G©`¦Ì¤p¤k¤l10141142 µoªí®É¶¡:2016/4/3 ¤U¤È 02:27:53²Ä 3793 ½g¦^À³
|
¤Ñ©R¤j: ¯Eª©¦³±z̳o¨Ç°ª¤â¦b,¦n´Î!!! ·PÁ±z~~~ |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2016/4/3 ¤U¤È 01:27:16²Ä 3792 ½g¦^À³
|
¤Ñ©R¤j¡A·PÁ±z¥Î¤ß¾ã²zÂà¸ü¥X¨Ó§¹¾ã¤º®e¡A¥i¿×¦A¥[±j¾d©T¯E¤ÍÌ«H¤ß¡A¥\¼wµL¶q¡C ¾Ç¦Ó®É²ß¤§¡A¤£¥ç»¡¥G¡H·Å¬G¦Óª¾·s¡A¥i¥H¬°®v¨o¡C |
|
|
·|û¡G12310132455 µoªí®É¶¡:2016/4/3 ¤U¤È 01:23:26²Ä 3791 ½g¦^À³
|
www.mobile01.com/topicdetail.php?f=132&t=4756958 Mobile01¤Wªº¤å³¹¡A¥²¶·µn¤J¤~¯à¬Ý |
|
|
·|û¡G12310132455 µoªí®É¶¡:2016/4/3 ¤U¤È 01:06:39²Ä 3790 ½g¦^À³
|
¤Ñ©R¤j¡A¨º¤@½gÁÙ¦b°Ú¡A¥u¬On»°§Ö³Æ¥÷¡A¤£µM¦b¤£¤[´N¤£¨£¤F¡A¤£ª¾cyril74¬O¯E¤Í¶Ü |
|
|
·|û¡G12310132455 µoªí®É¶¡:2016/4/3 ¤U¤È 12:42:49²Ä 3789 ½g¦^À³
|
¤Ñ©R¤j¡A ¨º£¸½g¦b¸ê·½¦^¦¬±í¤F¡A³oºØ¥¿¤Ï¨â·¥ªº°ÝÃD¦b01¡A«Ü¦³¥i¯à·|§R°£¡A¦]¬°¹H¤Ïª©³W |
|
|
·|û¡GLu10141514 µoªí®É¶¡:2016/4/3 ¤W¤È 10:59:55²Ä 3788 ½g¦^À³
|
¦³¨S¦³¤Hª¾¹D¡G OBI-822¦b°¨°º¬ö©ÀÂå°|¶i¦æ¡u¤G´ÁÁ{§É¡v¸ÕÅç¡AªvÀø§Z±_Àùªºªì¨Bµ²ªG¡H ³oÂI«Ü«n¡A¦pªG¦³®Ä¡A¹ï©óOBI-822¥Î¦b¥t¥~14ºØÀù¯g¤~¦³«H¤ß¡I¡I ¯E¹©¯à¤£¯à¤W¤d¡A©M³oÓÀ³¸Ó¦³«Ü©ú½TªºÃö«Y¡I ¥t¡AMegan¤j¡A§Aªº°ÝÃD¥H«e³£²á¹L¤F¡A¦b³o´XÓª©¡A¦Û¤v©¹«eª¦¤å¡A´N¦³µª®×¡C |
|
|
·|û¡GMegan10142227 µoªí®É¶¡:2016/4/3 ¤W¤È 10:01:28²Ä 3787 ½g¦^À³
|
¦U¦ì«e½ú¦n¡A ¤pªº¯u¤ß·Q½Ð°Ý¦U¦ìÃö©ó¯E¹©ªº°ÝÃD¡A¥H§@¬°¥¼¨Ó¾Þ§@ªº°Ñ¦Ò¡A ¯E¹©¬O¤j®a¤½»{ªº·sÃÄÀsÀYªÑ¡A³o²@µLºÃ°Ý¡A ·Q½Ð°Ý¦U¦ì¹ï¯E¹©«H¤ßªº¨Ó·½¬O¤°»ò¡H ¥«³õ«Ü¤j¡H §Y±N±ÂÅv¡H FDA conditional approval? ¦ý³o¨Ç°²³]³£¬O«Ø¥ß¦b¼Æ¾Ú«Ü¦nªº°²³]¤U¤~¦¨¥ß¡A ¦ý¥Ø«e¼Æ¾Ú¨Ã¨S¤Hª¾¹D §Ú¬ã¨sªº¤£¬O«Ü²`¡A¦ý³Ìªñ¯E¹©Âøµ«Ü¦h¡A¤×¨ä¬O¸Ñª¼¤£¦p¹w´Á«á¡A ¦]¦¹·Q¨Ó±M·~ªº°Q½×ª©´M¨D¸Ñµª¡A¥ýÁ¹L¦U¦ì¤F |
|
|
·|û¡Gyuki10141394 µoªí®É¶¡:2016/4/2 ¤U¤È 09:28:24²Ä 3786 ½g¦^À³
|
123¤j¡A¨¯W¤F·PÁ§A¡K¡Kµ¹§A10000ÓÆg¡A¥[ªo |
|
|
·|û¡G¼ï¤¤Áú10141277 µoªí®É¶¡:2016/4/2 ¤U¤È 09:08:36²Ä 3785 ½g¦^À³
|
¦U¦ìÆ[²³............ §õ¤pÀs¬O¤]¡I¡I¡I |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/4/2 ¤U¤È 06:06:54²Ä 3784 ½g¦^À³
|
PT¤j ¥¿¬O³o¦ìµóÀYµe®aS¾Ç¤å¡A¨¦ô¹Ï¤ù ¥i¬Ý¨ì§@«~¡A¤T¦Ü¤»¤ÀÄÁ§¹¦¨¡Aè¶}©l ¥H¬°¬Oµe§@¥¢±Ñ¡AÄ~Äò¬Ý¤U¥h·|¥X²{¦p¹Ú¦ü¤Û ªºÅå³ß! |
|
|
·|û¡GPT10139061 µoªí®É¶¡:2016/4/2 ¤U¤È 05:23:21²Ä 3783 ½g¦^À³
|
¥xÁÞ¤j ¬O³o¦ì¶Ü? ºë±m! www.youtube.com/watch?v=G8HrTZaAvwY ²H¤ôµóÀYÃÀ¤H,n¬Ý¨ì³Ì«á,¤jÅå©_!!!!! WOW AMAZING !!! |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/4/2 ¤U¤È 05:11:53²Ä 3782 ½g¦^À³
|
3¨º¦ì²H¤ô³Ð§@µe®a¡A¦bµ¼Ö¦ñ«µ¤U§@µe¡A¥Ñ¥²H¨ìÅå©_¡A«Ü¹³±i¸³»¡ªºË¦Y¥Ì½©¡Aº¥¤J¨Î¹Ò¡A¤]¹³¶ÀÁ`»¡ªº«Ü¦h¦]¯À¥[¦b¤@°_¬Ý¤£¥X®t²§¡A³Ì«á¨º¦ìµe®a§âµeËÂà¡A¥O¤HÅåÆA¡A·í³õ¤Þ°_¼ö¯P´xÁn¡C¨ÅÀùOBI822Á{§É¼Æ¾Ú¤»¤ëªì§Y±N½¶}¡A§Y±NËÂà¡A¶}±Ò¤HÃþÂå¾Ç¥v¤W¥HÁÞ¬°¼Ð¹vªº¤j¬ö¤¸¡C |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/4/2 ¤U¤È 04:39:53²Ä 3781 ½g¦^À³
|
¯E¹©¸Ñª¼ªì¨B¤ÀªR»P²H¤ôµe®a 1¤µ¤Ñ¤Ñ®ð¤£¿ù¡A»P®a¤H¨Ó¨ì®v¤j¹ï±¡A§Ú¦b§ä ´M¦~»´®É«¦Ò¤j¾Ç¯²«Îªº¦a¤è¡Aª«´«¬P²¾¡A·í¦~ªºªL°È§½©Ð¤l¤w¸g©î°£§ï«Ø¤j¼Ó¡A¦Ñ«ÎÁö¤£¦b¡A¸}©³¤U¨Ì¾֦³¦~»´®É¥Nªº¦^°O¾Ð¡C 2±q¤K¨½§¤´ç½ü¨Ó¨ì²H¤ô¬Ý¨ì¤@¦ì¤ô¨¬»RÁЪºµe®a¦bªíºt§@µe¡Aè¶}©l¥H¬°µe¹³¥²HµL©_¡A¤@ª½¬Ý¤U¥h¤~¥X²{¥O¤HÅå³ßªº§@«~¡A§Ú·Q¨ì¸Ñª¼ªì¨B¤½§i»P¥¼¨Óªº²Ó½o¤ÀªR¡A¥Í©Rªº²`«×À³¬Ý³Ì«á¡A¤£¬Oè¶}©l¨º¤@¨è¡C |
|
|
·|û¡G12310132455 µoªí®É¶¡:2016/4/2 ¤U¤È 04:10:00²Ä 3780 ½g¦^À³
|
32¤À03¬í¶}©l¡A34¤À47¬íµ²§ô 48¤À19¬í¶}©l¡A50¤À¾ãµ²§ô 1¤p®É06¤À32¬í¶}©l¡A1¤p®É10¤À45¬íµ²§ô ½ÐÓ¬°¦Û¦æµûÂ_¡AÁÂÁ |
|
|
·|û¡G12310132455 µoªí®É¶¡:2016/4/2 ¤U¤È 03:25:56²Ä 3779 ½g¦^À³
|
§Ú¬Ý¨ì¤F¥L¬O¬Ýcnyes.com ºô¯¸ªº~~ |
|
|
·|û¡G12310132455 µoªí®É¶¡:2016/4/2 ¤U¤È 03:22:11²Ä 3778 ½g¦^À³
|
¤p®æ¤j¡A¨ä¹ê¥L¦pªG¥h¬Ý¤½¶}¸ê°TÆ[´ú¯¸´N¨S¿ù¤F¡C¥L¤£ª¾¬O¬Ýþ¤@Óºô¯¸¡Aºô¯¸¿ù»~©Ç½Ö |
|
|
·|û¡G¤p®æ10136562 µoªí®É¶¡:2016/4/2 ¤U¤È 03:11:42²Ä 3777 ½g¦^À³
|
¦n¯º,®³10412ªº¸ê®Æ,»¡¦¨10501ªº¸ê®Æ,¨Ó»¡¤½¥q»¡·W ¬On¥´¤½¥q¨S¦³«H¥Î¶Ü?¯u¬O¥i´c. |
|
|
·|û¡GCK10142015 µoªí®É¶¡:2016/4/2 ¤U¤È 03:07:34²Ä 3776 ½g¦^À³
|
À³¸Ó¬O»¡¬Q¤ÑTVBS¦bÁ¿¯E¹©¨ºÓ¸`¥Ø ¶V¬Ý¶V¥Í®ð ¤½¥q¤]§Ô«Ü¤[¤F§a? þ¸Ì°Ê¤£°Ê´Nn§i¤H? |
|
|
·|û¡G12310132455 µoªí®É¶¡:2016/4/2 ¤U¤È 03:01:48²Ä 3775 ½g¦^À³
|
§Ú¥¿¦b¥´³v¦r½Zµ¹¤½¥q¡A§Ú¥u¯à»¡±d¥ý¥Í¤£¥h¤½¶}¸ê°TÆ[´ú¯¸¬d¡A®`¦º¦Û¤v¡C «e±ÁÙ¦³¤@¬q¡A¬Y¤H»¡¤½¥q°Ê¤£°Ê»¡n§i¤H¡A«á±»¡¤½¥q§ÞÂà2¦¸..... µ¥§Ú¾ã²z§¹¦Aµ¹¥L®a¬Ý |
|
|
·|û¡G¤p®æ10136562 µoªí®É¶¡:2016/4/2 ¤U¤È 02:58:14²Ä 3774 ½g¦^À³
|
123¤j è¤~¥h¤½¶}Æ[´ú¯¸¤ñ¹ï¤@¤U,«ùªÑ½T¹ê¨S¦³ÅÜ¤Æ .³o¦ì±d¤¯«T¥ý¥Í,¦b¸`¥Ø¤Þ¥Î¿ù»~¸ê°T´c·N抺¶Â ¤½¥q. |
|
|
·|û¡GQQ10140589 µoªí®É¶¡:2016/4/2 ¤U¤È 02:44:40²Ä 3773 ½g¦^À³
|
©êºp¤W½gº|±¼µ²§À ¡§ÁÙµ¹°|ªø¤@Ó¤½¹D¡¨ |
|
|
·|û¡GQQ10140589 µoªí®É¶¡:2016/4/2 ¤U¤È 02:38:50²Ä 3772 ½g¦^À³
|
¤p¦Ì¦à¤j: ÁÂÁ±z´£¨Ñªº¤Ñ¤UÂø»x°T®§. §Ú¨Ì¦¹»`¨ìªººô¯¸¸ê°T¦p¤U: ¤@) ¯E¹©±N¯¸¤WASCO»R¥x µoªíÀù¯g·sÃĸѪ¼½×¤å www.cw.com.tw/article/article.action?id=5075526&utm_source=Facebook&utm_medium=Social&utm_campaign=Daily ¡K¡K ¡§¯E¹©¸³¨Æªø±i©À·O¨Ãªí¥Ü¡A¥Ø«e¶i¦æ³]p¼Ú¬ü¤T´ÁÁ{§É¸ÕÅç¡A¥i±æ¦b¤@¦~¤º§¹¦¨¡C¡¨ ........ ±i¸³¨Ã¨S¦³³o»ò»¡°Ú?! ¨S¦³¡¨¤@¦~¡¨³oӮɶ¡ªí¹F ¤G) ¯E¹©§Q¯q»¡¤£²M ¯Î±Ò´f»X¹Ð www.cw.com.tw/article/article.action?id=5075433 §Ú¤]»{¬°¤Ñ¤U³o½g·|¹ï°|ªø³y¦¨±þ¶Ë¤O¦]¬°¤¤¶¡¤Þ¾Úªº¸ê®ÆÁö¥i¯à¥¿½T, ¦ý¦b®ÉªÅI´º¤U, ¥H²{¦b¬Ý¹L¥h, «o¤]¦³«Ü¦h¥i¯à«ç»ò¤]»¡¤£²Mªº¦a¤è. §Æ±æª©¤W¦³¸û¤F¸Ñªº¤j¤j¯à´£¥X¬Ýªk. §Æ±æ¦b¯àÁÙì·í®Éªº®ÉªÅI´º¤UÁÙµ¹°|ªø |
|
|
·|û¡G12310132455 µoªí®É¶¡:2016/4/2 ¤U¤È 01:37:21²Ä 3771 ½g¦^À³
|
¬°¤FÃÒ¹ê§Ú¨S»¡ÁÀ www.youtube.com/watch?v=iZhZm35qKkg ½Ð¦U¦ì¬Ý¬Ý 48¤À19¬í~¨ì50¤À¾ã |
|
|
·|û¡Ganthony10142049 µoªí®É¶¡:2016/4/2 ¤U¤È 01:32:43²Ä 3770 ½g¦^À³
|
ª©¤W½Ñ¦ì¯«¤j ²M©ú°²´Á´r§Ö ¦³Ãö¦Ü©óOBI-822¬O§_nÄ~Äò¶i¦æ¤T´ÁÁ{§É¡A¯E¹©¤]ªí¥Ü¡A°Æ¸³¨Æªø³\¤Í®¥4¤ë2¤é±N¦b^°êÛ´°Á|¦æ±M®a·|ij¡A°Q½×OBI-822¤T´ÁÁ{§É³]p³W¹º¡A¬O§_¯à§K°µ¤T´ÁÁ{§É¡A¥Ø«eÁÙ¤£¯à¤U©w½×¡C...°²³]...¦pªG±M®a·| ij¬O§K°µ¤T´Á...¨º¬O¤£¬O¤S¬O¤@¤j§Q¦h??? |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/4/2 ¤U¤È 12:53:59²Ä 3769 ½g¦^À³
|
¦Ñ¥v¤j ¦³±z¡A´N¦³Åå³ß ¦³±z¡A´N¦³·sª¾ ¦³±z¡A´N¦³´Á«Ý¡A¯uªº¡A±zÅý¤p§ÌÅÜÃi¤F ÁÂÁ±zµL¨pªº¤À¨É¡I |
|
|
·|û¡GQQ10140589 µoªí®É¶¡:2016/4/2 ¤U¤È 12:11:35²Ä 3768 ½g¦^À³
|
¦Ñ¥v¤j: Æg !!! ±z«H¤â©à¨Óªºª¾ÃÑ´NÅý²³¯E¤Í¨ü¯q¦h¦h. ·PÁ !!! |
|
|
·|û¡G¤p¦Ì¦à10141842 µoªí®É¶¡:2016/4/2 ¤W¤È 11:14:52²Ä 3767 ½g¦^À³
|
¤Ñ¤UÂø»x¤£¬O¤@¯ëªº¤K¨öÂø»x¡A¹ï¯Î°|ªøªº±þ¶Ë¤O³Ì¤j¡A³Ì¥ý¤Þ¥Î¤¤¬ã°|§Q¯q¦^Áתºªk±ø¨Óµû½×¡A²{¦b´CÅé³£®Ú¾Ú¦¹³ø¾É¨Ó§å§P¡A§Ṳ́£¬Oªk«ß±M®a¡A¤£¯àµûÂ_¤Ñ¤UÂø»x¤Þ¥Î¬O§_¥¿½T¡A¯à§_½Ð¯E¹©±M·~«ß®v´N¨Æ¹ê¨Ó»¡©ú¡A¦³¿ù»~ªº¦a¤è¡An¨D¤Ñ¤UÂø»x§Y¨è¤½§i×¥¿¡C §Ú¤H¦b¦^¶m±½¹Ó³~¤¤¡A¨S¹q¸£¤£¤è«K¡A¯à§_½Ð¯E¤ÍÀ°¦£¡C |
|
|
·|û¡GLin10142144 µoªí®É¶¡:2016/4/2 ¤W¤È 11:13:55²Ä 3766 ½g¦^À³
|
¦³«í¤j¤p§Ì«D±`¤ä«ù§Aªº·QªkÀ³¸Ó¥´Ó¹q¸Ü¥h¤½¥q¦A´£¿ô¤@¤U¡D¼Æ¾Ú¤]nÂê¦n²{¦b¯uªº«Ü¦MÀI¡A52O¤§«e |
|
|
·|û¡G¦³«í10141521 µoªí®É¶¡:2016/4/2 ¤W¤È 10:46:24²Ä 3765 ½g¦^À³
|
123¤j ¤ä«ù!§Æ±æ¤½¥q¹ïÄY«¤£¹ê¨¥½×´£§i,¥H¥¿µøÅ¥!ºûÅ@ªÑªFÅv¯q! |
|
|
·|û¡G¤p·s10141589 µoªí®É¶¡:2016/4/2 ¤W¤È 10:23:24²Ä 3764 ½g¦^À³
|
·x·x¤j,¤£ª¾¦³¨S¦³Time ¥þ¤å¥ipost ¤W¨Ó,¦]¦n¹³n¥I¶O¤~¥i¬Ý¥þ¤å. TIME¡¦s new cover: Immunotherapy |
|
|
·|û¡G12310132455 µoªí®É¶¡:2016/4/2 ¤W¤È 07:42:12²Ä 3763 ½g¦^À³
|
«ß®v¤£¬O¦³¸É¥R»¡©ú¥hAsCO³ø§i¡A¤£¬O¥Nªí¯E¹©´N¯à®³ÃÄÃÒ¡A¤]¤£¬On§ä¤HI®Ñ¡C¦pªG¦³¬Ýªº¤HÀ³¸Ó«Ü²M·¡¡C ¬F½×¸`¥Ø³£¦b½|¶i¥h³ø§i´N°±µP·dÔ£¡A§Ú·Q¦pªG¤£°±µP¡A¬O§_n³Q»¡¤º½u¥æ©ö¡C ¦pªG¤µ¤Ñ¯E¹©¥Ó½Ð°±µP1¬P´Á¡AµM«á¦b±Ò°Ê¸Ñª¼µ{§Ç¡A³o¼Ë¬O¤£¬O§ó¨S¦³¨S¦³¤º½u°ÝÃD¡C¨Æ¹ê¤W®Ú¥»´N¨S¦³ ¬Y¬F½×¸`¥ØÁÙ®³3¤ë31ªº°OªÌ·|½|¸³¨Æªø»¡§AÌÔ£³Ì°ª¹D¼w¼Ð·Ç¡A¤£¬O»¡1Ó¤ë«e¸T¤î½æªÑ¡A¬°Ô£¤½¶}¸ê°TÆ[´ú2¤ë¥÷¦³Åã¥Ü½æªÑ¡A§ÚÁÙ¯S§O¥h¬d¤F¤@¤U¡A®Ú¥»¨S¦³¡A¬O§Ú²´·ú¦³°ÝÃD¶Ü¡Aµ¥¤µ¤Ñ¸`¥Ø¼v¤ù¦bºô¸ô¤W¡A§Ú·|±Hµ¹¤½¥q¡A¥Hµø¥¿Å¥¡C |
|
|
·|û¡GLin10142144 µoªí®É¶¡:2016/4/2 ¤W¤È 06:58:35²Ä 3762 ½g¦^À³
|
²{¦bÁÙ¦b½×ªÅªº¤H¬Ý¨ì²´¯]¯uªº·|±¥¤U¦Ô±i¸³¨Æªøªº¨¥»y³o¼Ë¸Û¤ß³s«ß®v¦h¦bÀ°±Ä±þ¨®ÁÙ¦³¤°»ò¦nªÅªº¤j®an§ó¦³«H¤ß¤~対´NÅý®É¶¡¦Ôµý¤@¤Á§a¡I |
|
|
·|û¡G¦³FUªº¤H10136189 µoªí®É¶¡:2016/4/2 ¤W¤È 12:48:54²Ä 3761 ½g¦^À³
|
ªô¤Ñ¤j~~~ ¨S¦³¤H¤£Åý§A¦b³oÃä½×ªÅ,¥u¬O³oÃ䪺¤j¤j½×¦h³£¬O¦³¨Ì¾Ú´£¥X°Q½×¬ã¨s,¦Ó§A½×ªÅ´N³æ¾Ì¤@¨Ç¦Û¤vªº·Qªk´N´£¥X¨Ó½×z¯E¹©ªº¤£¦n,¹ê¦b¬OµLªkÅý¤H±µ¨ü,¤p§Ì§Ú³£¤w¸g«Üªù¥~º~,¬Ý±z©Ò¦^ªº¤º®eµL¥ô¦ó®Ú¾Ú´N¬O¤Wªù°Q±Ð.³o¼Ë¸Ó¦p¦óÄ~ÄòÅý¨ä¥L¤j¤j¦^À³±z.³o¸Ì«ÜÅwªï¹ï©ó¯E¹©¦³¤£¦P¨£¸Ñªº·Qªk,¦ý¯uªºn¦³¨Ç®Æ¦A¨Ó«ü±Ð°Q½×,¯uªº³Ì¦nn¦³®Æ,¤£µM¥i¯à³Q°ÝÓ´X¥y°ÝÃD´N·|¤£ª¾¹D¸Ó»¡Ô£,¯u¤ß«Øij±z. |
|
|
·|û¡G¦Ñ¥v10140531 µoªí®É¶¡:2016/4/2 ¤W¤È 12:41:50²Ä 3760 ½g¦^À³
|
HI¥C¤Ñ¥S»P±z¤Á½R §Ú¥H¿ÕµØCAR-T¬°¨Ò¡A¦åÀù§¹¥þ½w¸Ñ²v°ª¹F90%¡A27/30=90%¡A½T¹ê«Üº}«G ¦ý½Ðª`·N¡A³o¼Æ¦r¥u¬O«ü²Ä¤@Ó¤ë ±q²Ä¤»¶g°_³o¨ÇCRªº¤H´N¶}©l´_µo¡A¤@¦@¦³6Ó¤H¦b²Ä¤»¶g¨ì¥b¦~¤º´_µo¡A²Ä7Ó¤H¦b8.5Ó¤ë´_µo ÁÙ¦³¤@ÓCRªº¯f¤H¦]¬°°©Åèµo¨|¤£¨}¯gÔ¸s¥h¥@ 27¦ìCR¦©°£¤Wz8¤H¡AÁÙ³Ñ19¤H¡A¨ä¤¤¦³4¤H°h¥XÁ{§É±µ¨ü¨ä¥LªvÀø ¯u¥¿«O«ù§¹¥þ½w¸Ñ¥B¨S¦³±µ¨ü¨ä¥LªvÀøªº¥u¦³15¦ì ¤»Ó¤ëªºEFS¾÷²v¬O67% ¤¤¦ìEFS¤j¬ù¬O9Ó¤ë §Ú°O±oCAR-TÀøµ{¦n¹³¬O50¸U¬üª÷(²{¦b¤£ª¾¹D¦h¤Ö) ±z¥i¥Hµû¦ô¤@¤U³o50¸U¬üª÷ªº®Ä¯qȤ£È±o ¥t¥~¦³Ãö¥_·¥¬P 1.ªk»¡·|¤W¦³´£¨ì¨xÀù¤T´ÁÁ{§É¥i¯àµLªk....... 2.ADI-PEG 20n·f°t¤ÆÀøÃħí¨î§K¬Ì¨t²Î.....¦b¤jÃļt²´¤¤·|¥´§é¦© 3.³Ì¦³¾÷·|ªº¬OªÍ¶¡¥ÖÀù¡A±z¥i¥H¬d¬d¬ü°ê¯f±w¤H¼Æ |
|
|
·|û¡G°Ñ¤@©@10141487 µoªí®É¶¡:2016/4/2 ¤W¤È 12:37:08²Ä 3759 ½g¦^À³
|
ªô¤Ñ¤j¡A·PÁ±z´£¨ÑÄ_¶Qªº·N¨£¡C ½×ªÅ¯E¹©·íµM¨S°ÝÃD¡A¥un±z´£¨ÑSolidªº»¡©ú¯E¹©¨º¤£¦n¡A¬Û«H¤j®a¤]¬O¥i¥H±µ¨üªº¡C ¤p§Ì´£¨Ñ¤@ÂI¬Ýªkµ¹±z°Ñ¦Ò¡A¥h¦~ASCOªº«ÂI¬Oimmune checkpoint´XÓÃĪº³æ¿W¨Ï¥Î©M¦X¨Ö¨Ï¥ÎÀø®Ä¦¨ªG¡A¤µ¦~ASCOª½±µ´N±N¥DÃDq¬°§K¬ÌÀøªk¡A¯E¹©¬O³Ìª½±µ¬ÛÃöªº¡A¦Ó¥BÀù¯gªvÀø¥¼¨Óªº¨«¦V«Ü¥i¯à¬O§K¬ÌÀøªkªºÁp¦X¥ÎÃÄ¡A¯E¹©ªº¾÷¨î¸òimmune checkpoint¤£¦P¡A«Ü¦³¾÷·|¬O¦U®a¤j¼tÁp¦X¥ÎÃĪº¹ï¶H¡A¥ú³o¶ô´N·|¦³«Ü¤jªº·Q¹³ªÅ¶¡¡C §Æ±æ³o²³æªº»¡©ú¯àÅý±zÄÀÃh¡C |
|
|
·|û¡G¥ôÄP¤¸10142024 µoªí®É¶¡:2016/4/2 ¤W¤È 12:29:07²Ä 3758 ½g¦^À³
|
¿P³¶¦wª¾ÂEÃ[¤§§Ó.§O¦b®³¤¤¸Î.¥_·¥¬P¸ò¯E¹©¤ñ.¦¦Âk°§a.³°x«Ü²rªº³á |
|
|
·|û¡G·x·x10141215 µoªí®É¶¡:2016/4/2 ¤W¤È 12:20:10²Ä 3757 ½g¦^À³
|
TIME¡¦s new cover: Immunotherapy.2016.3.24 (°ê»Ú´CÅé¶}©lÃöª`³oÓijÃD¤F!Æg) What if your immune system could be taught to kill cancer? time.com/4270414/in-the-latest-issue-64/ |
|
|
·|û¡G¥ôÄP¤¸10142024 µoªí®É¶¡:2016/4/2 ¤W¤È 12:19:34²Ä 3756 ½g¦^À³
|
¤p³Â³¶¼T¼T¥s.¦U¦ì¤j¤j¤£¥²²z·| |
|
|
·|û¡Gªô¤Ñ10135156 µoªí®É¶¡:2016/4/2 ¤W¤È 12:18:19²Ä 3755 ½g¦^À³
|
§Úª¾! ¦b³o½×ªÅ Á`¬O¤d¤Ò©Ò«ü! ²z©Ê·Q·Q ȱo§_? ¬ÕÁ«¤£Ãö§Ú¨Æ! ¦P¬OªÑ¤Í Å¥¤@Å¥¤£¦P·N¨£Á`¬O¦nªº ¦ýÄ@§Ú©Ò¨¥¬O¿ùªº! ¯¬ºÖ¦U¦ì! ¤]Ä@¯E¹©¦p¦U¦ì©Ò±æ ¥Ã»·ªÑ¤ý µL¤H¥i¤Î! ¤]§Æ±æ¥L¦¨¬°¥xÆW¤§¥ú ·Ó©Ø©Ò¦³Àù¯g¯f¤Í! |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/4/2 ¤W¤È 12:13:09²Ä 3754 ½g¦^À³
|
¨ºÓ¤Ñªº ³Q¹Ç ´N¤W¨Ó¥s¶Ü §Ú̦hÀY³Q¥´®É §A«ç¤£¤W¨ÓÀ°§ÚÌ |
|
|
·|û¡G§d½n¶¯10142119 µoªí®É¶¡:2016/4/2 ¤W¤È 12:10:35²Ä 3753 ½g¦^À³
|
·íµM¬O¤¤¸Î¤ñ¯E¹©¦n°Ú ¨Ä¡ã¥hºÎ¤F ±ß¦w |
|
|
·|û¡Gphliao10139754 µoªí®É¶¡:2016/4/2 ¤W¤È 12:06:44²Ä 3752 ½g¦^À³
|
À³¸Ó§ï¦W¥s®L¤Ñ¤F¡A¤£ª¾¤°»ò¬O¥V¤Ñ |
|
|
·|û¡Gªô¤Ñ10135156 µoªí®É¶¡:2016/4/2 ¤W¤È 12:02:38²Ä 3751 ½g¦^À³
|
ÁÂÁÂw¥S: »¡¹ê¦b ¥Í§ÞªÑ §Ú«ù¦³¹L¤¤¸Î 120¥X²æ«á´N¨S¯dÅʹL §ó¦óªp ¥L«Å¥¬±ÂÅv³ºµM¦p¦¹(¤£«Kµû½×) ¥B»¡¸¹¹©§a !¥L·|¤ñ¤¤¸Î¦n¶Ü????? |
|
|
·|û¡GPT10139061 µoªí®É¶¡:2016/4/2 ¤W¤È 12:00:34²Ä 3750 ½g¦^À³
|
¼Ó¤U¨ºÓ¬Æ»ò¤Ñªº ¥«³õ¤£¬O¥Î·s¥x¹ô§i¶D§A¤F¶Ü? §O¦A²V¤F. ºC¨«¤£°e. |
|
|
·|û¡G§d½n¶¯10142119 µoªí®É¶¡:2016/4/2 ¤W¤È 12:00:03²Ä 3749 ½g¦^À³
|
¥«³õªº»ùÈ ªÑ»ù·|»¡¸Ü ¦ó¥²³o¼Ë°Q½×ÅçÃÒ©O¡H¤w¸g§n½¤Ñ¤FÁÙ¤£²Ö°Ú...¬Û«Hªº¤H¯d¤U¨Ó¤p¤ßÀ³¹ï¡A¤£«Hªº¤HÀRÀq¬ÝÀ¸...¤U³æªº¬O¦Û¤vªº¤â ¦Û¤vt³d´N¦n... |
|
|
·|û¡G·x·x10141215 µoªí®É¶¡:2016/4/1 ¤U¤È 11:56:55²Ä 3748 ½g¦^À³
|
²{¦b¬O¬K¤Ñ,¬î¤Ñ¤£n¥X¨Ó¾x³õ!ÁÂÁ |
|
|
·|û¡Gªô¤Ñ10135156 µoªí®É¶¡:2016/4/1 ¤U¤È 11:51:18²Ä 3747 ½g¦^À³
|
¼H~ ¤£¤[(¤@¦~§a) ¬Ý¬ÝÐù! ªp¥B!!!°ê»Ú©ÒÉqªº§K¬ÌÀøªk¤£¬O¯E¹©³oÃþ!¦Ó¬O§K¬Ì²ÓMÀøªk!!!¥h¦ôª¯¤@¤U!! ¤×¨ä¬OCAR-T ¦åÀùªv¡²v92% ¯E¹©? 400? ¾ÌÔ£? §i¶D§Ú? |
|
|
·|û¡Gwalker10141977 µoªí®É¶¡:2016/4/1 ¤U¤È 11:46:58²Ä 3746 ½g¦^À³
|
ªô¥S, ³o¸Ì¦³¤@¨Ç¸ê°T, ´£¨Ñ±z°Ñ¦Ò www.mobile01.com/topicdetail.php?f=291&t=4755575&p=2#59714265 |
|
|
·|û¡GµL¤j10141864 µoªí®É¶¡:2016/4/1 ¤U¤È 11:39:30²Ä 3745 ½g¦^À³
|
ªô¤Ñ¤j.. ¥«³õµ¹ªº»ùÈ.. ¯E¹©´N¬O400,6550´N¬O75.. ªÑ»ù·|»¡¸Ü..³s³oÓ²³æ¹D²z³£¤£À´.. ·í¯E¹©400ÅÜ100,¨º6550¥i¯à¥u³Ñ¤U18¤¸.. ¯¬ºÖ±zªº6550.. ªÑ¥«¾Þ§@,¤ß±a¤£¥¿¦Ó»y¤£¥¿,¯uªº¥u¯à¯¬ºÖ±z,´L«±z©Ô.. |
|
|
·|û¡Gªô¤Ñ10135156 µoªí®É¶¡:2016/4/1 ¤U¤È 11:29:57²Ä 3744 ½g¦^À³
|
¥i¼¦ªº¤@¸s¯E»Ûè ¥B¬Ý6550§a! ø®Ñ¸¹¹©¶Ü? ¦P¼ËÃD§÷ ¤@Ó¬G·N°±µP ¥t¤@Ó·Ó±`¥æ©ö 400:75 ????? 400ªÑ»ùnµ¥¦h¤Ö¦~¤~¦³¥¦¹ê½èªº»ùÈ?(²£¥ÍEPS) ? ½Ñ¦ì¥¼§K¤Ó¤Ñ¯u¤F ! ¿ô¿ô§a! §O»¡§K¬ÌÀøªk¤F ¬ü°ê§K¬ÌÀøªk¤£¬O¯E¹©³oÃþªº!!!! ¥h¬Ý¬Ý¦P¼Ë¨ú±oASCOªº6550 ¤H®a¦h§C½Õ ¸¹¹©«o¬G§Ë¥Èµê °±µP! ²z©Ê¤@ÂI !!!! ´Á«Ý¤»¤ë¶Ü? ¨º6550 §ó¥i´Á«Ý |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2016/4/1 ¤U¤È 10:50:58²Ä 3743 ½g¦^À³
|
¤Ñ©R¤j¡A ÁÂÁ±z¸Ô²Óªº¤ÀªR¡A¹ï·Ó²{¦³ªº¬ÛÃö¸ê°T¡A¥i«H«×¬Û·í°ª¡A¤£¹L·íªì¤p§Ì¤]¬O¥Î¥[Åv¥§¡PFS, ºâ¥X¬ù15Ӥ륪¥k¡A¤£¹L³o¦¸¸Ñª¼¤£¦p¹w´Á¡A¤D¦]¬°ªø§À®ÄÀ³¡A©Ò¥H¤¤¦ì¼ÆPFS»P¥[Åv¥§¡PFS·|¦³¬Û·í®t²§ Àù¯g§K¬ÌÀøªk¬O³Ìªñ³Ì·sªºªvÀøÅã¾Ç¡A¨Ì¾ÚAnti PD-1, PD-L1¸gÅç¡AKM¦±½u³£¦³«e±´XÓ¤ëªÈµ²¤@°_¡A«á¨Ó³vº¥©Ô¶} µM«á¶V¨Ó¶V½w¡A¨ì¤F2¦~«á¹êÅç²Õ´X¥G¦¨¬°¤ô¥½u¡C ¥HÀù¯g¦³®ÄªvÀø(¸~½F¤j¤p´î¤Ö30%¥H¤W)¤ñ²v¡A¥un20%¨ü¸Õ±wªÌ´N¬O·¥¤jªº¦¨¥\¡A¦p±z¹w´ú822·¥¤j¥i¯à¨ã¦³©Î¶W¹L³oºØÀø®Ä ³o¼Ë¨¤«×¨Ó¬Ý¤@´Áµ²ªG¤]¥i¥H¦LÃÒ¡A³o¨Ç40´Xw¯à¶W¹L9~10¦~ªºOS´N¥i¥H¤jÁx²q´ú¤w¸g¬ONED¤F |
|
|
·|û¡Gªü®¶10139782 µoªí®É¶¡:2016/4/1 ¤U¤È 10:33:31²Ä 3742 ½g¦^À³
|
¬W¬W©j.±z¥H¤¤°ê°ê¥ÁÄÒ¤§´L.... ¤]¸Ó¥H¦P¼Ëªº¼Ð·Ç¨ÓÀ˵ø¦Û¤v www.worldjournal.com/3875042/article-%E6%AE%B5%E5%AE%9C%E5%BA%B7%E8%B3%AA%E7%96%91%E8%82%A1%E7%A5%A8-%E6%B4%AA%E7%A7%80%E6%9F%B1%EF%BC%9A%E5%85%A8%E5%85%AC%E9%96%8B%E9%80%8F%E6%98%8E/ ¤£¥i¥H¥H³oÓ¤H¨Æ°È¡A¸òÄҰȵLÃö¡A¦pªG¦³»Ýn¡A·|¦Û½Ð«ß®v¥X±»¡©ú¡A¤]»¡Y´CÅé·Q¤F¸Ñ©Ò¦³¨ÓÀs¥h¯ß¡A¥i¦VºÊ¹î°|½Õ¾\¸ê®Æ¡A³£¦³§¹¾ãªº°O¸ü¼Ò½k±a¹L¼Ú....¨º¯Î±Ò´f¬O§_¤]¯à¥HY´CÅé·Q¤F¸Ñ©Ò¦³¨ÓÀs¥h¯ß¡A¥i¦VºÊ¹î°|½Õ¾\¸ê®Æ¡A³£¦³§¹¾ãªº°O¸ü¶Ü? tw.news.yahoo.com/video/%E8%A3%9C%E7%94%B3%E5%A0%B1%E4%B8%8A%E5%84%84%E8%82%A1%E7%A5%A8-%E6%AE%B5%E5%AE%9C%E5%BA%B7%E7%B1%B2%E6%B4%AA%E7%A7%80%E6%9F%B1%E8%AA%AA%E6%B8%85%E6%A5%9A-122600221.html |
|
|
·|û¡G¤p·s10141589 µoªí®É¶¡:2016/4/1 ¤U¤È 09:45:32²Ä 3741 ½g¦^À³
|
·í¦÷§Q²¤¥Î±æ»·Ãè¬Ý¨ì¤ì¬Pªº½Ã¬P¶µÛ¤ì¬PÂà¦Ó¬D¾Ô¦a¤ß»¡¤§«á ¦÷§Q²¤³Q§P¡u¦³±j¯P²§ºÝ¶ûºÃ¡v¡A§YÁnºÙ¤Ó¶§¦b¦t©zªº¤¤¤ß¡A¦a²y¤£¬O¤¤¤ß¦Ó¥B¦b¹B°ÊµÛ¡A¹ï«ù¦³¨Ã¬°¦¹ÅG»éªÌ»P¯«¸t¸g¤å¬Û®¯¡C¥L¥²¶·¡uµo»}©ñ±ó¡B¶A©G¨Ã¹½±ó¡v³o¼ËªºÆ[ÂI¡C ²§ºÝ¼f§P®x«ü¥Ü±N¥L¥¿¦¡©ë®·¡A²Ä¤G¤Ñ¥L±N·|¦b®a¤¤²×¨³n¸T¡C ¥Lªº®¯°fªº¡m¹ï¸Ü¡n±N³Q¬d«Ê¡F¦b§P¨M¤§¥~¡A¥L©Ò¦³ªºµÛ§@±N³Q¬d«Ê¡A¤µ«á¥L¤£¯à¦bÄ~ÄòµÛ®Ñ¡C ®Ú¾Ú¬y¦æªº¶Ç©_¡A¦b«Å¥¬©ñ±ó¦a²y³ò¶¤Ó¶§±ÛÂ઺²z½×®É¡A¦÷§Q²¤´¿¸g³ä³ä¹D¡u¦ý¬O¡A¦a²y¨ÌµM¦bÂà°Ú¡v |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2016/3/31 ¤U¤È 05:19:04²Ä 3740 ½g¦^À³
|
©Ó¤W½g¡A¤Ö¥´´XÓ¦r ¤£¹L³Ìªñ³Q»¡´¿曑³£±þ¤F¥L¶ý¤F¡A¥L¶ýÁÙ¥X¨Ó¼á²M»¡´¿曑¨S±þ¤H"¤]¨S¤H«H" ®M¥y¦W¤H«e¨â¤Ñ»¡¹Lªº¸Ü"¯u¬O¨£°¤F" ¥t¥~¬Ý¤µ¤Ñ¤½¥q»¡ªk»P¸Ñª¼«áªk»¡·|«e«á¤@P¡A§ó¥[¬Û«H¤½¥q¬O«Ü¦³¸Û«Hªº ·íµM¤]¯à»¡¬OStay foolish, ©Ò¥H³Q´CÅé¦W¼LKªº¥|³B°k« ©Î³\¦l¥©¤@ÂI¯à°÷´î¤Ö³Q§ðÀ»¡A¤£¹L¤S¦n¹³¸ò°È¹êªº¬ì¾Ç®a¸Û«Hªº¤½¥q§Î¶H·|¦³¸¨®t ©Ò¥HÁÙ¬O³o¼Ë´N¦n¡A ©¯¦n³o¦¸¥xÁÞÄ¥¶¤¦³ASCO¤Î®É«B¤~¨S³QÀ»¨I¡A¤£µM·d¤£¦n·|¹³·íªìªº¤j©M¸¹¤@¼Ë https://zh.wikipedia.org/wiki/%E5%A4%A7%E5%92%8C%E8%99%9F%E6%88%B0%E8%89%A6 ¤j©M¡]やまと¡þヤマト¡^[5]¬O¤j¤é¥»«Ò°ê®üx«Ø³y¡A¨Ã¥B¬°¥v¤W³Ì¤jªº¾ÔÄ¥¡C¤j©M«¬¾ÔÄ¥¤@¸¹Ä¥¡C ¡u¤j©M¡v©ó¤Ó¥¬v¾Ôª§¡]¤jªF¨È¾Ôª§¡^¶}¾Ô«áªº1941¦~¡]¬L©M16¦~¡^12¤ë16¤é¶}©lªA§Ð[6]¡A¨Ã¦b1942¦~¡]¬L©M17¦~¡^2¤ë12¤é¦¨¬°Áp¦XÄ¥¶¤ºXÄ¥[7]¡C¸Ó¥ô©Rª½¦Ü1943¦~¡]¬L©M18¦~¡^2¤ë¡A¥Ñ§ï¨}¤F¥q¥O³¡³]³Æªº¦P«¬Ä¥¡uªZÂáv¶i¤J·¡§JÁã¦a«á±µ´À¬°¤î¡C1945¦~¡]¬L©M20¦~¡^4¤ë7¤é¡A¡u¤j©M¡v¦b¤Ñ¤@¸¹§@¾Ô´Á¶¡¡A¾D¨ü¬üx¯S»ºÄ¥¶¤ªº²r¯P§ðÀ»¡A©ó§{¤§Ìa®ü°ì³QÀ»¨I¡C ¡u¤j©M¡v·í®É¨ü¨ì¬üx¯èªÅ¶¤386¬[¡]¾Ô°«¾÷180¬[¡BÅF¬µ¾÷75¬[¡B³½¹p¾÷131¬[¡^©Î367¬[[148]¸¾÷ªº©¹´_ªiª¬§ðÀ»¡C |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/3/31 ¤U¤È 05:01:48²Ä 3739 ½g¦^À³
|
¤Ñ©R¤j §Þ³N¤è±¡A¤p§Ì¤£¬O±M®a¡A»¡ªº¸Ü±z¥i¥H¤£«H¡C±z¥i¥H¨ì 822/833 ¨ºª©¡A¥h°Ý Cliff¤j ©Î ¥xÁÞ¤j¡A¥L̬Oª©¤W§Þ³N³Ì¦b¦æªº¯E¤Í¡C²Î¤@§ëÅU±i¬ã¨sûªº³ø§i¸Ì©Î¬O¤W¦¸ªk»¡·|ªº¿ý¼v·í¤¤¡A³£¦³½T¹ê´£¨ì¦w¼¢¾¯¥Îªº¬O cyclophosphamide¡C ³oÓ¿ù»~¡A¯Eª©³\¦h¤H³£¦³¹L¡A¤Þ¥Î¸ê®Æ®É´N¥H³_¶Ç³_¤F¡C¿ù»~ªº°_·½¡A¬O¤½¥q¤è±»¡¡G¡y·íªì Herceptin Á{§É¹êÅ窺 end point ´N¬O¤ñ¹ï·Ó²Õªº PFS ¦h 50%¡A©Ò¥H PFS °µ¨ì¬ù 9 Ó¤ë´N¥i¥H¹F¨ìÅãµÛ©Ê¡C¡z¥i¯à·í®É³\¦h¯E¤Íªº¥\½Ò°µ±o¤£°÷¡A±i«a§õÀ¹¡A´N¦¨¤F¥Î Herceptin ·í¹ï·Ó²Õ¥ÎÃijo¼Ëªº»~¸Ñ¡C¤p§Ì¦Û¤v¦¥ý¤]¦³¹LÃþ¦üªº»~¸Ñ¡C Herceptin ¥u¯à¥Î©ó¤Ö³¡¤À¨ÅÀù¯f¤H¡A¦ý¬O 822 ¥i¥H¥Î©ó©Ò¦³¨ÅÀù¯f¤H¡A¤£¥²¨Æ¥ý¥H¥ô¦ó¼Ð¹v¨Ó¿z¿ï¯f¤H¡A¬O¥´¤F¬Ì]¤§«á¬Ý§ÜÅéªí²{¡C |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2016/3/31 ¤U¤È 04:59:57²Ä 3738 ½g¦^À³
|
¬ÝÃlµL¤j¡A ½T¹ê¬O¤£»Ýn¸ò¬Y¨Ç¤H¤@¯ë®æ½Õ¡A ¤£¹L³Ìªñ³Q»¡´¿曑³£±þ¤F¥L¶ý¤F¡A¥L¶ýÁÙ¥X¨Ó¼á²M»¡´¿曑¨S±þ¤H¡A ®M¥y¦W¤H«e¨â¤Ñ»¡¹Lªº¸Ü"¯u¬O¨£°¤F" §Ú̽T¹ê¤£À³¸Óªgªg¦Û³ß¡A¶ÀÁ`»¡¹L³o¬O¤@±ø§¢©V¸ô¡A«á±¤£ª¾ÁÙ¦³¦h¤ÖÀIªý¥ÛÀY¦b¾×µÛ¯E¹©«e¶iªº¹D¸ô¤W Stay foolish.... |
|
|
·|û¡Gjm042310140224 µoªí®É¶¡:2016/3/31 ¤U¤È 04:55:52²Ä 3737 ½g¦^À³
|
¤p¶§¤j ©êºp¡A¤p§ÌÀH¤f»¡»¡¦Ó¤w ¤p§Ì¤£³ßÅwfb¡A¨´¥¼¶}¤á |
|
|
·|û¡G¤p¶§10139627 µoªí®É¶¡:2016/3/31 ¤U¤È 04:49:51²Ä 3736 ½g¦^À³
|
jm0423¤j¤ä«ù§Aªº°µªk¡A¥[ªo¡A¬Ý§A¤F §Ú¤]¨C¤Ñ¥h¥LªºFB¥h°ÝÔ¥L¡A«Ü©úÅã³o®Ú¥»´N¬O¦b¾i®×µM«á¦A¨ÓÓ¬Fªv¯}Ãa |
|
|
·|û¡Gjm042310140224 µoªí®É¶¡:2016/3/31 ¤U¤È 04:43:37²Ä 3735 ½g¦^À³
|
¤p§ÌÀ³¸Ó¥h´¿½P²×fb¶æÁn »¡¤p§Ì¨º¤Ñ¶R¶^°±¡A ¹j¤Ñ´N´X¥Gº¦°± ¤½¥q¤µ¤Ñ§óµo§G«°T ¬O¤º½u¥æ©ö |
|
|
·|û¡Gjm042310140224 µoªí®É¶¡:2016/3/31 ¤U¤È 04:36:30²Ä 3734 ½g¦^À³
|
±ø¤j ¤p§Ì´N¬O·í¤Ñ³Ì¶Ìªº ÁÙ¨S¶^°±´N¶R¡A¶^°±¤]¶R¡A¤H±ó§Ú¨ú ¤°»ò¸¨©³°T¸¹ÁÙ¥¼¥X²{ ÀH«K°Õ¡A¶Ì¤H¦³¶ÌºÖ |
|
|
·|û¡G¬ÝÃlµL10141462 µoªí®É¶¡:2016/3/31 ¤U¤È 04:31:43²Ä 3733 ½g¦^À³
|
±ø¤j .......... Ó¤Hı±o¡A±z¤£¥Î©M¸¨ªº©M§O¤H¤@¼Ëªº®æ½Õ ¡K ¦]¬°±z²{¦bªº¦æ¬°¡A©M«e¨â¤Ñªº¥L¨S¤°»ò¨â¼Ë®@ ^_^ §Ù¤§¡A·V¤§¡A¤¬«j¤§¡C |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2016/3/31 ¤U¤È 04:28:34²Ä 3732 ½g¦^À³
|
³s¨H¤j¦Ñ³£»¡©ú¤Ñ¥i¯à·|º¦°±ªO(©ñ§¬¶)¤F ¦Ó³oÓ¥u¬O"ÁÞ¤k"À¹µÛ±¨ã¥X³õ¦Ó¤w¡A6¤ë¤~·|±N±¨ãºK¤U¡A©¡®É´N·|"ÅF°Ê§öªL¡AÅå°Ê¸UÃÄ" ©ú¤Ñ¬O¥|¤ë¤@¤é·M¤H¸`, ¦pªG©ñ§¬¶¡A¤]¬O§Ú̳o¸sÅó±ø±øªº·M¤Hªº¸`¤é¡An¼y¯¬§r ¦]¬°¥u¦³·M¤H¤~·|Åó±ø±ø¡A¼F®`ªº¤H³£«Ü·|ÁÈ®t»ù¡A ¨Ò¦p³oÓ¬P´Á¦³·í¤Ñ¶}½L½æ¦b°ªÂIªºÁo©ú¤H¡AÁÙ¹ï¨S½æ¦Ó·í¤Ñ¤@«×¶^°±ªº¤H§N¼J¼ö¿Ø¡A¶Ë¤fÅxÆQ ~~ ¨S¿ù¡A§ÚÌ´N¬O³Ì²Âªº¶Ì¤l¡A¤~·|¬Û«H¯Î¦Ñ¡A¤¨¦Ñ¡A±i¸³ªº¸Ü¡A¥Î¹ê»Ú¦æ°Ê¤O®¼¨ì©³ ´N¹³¸ë§B´µ»¡¹Lªº¡ustay hungry stay foolish¡v¡A¶Ì±o«Ü¥i·R§a¡A«¢«¢ |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2016/3/31 ¤U¤È 02:46:14²Ä 3731 ½g¦^À³
|
Ben¤j¡A ÁÂÁ https://www.youtube.com/watch?v=dKvtR57c0wQ 3/31¯E¹©«¤j°T®§°OªÌ·|-udn tv 1:18:10 ±i¸³»¡"§ÚÌ·|§â³oÓ²£«~°µ¦n¡AÅܦ¨¥xÆW¤§¥ú" ®¥³ß¦U¦ì¯E¤ÍWºÉ¥Ì¨Ó¡A¦³¶R¦n¶Rº¡ªº¸Ü§ó·|¦³·Pı «¢«¢¡A±i¸³¤]²×©ó¤£¥Î¦A¸ú¨¾ªÅ¬}¤F(ªÅxŧÀ») ¯E¹©¥[ªo¡A¯E¤Í¥[ªo ~~ |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2016/3/31 ¤U¤È 02:46:14²Ä 3730 ½g¦^À³
|
Ben¤j¡A ÁÂÁ https://www.youtube.com/watch?v=dKvtR57c0wQ 3/31¯E¹©«¤j°T®§°OªÌ·|-udn tv 1:18:10 ±i¸³»¡"§ÚÌ·|§â³oÓ²£«~°µ¦n¡AÅܦ¨¥xÆW¤§¥ú" ®¥³ß¦U¦ì¯E¤ÍWºÉ¥Ì¨Ó¡A¦³¶R¦n¶Rº¡ªº¸Ü§ó·|¦³·Pı «¢«¢¡A±i¸³¤]²×©ó¤£¥Î¦A¸ú¨¾ªÅ¬}¤F(ªÅxŧÀ») ¯E¹©¥[ªo¡A¯E¤Í¥[ªo ~~ |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/3/31 ¤U¤È 02:09:37²Ä 3729 ½g¦^À³
|
¤Ñ©R¤j¡A ¹ï·Ó²Õ¥Îªº¬O cyclophospamide¡A¤£¬O Herceptin¡C¤w¸g¦³¤Ó¦h¤H·d¿ù¤F¡C Herceptin ¥u¹ï HER-2 ªí²{ªÌ¦³®Ä¡A¥u¦û©Ò¦³¨ÅÀù±wªÌªº 23%¡C 822 «ç»ò·|¥u¸ò³oÓÃÄ¨Ó PK¡A©ñ±ó¨ä¥Lªº¥«³õ©O¡H |
|
|
·|û¡GBenjamin10139027 µoªí®É¶¡:2016/3/31 ¤U¤È 02:01:43²Ä 3728 ½g¦^À³
|
Åó±ø±ø¤j¡G ¼ÐÃD¤£¥Î§ó§ï¡A¨SÔ£¤£¦n¡C³o¼ÐÃD§Ú¬Oı±oº¡¦X¾A¡Bº¡¶K¤Áªº¡C ı±o¼ÐÃD¤£¦n¡A¤j¤£¤F¤£n¶i¨Ó¬Ý´N¬O¤F¡Aþ¦³¥s¤H§ï¼ÐÃDªº¹D²z¡H |
|
|
·|û¡GFLYER10133103 µoªí®É¶¡:2016/3/31 ¤U¤È 01:54:50²Ä 3727 ½g¦^À³
|
¦¹®É¯Î°|ªøªº¤ß¹Ò¥²©w¬O¦Ê·P¥æ¶°! §Æ±æ¥L¦bASCOµoªí·|¤W±NÁ{§É¼Æ¾Ú¦¨ªGµ¹µo´§ó¥ú¤j! ¤]½Ð¨º¦ì²z±M¯à®¼¨¦Ó¥X¡A¾Ú¹êÁÙì·í®É«Øij½æªÑªº©l¥½¡C |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2016/3/31 ¤U¤È 01:42:52²Ä 3726 ½g¦^À³
|
¦^À³¼ÐÃD¬O§_§ó§ï¡A¨ä¹ê§ÚÓ¤H¨S¦³·N¨£¡A¦]¬°³o¬OÓ¤½²³°Q½×°Ï¡A ¤j®a¥æ¬y¤À¨É¸ê°T¡AÀò±o§ë¸êª¾ÃÑ»P§PÂ_¯à¤O¡A¥un¯àÀò±o¥¿¦V¦^õX¡A´N¬O³Ì¤jªº·P°Ê ¹³¤µ¤ÑÀò±oASCO Oral presentation¤@¼Ë¡A¤@¦~«eªº5112¡A²{¦b¤Ï¦Óı±o¶V¨Ó¶V¤£¬O¹Ú·Q¤F §Úı±o¦pªGnקï¥i§ï¦¨"¯E¹©»ùÈ»P»ù®æµû¦ô" -->»ùȵû¦ô (¥«³õ©w¦ì¡A¼ç¤O¡AÀò§Q¡AEPS¡Aµû¦ôµu¤¤ªø´Á»ùÈ»P»ù®æ¤ÀªRµ¥¡A¦p¦P¤é²±/²Î¤@¤ÀªR) |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/3/31 ¤U¤È 01:37:13²Ä 3725 ½g¦^À³
|
¤µ¤Ñ´CÅ馳ÃöASCO«ÂI 1¯E¹©¤µ¤Ñ¥¿¦¡«Å¥¬¨ä¨ÅÀù¬Ì]¸Ñª¼½×¤å¡AÀò±o¬ü°ê¸~½FÂå¾Ç¦~·|¡]ASCO¡^±µ¨ü 2¥Î³Ì°ªµ¥¯Åªº¤fÀY³ø§i 3¬ü°êASCO»{¦P¯E¹©ªº¬ãµo¦¨ªG¡A³o±N¬O¯E¹©ªº¤@¤j³Ó§Q 4¨Ì2014¦~²Îp¡A¤fÀY³ø§i½×¤å¶È¦û©Ò¦³§ë½Z½×¤åªº3.8¢H¡C 5ASC½×¤å¦³¤fÀY³ø§i¡BÁ{§É¬ì¾Ç°Q½×¡B¾À³ø°Q½×¡B¾À³ø®i¡B¥Zµn½×¤å´XºØµ¥¯Å¡A¨ä¤¤¡A¤fÀY³ø§iµ¥¯Å³Ì°ª¡C 6®Ú¾Ú¤j·|²Îp¡A¤µ¦~Àù¯g¬ÛÃö½×¤å§ë½Z¼Æ¤w¹F5800¦h½g¡C |
|
|
·|û¡G561910141205 µoªí®É¶¡:2016/3/31 ¤U¤È 12:55:47²Ä 3724 ½g¦^À³
|
°Ñ¥[ASCO¡A Oral Presentation¡A´N¬O»OÆW¤§¥úªìµn³õ¡C °OªÌ·|¤W¡A¨k¤k»aÃǶä¶ä¶ä¡Aµo¨¥ºÉ¬O¦ÃöG½èºÃ¡C±i¸³¤Ó¦³@¤ß¤F¡C«ß®v¦^µª±o¦n¡AªÑ»ù¶^¤£¬O¨CÓ¤H³£¤£°ª¿³¡A·N¦³©Ò«ü¡A¥O»aÃǼȮɵy·²¡C¥ß©eªÅ¤è°OªÌ´CÅé³\¦h¤H³£Âǥѥ´À»¯E¹©¦ÓÀò§Q¡C±i¸³¯Î°|ªø¡A¤Hµ½³Q´Û¡A¬Ý¨Ó¤½¥q»Ýn¥[强¤½Ãö¤õ¤O¡C ´¿¸gÁo©úªº¨H¤j¨Ð¡A½k¨½½k¶î°Ñ»P¥´À»¯E¹©¡A´N¹³·í¦~¤@¸s«C¤Ö¦~°Ñ»P¬õ½Ã§L¥´¯{·m¡C |
|
|
·|û¡G¥ôÄP¤¸10142024 µoªí®É¶¡:2016/3/31 ¤U¤È 12:44:28²Ä 3723 ½g¦^À³
|
¤£½æªÑ¨S¤°»ò.¤j®a¶i¥h·mº¦°±.Åý¥LÌ·Q¶R¶R¤£¨ì.®ð¦º¥LÌ...º¦°±ÂêÓ¨â¸U±i.¦¨¥æ1±i..®ð¦º¨º¨Ç©¿¦h©¿ªÅªº¯Q¾~¼L ¡§®¥³ß¤j®a¡¨«¢«¢ |
|
|
·|û¡GLin10142144 µoªí®É¶¡:2016/3/31 ¤U¤È 12:36:41²Ä 3722 ½g¦^À³
|
¦U¦ì¤j¤j®¥³ß¤µ¦~¥ý¬Ý15xx |
|
|
·|û¡GLIN10137582 µoªí®É¶¡:2016/3/31 ¤U¤È 12:12:05²Ä 3721 ½g¦^À³
|
¶ÀÁ`:³Ì«á¾÷¥G¨S¤H´_µo~«p§À |
|
|
·|û¡G³¯¤Ñ®¦10141363 µoªí®É¶¡:2016/3/31 ¤W¤È 11:53:39²Ä 3720 ½g¦^À³
|
¤j®a§Ô¨ì²{¦b¤F ¤@°_«Å¥Ü ¤£½æªÑ ¹Ç¦ºªÅÀY ¹Ç¦º °Û°I¥xÆW¥Íª«¬ì§Þªº±ÑÃþ |
|
|
·|û¡G´¡ªá¤G10142127 µoªí®É¶¡:2016/3/30 ¤U¤È 11:50:34²Ä 3719 ½g¦^À³
|
¥xÁÞ¤j¡AÁÂÁ±z¡I |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/3/30 ¤U¤È 11:05:15²Ä 3718 ½g¦^À³
|
±ø¤j¡A ¥H¤UÂà¶K¥xÁÞ¤j¦b 822/833 ª©ªº¶K¤å¡G ·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/3/30 ¤U¤È 10:22:41 1 822 833 ¥H¥~ªº²£«~¦]¦³«Ü¦h822 833Ä_¶Q¸ê°T,Cliff¥S °ò¥»±«Ü±j¤S¬O«e½ú,½ÐCliff¥S§â¼ÐÃD»P¤º®e ¼W×ÂX¥R§Y¥i,¥H«á¦³Ãö¤½¥q¬ãµo²£«~ªº°ò¥»±¦U¦ì¤j¤j¶°¤¤¨ì³oª©¤À¨É,¼ÐÃD»Pª©±¤º®eÀ³¥ÑCliff¥S¨M©w 2 ±ø¤j5112ª©¥i·íºî¦Xª©¤è¦V¥Ñ±ø¤j¬É©w 3 ³oÓ·s¶}ª©«Øij§R°£ 4 ¦]¬°¦³¤H»{¬°¦b5112ª© ¶K¤å·|»~¾É§O¤H,©Ò¥H¤~¦³µL®a¥iÂk¤§·P,³o¥y¸Ü³ºµMÅý°ÝÃDÀò±o¸Ñ¨M ,²{¦b¦³®a¥iÂk¤F ¥H¤W«Øij¬O°ò©ó¤ÀÃþ±i¶K Åý¤j®a¤è«K·j´M¸ê°T ÁÂÁ¤j®a ±ø¤j¡A »¡¹ê¸Ü¡A¤p§Ì·|¶}©l¬ã¨s¯E¹©¡AÁÙ¯uªº¬O¦]¬°¬Ý¨ì¤F³oÓ¼ÐÃD (®Ú¥»¨S¬Ý¨ì¾÷²v¬O1%)¡C©Ò¥H¦³¤H»¡³oÓ¼ÐÃD·|»~¾É·s§ë¸ê¤H¡A½T¤]¤£¯à»¡¬OµLªº©ñ¥Ú¡C¤£¹L¦¹ª©¹ï©ó¤½¥q»ùȵû¦ô¥H¤Î§ë¸ê«e´ºµ¥¬ÛÃöijÃD¡A½T¹ê¤]¬O¯E¤Í«õÄ_ªº¦a¤è¡C ¥xÁÞ¤j§Æ±æ¥Ñ±z«·s©w¸q¦¹ª©ªº°Q½×¤è¦V¡A¯E¤ÍÌÀ³¸Ó¤£·|¦³²§Ä³¡C¼ÐÃD»Pª©ÀY¤å³¹¬O¤@¦~«e©wªº¡A¤µ¤Ñªº®ÉªÅ¤U¬O§_n½Õ¾ã§ó·s¡A¤]¬O±z»¡¤Fºâ¡C ´¡ªá¤G¤j¡A ©¹«á ASCO »P§K¬ÌÀøªkªº°ÝÃD¡A«Øij²¾¾r¨ì 822/833 ¨º¤@ª©¥h´£°Ý»P°Q½×¡C¨ºùسo¤è±ªº¬J¦³¸ê®Æ´N«Ü¦h¤F¡C ª©¥D¤j¡A ¤p§Ì¤@¤Ñ§ê¨â¦¸¤^¤¢¡A³oÓ¬ö¿ý©È¬On¦b¥²´Iºô«O«ù³\¤[¤F¡C ³Â·Ðª©¥D¤§³B¡A½T¹ê¤£¦n·N«ä¡C |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/3/30 ¤U¤È 10:56:36²Ä 3717 ½g¦^À³
|
´¡ªá¤G¤j Clinical Cancer Advances 2016: ¤º®e¥Dn¥H2015¦~¬°¥D ( PD-1/PD-L1 immune checkpoint) 2016¦~6¤ë¤~µoªíªº³ø§iÀ³·|¦C¤JClinical Cancer Advances 2017 822¦pªGn¤J¿ïASCO, Clinical Cancer Advances 2016 ¤]¤£¯à³zÅS¸ê°T (¦p¦P»¡¥X¼Æ¾Ú ´N¶iµLªk¤J¿ïASCO½×¤åµoªí¤@¼Ë ) ¤£¹L¤U±¦³¤@¬q½×z»¡¥XÀù¯gÃĪºÄ@´º: ³o¬OOBI 822ªºÀu¶Õ §K¬ÌÀøªk¯à§ó«ù¤[±±¨îÀù¯g(OS),¤ñ¶Ç²Î¤ÆÀøÃÄ,¼Ð¹vÃÄÅý¬Y¨Ç¯f±w§ó®e©ö§Ô¨ü, ¤U¤@Ó¬D¾Ô¬OÂX±i§K¬ÌÀøªk¹ï²³¦hÀù¯g¯f±wªº§Q¯q Increasingly, we¡¦re seeing that immunotherapy is able to control cancer growth longer, and may be easier for some patients to tolerate than traditional chemotherapies and targeted drugs, said Clinical Cancer Advances 2016 Co-Executive Editor Don S. Dizon, MD, FACP. The next challenge is to expand the benefits of immunotherapy to more people with cancer. |
|
|
·|û¡G¼ï¤¤Áú10141277 µoªí®É¶¡:2016/3/30 ¤U¤È 08:38:55²Ä 3716 ½g¦^À³
|
´¡ªá¤j¡A·PÁ¡I¡I ©³¤U¯d¨¥¤]«Üºë±m¡C·P®¦¦A·P®¦¡I¡I |
|
|
·|û¡G©`¦Ì¤p¤k¤l10141142 µoªí®É¶¡:2016/3/30 ¤U¤È 06:56:37²Ä 3715 ½g¦^À³
|
´¡ªá¤G¤j: ÁÂÁ±z.³o¦ìCEO¼gªº¦n!§Ú¤×¨ä»{¦P¤å³¹³Ì«á¤@¬q. |
|
|
·|û¡G´¡ªá¤G10142127 µoªí®É¶¡:2016/3/30 ¤U¤È 05:40:35²Ä 3714 ½g¦^À³
|
talk.ltn.com.tw/article/paper/973613 |
|
|
·|û¡Gªø¦¿11¸¹10136804 µoªí®É¶¡:2016/3/30 ¤U¤È 05:12:10²Ä 3713 ½g¦^À³
|
«Øij¤j®a¥´¹q¸Üµ¹¤½¥qªí¹F¤ä«ù¨ìasco,¤@ªÃªì°J,°í«ù¨ì©³,¤d¸U§O¦A¥Ç¤F¤÷¤lÃMÆj¦¡ªº¿ù»~,§_«h¨Ì¥xÆW³o¸s¦aµl¬yª],©w¤S¨£Á_´¡°w,¤S¤£ª¾¹D·d¥X¤°»ò·¼É. è¬Ý·s»D¶]°¨¿O»¡¯Î°|ªø¤w½ÐÃ㤤¬ã°|ªø¤@¾,¥E¬Ý¤§¤U«Ü¾_Åå,¦ýÂà©À¤@·Q,¦b¥Ø«e¥xÆWªºß¼Lªv°ê,·°Å骺¥¼¼f¥ý§Pªºª^³ò¤U,³oÓ°|ªøªºÂ¾°È¤S¦³Ô£¥i¯dÅʪº,½ÐÃ㨬¥H»¡©ú¯Îªº¤£ÅÊ´Ì,¤£¦b¥G³oÓ¾¦ì,²{¦b§Ú¤w¸g¤£¦b¨ä¦ì¤F,¬Ý§A̦A®³¤°»ò¨Ó§ðÀ»?!¥u¬O§óı±o¥xÆW·U¨Ó·U¨S±Ï¤F,¦n¤H¤~³£¤£Ä@¬°°ê®a¥I¥X¤F!ü~~~~~~ |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2016/3/30 ¤U¤È 04:22:46²Ä 3712 ½g¦^À³
|
·PÁ¤ѩR¤j´£¨Ñªº¸ê°T~ |
|
|
·|û¡G´¡ªá¤G10142127 µoªí®É¶¡:2016/3/30 ¤U¤È 04:10:07²Ä 3711 ½g¦^À³
|
¥xÁÞ¤j«e½ú¡G www.asco.org/advocacy/asco-names-cancer-advance-year ³o½g¤å³¹±z¬Ý¹L¶Ü¡H ¥H¦¹¥i¥H·PıASCO·|±µ¨ü¡A¹ï¶Ü¡H |
|
|
·|û¡Gvivilove0510142197 µoªí®É¶¡:2016/3/30 ¤U¤È 03:50:45²Ä 3710 ½g¦^À³
|
À³¬O³oÓ®ø®§³y¦¨ªº§a....¤j®a©ãÄ_..§Æ±æ¥i¥H³Q±µ¨ü....ªüÀ±ªû¦ò.... ¯E¹©¦b¬Q¤Ñ«®À¶^°±¤§«á¡A¥Ñ©ó©ú¤Ñ±N½T©wOBI-822Á{§É¼Æ¾Ú»¼¥ó¥Ó½Ð¬ü°ê¸~½FÂå¾Ç¦~·|(ASCO2016)½×¤åµoªí¬O§_³Q±µ¨ü¡A¤µ¤ÑÀ£Ä_¶R½L¶i³õ¡AªÑ»ù¤@«×½Ä¨ì394¤¸¡Aº¦´T¹F9.44%¡C ¦ý´¿¥ß©e...¤@ª½°l¥´...¦³ÂI¤£¹D¸q ¡mª÷¿Ä¡nÄò°l¯E¹©®×¡A´¿»Ê©v¡G¤£¬O²¾°e´N¨S¨Æ 2016/03/30 10:39 ®É³ø¸ê°T ¡i®É³ø-¥x¥_¹q¡j¯E¹©®×¤SÅåÃz¤º¹õ¡A¥ß©e´¿»Ê©v¤µ¤é¦b°]©e·|Äò°l¡C´¿»Ê©vºò°lª÷ºÞ·|¬O§_ª¾¾å¯Î±Ò´f¤k¨à¯Î§Öq¦b¸Ñª¼«e½æªÑ¬O¥Î½Öªº¦W¸q¡B½Ö¥æ©öªº¡Aª÷ºÞ·|¥D©e¤ýÄ׬ªí¥Ü¬ÛÃö¸ê®Æ¤w²¾°eÀ˽աA¥B¯A¤ÎӸꤣ«K³zÅS¡C ¡@´¿»Ê©v±j½Õ¡G³o¬O¹D¼w¼h¦¸¡Bªk«ß°ÝÃD¡A¡u¤£¬O²¾°eÀ˽աBª÷ºÞ·|´N¨S¨Æ¡C¡v¥L»{¬°ª÷ºÞ·|¬O¸ê¥»¥«³õ¥DºÞ¾÷Ãö¡An±½°£¥«³õ¤º½u¥æ©ö¤§·¡A¤~¯àÅý¥Í§Þ²£·~¬Æ¦Ü¨ä¥L²£·~¦³§ó¤jªºµo®i¡C ¡@´¿»Ê©vª½«ü¡A¯E¹© (4174) ¸Ñª¼¥¢±Ñ«á¤º³¡¦³¶}·|¦]À³¡AY¬O·|ij¤º®e¦³¯A¤Î¹ï¥~Á¿ªk¡B¥ø¹Ï¼vÅTªÑ»ù¡A¨º´N¬O¹H¤ÏÃÒ¥æªk155±ø¡A³o¤£¬O¤U¥x´N¯à¸Ñ¨Mªº¡C ¡@¥ßªk°|¤µ¤é¼f¬dÃÒ¥æªk¼Wq²Ä14±ø¤§7¡A°Q½×¤W¥«Âd¤½¥q¬O§_n³]¸m³Ò¤u¸³¨Æ¡C·|«e¤ýÄ׬±µ¨ü±Ä³X®É«ü¥X¡A¯E¹©®×¤w²¾°eÀ˽աA¥þ®×·|ÅýÀ˽սլd«á¦AÂç²M¡Aª÷ºÞ·|²{¦b°µªº¬O¹ï¥Í§ÞªÑ²{¦bªº¾÷¨î§@ÀË°Q¡A¦p¦ó°µ¦n§ë¸ê¤H«OÅ@¡A¤w³d¦¨±M®×¿ì²z¡C¦oªí¥Ü¡A¤jªÑªF¥X¦b¸Ñª¼«e¥X²æªÑ²¼¡u·íµM¤£OK¡v¡A¦ý¤]nÂç²M¬O§_¬O¨Æ¹ê¡An¦³¬ÛÃöÃÒ¾Ú¡Aª÷ºÞ·|¤]¤£§Æ±æ¼vÅT¥Í§ÞªÑªºµo®i¡C(·s»D¨Ó·½¡G¤u°Ó§Y®É ÃQ³ì©É) |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/3/30 ¤U¤È 03:47:34²Ä 3709 ½g¦^À³
|
¹x¥Û¤j 999¤j 1ª©°÷¥Î´N¦n,«ÂI¬O¤H,¦p¦P³\¦h¤j¤j¤@¼Ë«Ü»{¯u¤À¨ÉÄ_¶Q¸ê°T,³o¤~¬O³Ì«nªº, ¨CÓ¤H³£¯à¿E°_¼ö±¡ºÉ¤O¥h§ä¸ê°T¨Ó¤À¨É,´Nºâ¬O¤@«h¤p¤pªº¤À¨É¤]·|¥O¤H·P°Ê³\¤[, 2¥²´Iºô¨CÓ¤À¨ÉªÌ³£¬O¤W¤Ñ¬£¨Óªº,¦³¨ä¯«¸tªº¾ú¥v¥ô°È,n·í¥¼¨Ó¥þ²yÀù¯g§K¬ÌÀøªk»â¯èªº¥xÆW¤§¨£ÃÒªÌ |
|
|
·|û¡G¥¤ß¦Ó½×10139639 µoªí®É¶¡:2016/3/30 ¤U¤È 03:39:20²Ä 3708 ½g¦^À³
|
¥¬¤j¡A ¡y¿ù¦ô±¡¶Õ¡z¬O«ü¸Ñª¼«á¨S¤½§G¼Æ¾Ú¦Ó¤@¸ô¾D»~·| ¥xÆW§ë¸ê¤H¤]³£¨S¸gÅç¡Aº¦¤W¥h¸Ñª¼¨S¹L´N»¡ª£§@¡A¤½¥q¤]¤£·Qn§r¡A¦]¬°nASCO,©Ò¥HµLªk®³¥X¼Æ¾ÚÅG¸Ñ¦Ó¥u¯à®Á¥´¡A©Ò¥H¦pªG¯uªº¨ì³Q¹Gn´£¨ÑÃÒ¾Ú¡A´N¥u¯à©ñ±óASCO,§Úı±o³o«Ü¤£§´¡AÅ¥¤F¥x¤jÁ{§ÉÂå®v»¡¡AASCO¦p¦PÀùÃĪº³Á¥[¸t¦a¡A©Ò¥HµL½×¦p¦ó¤@©wn°Ñ¥[ Åý¥þ²y²Ä¤@ÓÁÞ¤À¤lÃĪ«·P°Ê¥þ¥@¬É |
|
|
·|û¡G¤ß»·¦a¦Û°¾10141241 µoªí®É¶¡:2016/3/30 ¤U¤È 02:57:42²Ä 3707 ½g¦^À³
|
ªº½T¬O ³o°}¤l¤½¥q¨ü¨ì³o»ò¦hªº§ðÀ» ¤£´N¬O¦]¬°n¥hASCO¦ÓµLªk¤½¥¬¼Æ¾Ú, ¤~¨Ï¦³¤ß¤H¦³¤å³¹¥i°µ ¨º²{¦b¦pªG¤S¦Ò¼{n¤½¥¬ªº¸Ü ¨º³o°}¤lªº··«B«B¤S¨ì©³ºâ¬Æ»ò ³£¤w¸g¨«¨ì³o¤@¨B¤F ¨S¹D²zn§ïÅܧ@ªk§a «e¶iASCO Åý¥@¬É¬Ý¨ì¤~¬O³Ì«nªº§a |
|
|
·|û¡GRock10135634 µoªí®É¶¡:2016/3/30 ¤U¤È 02:49:06²Ä 3706 ½g¦^À³
|
¥¤ß¤j ·PÁ¤À¨É§Y®É°T®§ ¯uªº¥¤ß¦Ó½×¡A½Ö¦³¿ìªkÁpô¤½¥q°ª¼h©Î¤j®a¤@¤H¤@¹q¹L¥h ²´¥ú©ñ»·¡A½Ð¤½¥q§O¦]¬°¥xÆW²³¦hªºµLª¾¡A©ñ±ó¤@Ó«e¶i¥@¬Éªº¤j¦n¾÷·| ¤½¥q¦pªG¸Û«H°÷°ª¡A´NÀ³¸Ó«e¶iASCO(¦pªG³qª¾»P·|µoªíªº¸Ü) ¦Ó¤£¬O¬°¤F¥xÆW¤@°ï¨S¸£ªº¤H°µ¤£¸Ó°µªº¨Æ |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2016/3/30 ¤U¤È 02:40:10²Ä 3705 ½g¦^À³
|
¦A¦¸·PÁÂ¥¤ß¤j ¨C·íªÑ²¼¤U®À ¤p§Ì´N·|¦b²âÅ¥¤@¦¸ªk»¡¤º®e ¦ý¤@ª½·P¨ì¯Ç´eªº¬O ¶ÀÁ`¦bªk»¡·|¤W´£¨ì ¦bASCO«á«Ü¦hDATA PFS¬O¦³®Äªº ¬OCR §P©w? or ... ¤@ª½²q¤£³z ¦ý³oÂI¤]¬O¤ä«ù§ÚÄò©ê¯E¹©ªº¥D¦]! |
|
|
·|û¡Gander8110139526 µoªí®É¶¡:2016/3/30 ¤U¤È 02:26:54²Ä 3704 ½g¦^À³
|
¥¤ß¤j ÁÂÁ§AÄ_¶Qªº¸ê°T §A´£¨ì±i¸³¦^µª¡G¡u¥Îos,®É¶¡n¦h2¦~¡Asample size¤]n¦h«Ü¦h¡A¥t¥~os¤]¦³¯ÊÂI¡Apd«á±wªÌ·|¤£·|±Ä¨ú¨ä¥LÀøªk¦Ó¼vÅTos¤]¬O¦³¥i¯à¡v©Ò¥H³o¥i¥H¸ÑÄÀ³¡¥÷¯E¤ÍªººÃ°Ý¡A´N¬OÀ³¸Ó¦³¥i¯àª¾¹DPFS¥i¯à¤£¹F¼Ð¡A¦Ó¬°¦ó¨S¦³§ó§ïªºì¦]¡A ©h¥B¤£½×¦³¨S¦³¿ìªk§ïµû¦ô«ü¼Ð¡A¤½¥q¤]´¿¸g»¡2009¦~¨º®Én©Û¦¬¸ÕÅç¯f±w«ÜÃø¡A¦Ó¥B¦A©ì2¦~¡A¦pªG»Ýn§@¥þ²y3´Áªº¸ÕÅç¡A¤£½×³W¼Ò¤j¤p¡A¤]n©µ2¦~¡A¹ï«áÄò833µ¥ÃĪ«ªº®Éµ{¤]·|¦³¼vÅT¡A¤]³\¦]¬°³o¼Ë¡A©Ò¥HÀ³µÛÀY¥Ö¸Ñª¼¡C ¦Ó¥B«ÂI¬O¡A¥xÆW¯uªºÀ´Àù¯g§K¬ÌÀøªk¡AÀ´¥¦ªº¯S©Ê¡AÀ´¥¦¸Ó¦³ªºµû¦ô«ü¼Ðªº¤H¤Ó¤Ö¤F¡C ¯E¹©À³¸Ó§l¦¬¦¹¦¸±Ð°V¡A¦h¦h±Ð¨|°ê¤ºªº±M®a¡Bß¼L¡B©§±D¡B§ë¸ê¤H¡A¬Æ»ò¬O¥D°Ê§K¬ÌÀøªk¡A¯S©Ê¬O¤°»ò¡AÁ¿²M·¡¡B»¡©ú¥Õ¡C |
|
|
·|û¡G99910140657 µoªí®É¶¡:2016/3/30 ¤U¤È 02:02:47²Ä 3703 ½g¦^À³
|
¸ô»»ª¾°¨¤O¡A¤é¤[¨£¤H¤ß... ¨¸Å]¥~¹DªºªÅ¶¡«D¨Ó¦Û¯à...¦Ó¬O¨Ó¦Û¥Õ¹D¤¤¤HºD©ó¦Û±½ªù«e³·©Ò½ç©óªºªÅ¶¡¡C ¦]¬°¥Õ¹D¡A½Ã¹D¤§¤h¤H¤Hªº×¬°¬O´L«¡A´L«¡A¦A´L«¡C ¥xÁަѮv©R¦W¶}ª©§a¡I ¬°¦Û¤v¬°ª©¤W¥½¶i»P¥¼¨Óªº«á¶i½Ð©R©ó±z¡C ¦Ñ®v¶}ª©§a¡I ¥M®a¤÷¤§¶Õ¤£±¡¤§½Ð¡A½Ð¼e®¤¡CÁÂÁ±z¡C |
|
|
·|û¡G¥m¾´10141821 µoªí®É¶¡:2016/3/30 ¤U¤È 01:28:47²Ä 3702 ½g¦^À³
|
¥¤ß¤j±z¨¯W¤F |
|
|
·|û¡G99910140657 µoªí®É¶¡:2016/3/30 ¤U¤È 01:21:08²Ä 3701 ½g¦^À³
|
¥xÁަѮv¡G °ê¤§±N¤`¡A§¯Å]°©Ç¥|³Bâh... ¥¿¹D¤£¥X...¨¸¹D¤£·À... °ê®a¿³°I¡A¤Ç¤Ò¦³³d... ¬°¦Û¤v¡A¬°°ê®a¡A¬°¤l¤k...... Àµ¬ß¡A¬è½Ð±z¶}ª©§a¡I 20¦~¤~è¶}©l...«á±ÁÙ¦³833/834/868/888 ÁÙ¦³¨ä¥L...³£§ó»Ýn±z±Ð¾É»P´£¿ô... ¬Û«H²{¦b¦b¦¹ª©½Ñ¦h«e½ú¤j¤j³£¤w«D±`²M·¡¯E¹©===¬O«e¶i¤FÁÙ¬O¸¨«á¤F¡H ¯E¹©¬O§ó½T©w¯àªø§ë¡H ©Î¬O¤´¬O»¨½ä¡H¡H¡H ¦Ñ®v¶}ª©§a¡I ±Ï¥@´N¥Ñ±z¶}©l§a¡I ¦b¦¹ª©¥¿¸q¤§®v¡A^¤~ÀÙÀÙ¦ý¸sÀsµLº¤´¤£¼Ä...... ·O´dY±z¡AµÐÂÄY±z... ©R¦W¶}ª©§a¡I ·P®¦¡C |
|
|
|